,index,INDEX,Trial name,Drug Name,Indication(s),Drug Class,Year FDA,Approval,Uniprot,EntryName,Gene,Target class,Target_novelty,Status,LigandType,Subfamily,Class
0,0,543,crf-1 antagonist,561679,Anti-depressant,small molecule,-,-,P34998,crfr1_human,CRHR1,GPCR;Secretin,not established,in trial,Peptide ,Corticotropin-releasing factor receptors,Class B1 (Secretin)
1,1,10,"768974, parathyroid hormone analog",768974,Anti-osteoporotic agent,small molecule,-,-,Q03431,pth1r_human,PTH1R,GPCR;Secretin,established,in trial,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
2,2,19,"abarelix, plenaxis",abarelix,Antineoplastic agent,peptide,2003,2003,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,in trial,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
3,3,29,"ac-100,dentonin","ac-100,dentonin",dental ossificant,peptide,-,-,P34995,pe2r1_human,PTGER1,GPCR;Rhodopsin,established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
4,4,29,"ac-100,dentonin","ac-100,dentonin",periodontal ossificant,peptide,-,-,P43116,pe2r2_human,PTGER2,GPCR;Rhodopsin,established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
5,5,29,"ac-100,dentonin","ac-100,dentonin",periodontal ossificant,peptide,-,-,P43115,pe2r3_human,PTGER3,GPCR;Rhodopsin,established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
6,6,29,"ac-100,dentonin","ac-100,dentonin",periodontal ossificant,peptide,-,-,P35408,pe2r4_human,PTGER4,GPCR;Rhodopsin,established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
7,7,34,"acamprosate,campral",acamprosate,Antineoplastic agent,small molecule,2004,2004,P41594,grm5_human,GRM5,GPCR;Glutamate,established,approved,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
8,8,NRDD001,-,acebutolol,Antihypertensive agent,small molecule,1984,1984,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
9,9,NRDD003,-,aceprometazine,Hypnotics and Sedatives,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
10,10,NRDD006,-,acetophenazine,Antipsychotic agent,small molecule,1961,1961,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
11,11,NRDD006,-,acetophenazine,Antipsychotic agent,small molecule,1961,1961,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
12,12,44,aclidinium,aclidinium,Bronchodilator agent,small molecule,2012,2012,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
13,13,44,aclidinium,aclidinium,Bronchodilator agent,small molecule,2012,2012,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
14,14,44,aclidinium,aclidinium,Bronchodilator agent,small molecule,2012,2012,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
15,15,44,aclidinium,aclidinium,Bronchodilator agent,small molecule,2012,2012,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
16,16,44,aclidinium,aclidinium,Bronchodilator agent,small molecule,2012,2012,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
17,17,MMAmay2016_0039,aclidinium bromide + formoterol fumarate,aclidinium,Bronchodilator agent; COPD,small molecule,2012,2012,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
18,18,MMAmay2016_0040,aclidinium bromide + formoterol fumarate,aclidinium,Bronchodilator agent; COPD,small molecule,2012,2012,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
19,19,MMAmay2016_0041,aclidinium bromide + formoterol fumarate,aclidinium,Bronchodilator agent; COPD,small molecule,2012,2012,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
20,20,MMAmay2016_0042,aclidinium bromide + formoterol fumarate,aclidinium,Bronchodilator agent; COPD,small molecule,2012,2012,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
21,21,MMAmay2016_0043,aclidinium bromide + formoterol fumarate,aclidinium,Bronchodilator agent; COPD,small molecule,2012,2012,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
22,22,47,acp-104,acp-104,Antipsychotic agent,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
23,23,47,acp-104,acp-104,Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
24,24,47,acp-104,acp-104,Antipsychotic agent,small molecule,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
25,25,47,acp-104,acp-104,Antipsychotic agent,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
26,26,MMAmay2016_0747,selixipag,act-333679,Antihypertensive agent; treat pulmonary arterial hypertension,small molecule,-,2015,P43119,pi2r_human,PTGIR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
27,27,2267,"adenogesic, adenosine (intravenous)",adenosine,Analgesics;postoperative pain,small molecule,1989,1989,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,approved,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
28,28,2267,"adenogesic, adenosine (intravenous)",adenosine,Analgesics;postoperative pain,small molecule,1989,1989,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,approved,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
29,29,2267,"adenogesic, adenosine (intravenous)",adenosine,Analgesics;postoperative pain,small molecule,1989,1989,P29275,aa2br_human,ADORA2B,GPCR;Rhodopsin,established,approved,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
30,30,2267,"adenogesic, adenosine (intravenous)",adenosine,Analgesics;postoperative pain,small molecule,1989,1989,P0DMS8,aa3r_human,ADORA3,GPCR;Rhodopsin,established,approved,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
31,31,55,adl5747,adl5747,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
32,32,56,"adl5859, pf-04856880",adl5859,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
33,33,57,adl5945,adl5945,motilitant,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
34,34,58,adl7445,adl7445,motilitant,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
35,35,62,adx10059,adx10059,Anti-migraine Agents; for treatment of gastroesophageal reflux disease,small molecule,-,-,P41594,grm5_human,GRM5,GPCR;Glutamate,established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
36,36,63,adx415,adx415,Antihypertensive agent,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
37,37,2472,adx-48621,adx-48621,Antiparkinson agents,small molecule,-,-,P41594,grm5_human,GRM5,GPCR;Glutamate,established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
38,38,64,adx-71149,adx-71149,Antipsychotic agent; Anti-depressant; anxiolytic,small molecule,-,-,Q14416,grm2_human,GRM2,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
39,39,MMAmay2016_0243,adx71441,adx71441,for treatment of neurologic disorders,small molecule,-,-,Q9UBS5,gabr1_human,GABBR1,GPCR;Glutamate,established,in trial,Amino acid ,GABAB receptors,Class C (Glutamate) 
40,40,MMAmay2016_0244,adx71441,adx71441,for treatment of neurologic disorders,small molecule,-,-,O75899,gabr2_human,GABBR2,GPCR;Glutamate,established,in trial,Amino acid ,GABAB receptors,Class C (Glutamate) 
41,41,73,afamelanotide,afamelanotide,dermatological agent,small molecule,-,-,Q01726,mshr_human,MC1R,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
42,42,85,agn-214868,agn-214868,Analgesics; neuralgia,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
43,43,85,agn-214868,agn-214868,Analgesics; neuralgia,small molecule,-,-,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
44,44,85,agn-214868,agn-214868,Analgesics; neuralgia,small molecule,-,-,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
45,45,85,agn-214868,agn-214868,Analgesics; neuralgia,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
46,46,85,agn-214868,agn-214868,Analgesics; neuralgia,small molecule,-,-,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
47,47,85,agn-214868,agn-214868,Analgesics; neuralgia,small molecule,-,-,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
48,48,86,"agomelatine , ago178c, s-20098,valdoxan, thymanax",agomelatine,Anti-depressant,small molecule,-,-,P49286,mtr1b_human,MTNR1B,GPCR;Rhodopsin,established,in trial,Melatonin ,Melatonin,Class A (Rhodopsin)
49,49,87,"agomelatine, ago178c, s-20098,valdoxan, thymanax",agomelatine,Anti-depressant,small molecule,-,-,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
50,50,87,"agomelatine, ago178c, s-20098,valdoxan, thymanax",agomelatine,Anti-depressant,small molecule,-,-,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
51,51,87,"agomelatine, ago178c, s-20098,valdoxan, thymanax",agomelatine,Anti-depressant,small molecule,-,-,P48039,mtr1a_human,MTNR1A,GPCR;Rhodopsin,established,in trial,Melatonin ,Melatonin,Class A (Rhodopsin)
52,52,92,aiko-150,aiko-150,opioid antagonist,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
53,53,2361,"ip 751, ct-3",ajulemic acid,Analgesics;neuropathic pain,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
54,54,2361,"ip 751, ct-3",ajulemic acid,Analgesics;neuropathic pain,small molecule,-,-,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
55,55,MMA2016_0031,resunab,ajulemic acid,Anti-inflammatory agent; systemic schlerosis,small molecule,-,-,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
56,56,96,"akl-0707, ghrh analog",akl-0707,hormone replacement,small molecule,-,-,Q02643,ghrhr_human,GHRH,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
57,57,MMA2016_0028,akp-11,akp-11,psoriasis,small molecule,-,-,P21453,s1pr1_human,S1PR1,GPCR;Rhodopsin,established,in trial,Lipid ,Lysophospholipid (S1P) receptors,Class A (Rhodopsin)
58,58,100,alb-127158(a),alb-127158(a),Anti-obesity agent,small molecule,-,-,Q01726,mshr_human,MC1R,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
59,59,101,"albiglutide, gsk716155,syncria",albiglutide,Antidiabetic,protein,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
60,60,NRDD011,-,alcaftadine,Anti-Allergic Agents,small molecule,2010,2010,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
61,61,NRDD015,-,alfentanil,Analgesics; Opioid,small molecule,1986,1986,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
62,62,MMAmay2016_0108,"ox51,  sublingual alfentanil",alfentanil,Analgesics; Opioid,small molecule,1986,1986,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
63,63,107,"alfuzosin,uroxatral",alfuzosin,for treatment of benign prostatic hyperplasia,small molecule,2003,2003,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
64,64,107,"alfuzosin,uroxatral",alfuzosin,for treatment of benign prostatic hyperplasia,small molecule,2003,2003,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
65,65,107,"alfuzosin,uroxatral",alfuzosin,for treatment of benign prostatic hyperplasia,small molecule,2003,2003,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
66,66,115,alks 29,alks 33,for treatment of alcohol dependance; Anti-depressant,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
67,67,115,alks 29,alks 33,for treatment of alcohol dependance; Anti-depressant,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
68,68,115,alks 29,alks 33,for treatment of alcohol dependance; Anti-depressant,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
69,69,116,alks 33,alks 33,for treatment of alcohol dependance; Anti-depressant,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
70,70,116,alks 33,alks 33,for treatment of alcohol dependance; Anti-depressant,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
71,71,116,alks 33,alks 33,for treatment of alcohol dependance; Anti-depressant,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
72,72,118,alks 5461,alks 33,for treatment of alcohol dependance; Anti-depressant,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
73,73,118,alks 5461,alks 33,for treatment of alcohol dependance; Anti-depressant,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
74,74,118,alks 5461,alks 33,for treatment of alcohol dependance; Anti-depressant,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
75,75,MMAmay2016_0184,"alks 3831,  olanzapine + alks 33,samidorphan","alks 33, samidorphan",Anti-obesity agent; for antipsychotic-related metabolic weight gain,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
76,76,MMAmay2016_0184,"alks 3831,  olanzapine + alks 33,samidorphan","alks 33, samidorphan",Anti-obesity agent; for antipsychotic-related metabolic weight gain,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
77,77,MMAmay2016_0184,"alks 3831,  olanzapine + alks 33,samidorphan","alks 33, samidorphan",Anti-obesity agent; for antipsychotic-related metabolic weight gain,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
78,78,117,alks 37,alks 37,motilitant,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
79,79,117,alks 37,alks 37,motilitant,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
80,80,117,alks 37,alks 37,motilitant,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
81,81,119,"almorexant, act-078573",almorexant,sleep disorder treatment ,small molecule,-,-,O43613,ox1r_human,HCRTR1,GPCR;Rhodopsin,established,in trial,Peptide ,Orexin receptors,Class A (Rhodopsin)
82,82,119,"almorexant, act-078573",almorexant,sleep disorder treatment ,small molecule,-,-,O43614,ox2r_human,HCRTR2,GPCR;Rhodopsin,established,in trial,Peptide ,Orexin receptors,Class A (Rhodopsin)
83,83,120,"almotriptan,axert, almogran, amignul",almotriptan,Anti-migraine Agents,small molecule,2001,2001,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
84,84,120,"almotriptan,axert, almogran, amignul",almotriptan,Anti-migraine Agents,small molecule,2001,2001,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
85,85,NRDD019,-,alprenolol,Anti-Arrhythmia Agents; Antihypertensive agent,small molecule,-,-,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
86,86,NRDD019,-,alprenolol,Anti-Arrhythmia Agents; Antihypertensive agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
87,87,128,"alprostadil,alista",alprostadil,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,small molecule,1981,1981,P34995,pe2r1_human,PTGER1,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
88,88,128,"alprostadil,alista",alprostadil,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,small molecule,1981,1981,P43116,pe2r2_human,PTGER2,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
89,89,129,"alprostadil,femprox",alprostadil,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,small molecule,1981,1981,P34995,pe2r1_human,PTGER1,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
90,90,129,"alprostadil,femprox",alprostadil,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,small molecule,1981,1981,P43116,pe2r2_human,PTGER2,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
91,91,130,"alprostadil,topiglan",alprostadil,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,small molecule,1981,1981,P34995,pe2r1_human,PTGER1,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
92,92,130,"alprostadil,topiglan",alprostadil,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,small molecule,1981,1981,P43116,pe2r2_human,PTGER2,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
93,93,MMAapril2016_0157,"rayva, alprostadil + ddaip.hcl",alprostadil,for treatment of Raynaud's Disease,small molecule,1981,1981,P34995,pe2r1_human,PTGER1,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
94,94,MMAapril2016_0158,"rayva, alprostadil + ddaip.hcl",alprostadil,for treatment of Raynaud's Disease,small molecule,1981,1981,P43116,pe2r2_human,PTGER2,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
95,95,2039,"topical alprostadil cream,alprox-td, befar, vitaros",alprostadil,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,small molecule,1981,1981,P34995,pe2r1_human,PTGER1,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
96,96,2039,"topical alprostadil cream,alprox-td, befar, vitaros",alprostadil,for treatment of erectile dysfunction; for treatment of sexual dysfunction in women,small molecule,1981,1981,P43116,pe2r2_human,PTGER2,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
97,97,NRDD021,-,alvimopan,Opiate Antagonists,small molecule,2008,2008,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
98,98,2549,entereg,alvimopan,for treatment of opioid-induced bowel dysfunction,small molecule,2008,2008,P35372,oprm_human,MOR,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
99,99,MMAmay2016_0267,"alx- 0651, biparatopic nanobody","alx- 0651, biparatopic nanobody",Antineoplastic agent,antibody,-,-,P61073,cxcr4_human,CXCR4,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
100,100,1646,preos,alx1-11,Anti-osteoporotic agent,protein,-,-,Q03431,pth1r_human,PTH1R,GPCR;Secretin,established,in trial,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
101,101,1646,preos,alx1-11,Anti-osteoporotic agent,protein,-,-,P49190,pth2r_human,PTH2R,GPCR;Secretin,established,in trial,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
102,102,MMAmar2016_0116,am1030,am1030,Anti-inflammatory agent; atopic dermatitis,small molecule,-,-,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
103,103,144,am-152,am-152,Anti-inflammatory agent; antifibrotic agent,small molecule,-,-,Q92633,lpar1_human,LPAR1,GPCR;Rhodopsin,not established,in trial,Lipid ,Lysophospholipid (LPA) receptors,Class A (Rhodopsin)
104,104,145,am-211,am-211,Anti-inflammatory agent; antiallergy agent,small molecule,-,-,Q9Y5Y4,gpr44_human,GPR44,GPCR;Rhodopsin,not established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
105,105,146,am-461,am-461,Anti-inflammatory agent,small molecule,-,-,Q13258,pd2r_human,PTGDR,GPCR;Rhodopsin,not established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
106,106,MMAmay2016_0047,am-831,am-831,Antipsychotic agent; schizophrenia,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
107,107,MMAmay2016_0048,am-831,am-831,Antipsychotic agent; schizophrenia,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
108,108,MMAmay2016_0049,am-831,am-831,Antipsychotic agent; schizophrenia,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
109,109,MMAmay2016_0242,"ads-5102, amantadine hcl extended release",amantadine hcl, for levodopa-induced dyskinesia,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
110,110,148,amap102,amap102,Anti-inflammatory agent; DMARD,small molecule,-,-,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
111,111,148,amap102,amap102,Anti-inflammatory agent; DMARD,small molecule,-,-,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
112,112,1111,letairis,ambrisentan,Antihypertensive agent,small molecule,2007,2007,P25101,ednra_human,EDNRA,GPCR;Rhodopsin,established,approved,Peptide ,Endothelin receptors,Class A (Rhodopsin)
113,113,1111,letairis,ambrisentan,Antihypertensive agent,small molecule,2007,2007,P24530,ednrb_human,EDNRB,GPCR;Rhodopsin,established,approved,Peptide ,Endothelin receptors,Class A (Rhodopsin)
114,114,150,amd-070,amd-070,antiviral agent; HIV,small molecule,-,-,P61073,cxcr4_human,CXCR4,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
115,115,MMAapril2016_0116,amg 334,amg 334,Anti-migraine Agents,antibody,-,-,Q16602,calrl_human,CALCRL,GPCR;Secretin,not established,in trial,Peptide ,Calcitonin receptors,Class B1 (Secretin)
116,116,158,"amibegron, sr 58611",amibegron,Anti-depressant,small molecule,-,-,P13945,adrb3_human,ADRB3,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
117,117,160,"amiodarone hcl,amio-aqueous iv",amiodarone,Anti-Arrhythmia Agents,small molecule,1985,1985,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
118,118,160,"amiodarone hcl,amio-aqueous iv",amiodarone,Anti-Arrhythmia Agents,small molecule,1985,1985,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
119,119,161,"amisulpride,solian",amisulpride,Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
120,120,161,"amisulpride,solian",amisulpride,Antipsychotic agent,small molecule,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
121,121,MMAmay2016_0704,apd403,amisulpride,Antiemetics; chemotherapy induced nausea and vomiting,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
122,122,MMAmay2016_0705,apd403,amisulpride,Antiemetics; chemotherapy induced nausea and vomiting,small molecule,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
123,123,1491,oms-103hp,amitriptyline,Analgesics,small molecule,1961,1961,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
124,124,413,"c105, levo-amphetamine sulfate",amphetamine,for treatment of cognitive dysfunction; for treatment of ADHD,small molecule,-,-,Q96RJ0,taar1_human,TAAR1,GPCR;Rhodopsin,established,approved,Aminergic ,Trace amine receptors,Class A (Rhodopsin)
125,125,MMAmay2016_0357,d-amphetamine transdermal system (d-ats),amphetamine,for treatment of cognitive dysfunction; for treatment of ADHD,small molecule,-,-,Q96RJ0,taar1_human,TAAR1,GPCR;Rhodopsin,established,approved,Aminergic ,Trace amine receptors,Class A (Rhodopsin)
126,126,MMAmay2016_0658,"hld-100, reformulated amphetamine",amphetamine,for treatment of cognitive dysfunction; for treatment of ADHD,small molecule,-,-,Q96RJ0,taar1_human,TAAR1,GPCR;Rhodopsin,established,approved,Aminergic ,Trace amine receptors,Class A (Rhodopsin)
127,127,1862,"sli 381, spd 465,adderall, adderall xr, adderall ir",amphetamine,for treatment of cognitive dysfunction; for treatment of ADHD,small molecule,-,-,Q96RJ0,taar1_human,TAAR1,GPCR;Rhodopsin,established,approved,Aminergic ,Trace amine receptors,Class A (Rhodopsin)
128,128,175,"anamorelin, rc-1291",anamorelin,Appetite stimulant,small molecule,-,-,Q92847,ghsr_human,GHSR,GPCR;Rhodopsin,not established,in trial,Peptide ,Ghrelin receptors,Class A (Rhodopsin)
129,129,177,anatibant,anatibant,for treatment of traumatic brain injury,small molecule,-,-,P30411,bkrb2_human,BDKRB2,GPCR;Rhodopsin,established,in trial,Peptide ,Bradykinin receptors,Class A (Rhodopsin)
130,130,NRDD027,-,anileridine,Analgesics; Narcotics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
131,131,NRDD029,-,anisotropine methylbromide,Antispasmodics; Anti-ulcer Agents,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
132,132,NRDD029,-,anisotropine methylbromide,Antispasmodics; Anti-ulcer Agents,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
133,133,NRDD029,-,anisotropine methylbromide,Antispasmodics; Anti-ulcer Agents,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
134,134,189,ap1030,ap-1034,Anti-obesity agent,small molecule,-,-,Q01726,mshr_human,MC1R,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
135,135,189,ap1030,ap-1034,Anti-obesity agent,small molecule,-,-,P32245,mc4r_human,MC4R,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
136,136,2538,ap214,ap214,for treatment of post-surgical kidney injury,peptide,-,-,Q01726,mshr_human,MC1R,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
137,137,2538,ap214,ap214,for treatment of post-surgical kidney injury,peptide,-,-,P41968,mc3r_human,MC3R,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
138,138,2538,ap214,ap214,for treatment of post-surgical kidney injury,peptide,-,-,P32245,mc4r_human,MC4R,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
139,139,2538,ap214,ap214,for treatment of post-surgical kidney injury,peptide,-,-,P33032,mc5r_human,MC5R,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
140,140,192,apd125,apd125,for treatment of insomnia,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
141,141,MMAmay2016_0282,apd334,apd334,for autoimmune disorders,small molecule,-,-,P21453,s1pr1_human,S1PR1,GPCR;Rhodopsin,established,in trial,Lipid ,Lysophospholipid (S1P) receptors,Class A (Rhodopsin)
142,142,193,apd421,apd421,Antiemetics,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
143,143,2469,apd597,apd597,Antidiabetic,small molecule,-,-,Q8TDV5,gp119_human,GPR119,GPCR;Rhodopsin,not established,in trial,Lipid ,"GPR18, GPR55 and GPR119",Class A (Rhodopsin)
144,144,194,apd668,apd668,Antidiabetic,small molecule,-,-,Q8TDV5,gp119_human,GPR119,GPCR;Rhodopsin,not established,in trial,Lipid ,"GPR18, GPR55 and GPR119",Class A (Rhodopsin)
145,145,195,apd791,apd791,antithrombotic,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
146,146,MMAmay2016_0283,apd811,apd811,Antihypertensive agent,small molecule,-,-,P43119,pi2r_human,PTGIR,GPCR;Rhodopsin,established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
147,147,196,apd916,apd916,for treatment of sleep disorders; narcolepsy,small molecule,-,-,Q9Y5N1,hrh3_human,HRH3,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
148,148,MMAjun2016_0045,apelin,apelin,Cardiovascular disorders; Insulin sensitivity,peptide,-,-,P35414,apj_human,APLNR,GPCR;Rhodopsin,not established,in trial,Peptide ,Apelin receptors,Class A (Rhodopsin)
149,149,MMAjun2016_0005,"api246,  srx246","api246,  srx246",Treatment of affective and anger disorders,small molecule,-,-,P37288,v1ar_human,AVPR1A,GPCR;Rhodopsin,established,in trial,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
150,150,203,"aplindore, dab-452",aplindore,Antiparkinson agent; for treatment of restlegs legs syndrome,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
151,151,206,"apomorphine hcl,uprima, ixense",apomorphine,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,small molecule,2004,2004,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
152,152,206,"apomorphine hcl,uprima, ixense",apomorphine,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,small molecule,2004,2004,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
153,153,206,"apomorphine hcl,uprima, ixense",apomorphine,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,small molecule,2004,2004,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
154,154,207,"apomorphine hydrochloride,apokyn, apo-go",apomorphine,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,small molecule,2004,2004,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
155,155,207,"apomorphine hydrochloride,apokyn, apo-go",apomorphine,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,small molecule,2004,2004,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
156,156,207,"apomorphine hydrochloride,apokyn, apo-go",apomorphine,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,small molecule,2004,2004,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
157,157,976,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",apomorphine,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,small molecule,2004,2004,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
158,158,976,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",apomorphine,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,small molecule,2004,2004,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
159,159,976,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",apomorphine,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,small molecule,2004,2004,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
160,160,1009,intranasal apomorphine,apomorphine,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,small molecule,2004,2004,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
161,161,1009,intranasal apomorphine,apomorphine,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,small molecule,2004,2004,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
162,162,1009,intranasal apomorphine,apomorphine,for treatment of sexual dysfunction in women; for treatment of erectile dysfunction; Antiparkinson agent ,small molecule,2004,2004,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
163,163,NRDD032,-,apraclonidine,Antiglaucomic Agents,small molecule,1987,1987,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
164,164,209,"aprepitant, mk-869, fosaprepitant dimeglumine, mk-0517,emend",aprepitant,Antiemetics,small molecule,2003,2003,P25103,nk1r_human,TACR1,GPCR;Rhodopsin,established,approved,Peptide ,Tachykinin receptors,Class A (Rhodopsin)
165,165,216,arbaclofen,arbaclofen,symptomatic treatment for fragile X syndrome,small molecule,-,-,Q9UBS5,gabr1_human,GABBR1,GPCR;Glutamate,established,in trial,Amino acid ,GABAB receptors,Class C (Glutamate) 
166,166,216,arbaclofen,arbaclofen,symptomatic treatment for fragile X syndrome,small molecule,-,-,O75899,gabr2_human,GABBR2,GPCR;Glutamate,established,in trial,Amino acid ,GABAB receptors,Class C (Glutamate) 
167,167,NRDD034,-,arbutamine,Cardiotonic Agents,small molecule,1997,1997,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
168,168,NRDD036,-,arformoterol,Bronchodilator agent,small molecule,-,2006,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
169,169,2276,brovana,arformoterol,Bronchodilator agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
170,170,226,ari-3037mo,ari-3037mo,Vitamin B analog; for treatment for hyperlipidemia,small molecule,-,-,Q8TDS4,hcar2_human,HCAR2,GPCR;Rhodopsin,established,in trial,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
171,171,226,ari-3037mo,ari-3037mo,Vitamin B analog; for treatment for hyperlipidemia,small molecule,-,-,P49019,hcar3_human,HCAR3,GPCR;Rhodopsin,established,in trial,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
172,172,22,abilify,aripiprazole,Antipsychotic agent,small molecule,2015,2015,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
173,173,22,abilify,aripiprazole,Antipsychotic agent,small molecule,2015,2015,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
174,174,22,abilify,aripiprazole,Antipsychotic agent,small molecule,2015,2015,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
175,175,MMAmay2016_0260,alks 9070,aripiprazole,Antipsychotic agent; schizophrenia,small molecule,2015,2015,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
176,176,MMAmay2016_0261,alks 9070,aripiprazole,Antipsychotic agent; schizophrenia,small molecule,2015,2015,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
177,177,MMAmay2016_0262,alks 9070,aripiprazole,Antipsychotic agent; schizophrenia,small molecule,2015,2015,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
178,178,MMAapril2016_0314,arry-502,arry-502,Anti-Allergic Agents,small molecule,-,-,Q9Y5Y4,gpr44_human,GPR44,GPCR;Rhodopsin,not established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
179,179,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
180,180,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
181,181,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
182,182,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
183,183,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
184,184,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
185,185,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
186,186,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
187,187,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
188,188,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P25021,hrh2_human,HRH2,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
189,189,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
190,190,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
191,191,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
192,192,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
193,193,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
194,194,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P47898,5ht5a_human,HTR5A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
195,195,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
196,196,250,asenapine,asenapine,Antipsychotic agent,small molecule,2009,2009,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
197,197,253,asimadoline,asimadoline,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
198,198,MMAmay2016_0687,asm-024,asm-024,for asthma and COPD,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
199,199,NRDD037,-,astemizole,Anti-Allergic Agents,small molecule,-,1988,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
200,200,NRDD038,-,atenolol,Anti-Arrhythmia Agents; Antihypertensive agent,small molecule,1981,1981,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
201,201,263,athx-105,athx-105,Anti-obesity agent,small molecule,-,-,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
202,202,265,ati-7505,ati-7505,Parasympathomimetic,small molecule,-,-,Q13639,5ht4r_human,HTR4,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
203,203,2423,ati-9242,ati-9242,Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
204,204,2423,ati-9242,ati-9242,Antipsychotic agent,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
205,205,270,"atrasentan, abt-627,xinlay",atrasentan,Antineoplastic agent,small molecule,-,-,P25101,ednra_human,EDNRA,GPCR;Rhodopsin,established,in trial,Peptide ,Endothelin receptors,Class A (Rhodopsin)
206,206,977,inhaled atropine,atropine,nerve agent antidote,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
207,207,977,inhaled atropine,atropine,nerve agent antidote,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
208,208,977,inhaled atropine,atropine,nerve agent antidote,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
209,209,977,inhaled atropine,atropine,nerve agent antidote,small molecule,-,-,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
210,210,977,inhaled atropine,atropine,nerve agent antidote,small molecule,-,-,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
211,211,278,av608,av608,Anti-depressant; for treatment of irritable bowel syndrome; antispasmodic,small molecule,-,-,P25103,nk1r_human,TACR1,GPCR;Rhodopsin,established,in trial,Peptide ,Tachykinin receptors,Class A (Rhodopsin)
212,212,284,ave-1625,ave-1625,Anti-obesity agent; for treatment for Alzheimer's disease,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
213,213,563,"ctp-37,avicine",avicine,Antineoplastic agent; vaccine,vaccine,-,-,P22888,lshr_human,LHCGR,GPCR;Rhodopsin,established,in trial,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
214,214,290,avn-101,avn-101,for treatment of Alzheimer's disease,small molecule,-,-,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
215,215,291,avn-211,avn-211,Antipsychotic agent,small molecule,-,-,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
216,216,292,avn-322,avn-322,for treatment of Alzheimer's disease,small molecule,-,-,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
217,217,2490,avn-397,avn-397,anxiolytic;for treatment of Alzheimer's disease,small molecule,-,-,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
218,218,295,"avosentan, spp 301",avosentan,Antihypertensive agent,small molecule,-,-,P25101,ednra_human,EDNRA,GPCR;Rhodopsin,established,in trial,Peptide ,Endothelin receptors,Class A (Rhodopsin)
219,219,2269,avr123,avr118,wound healing accelerant,peptide nucleic acid,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
220,220,2269,avr123,avr118,wound healing accelerant,peptide nucleic acid,-,-,P29275,aa2br_human,ADORA2B,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
221,221,2269,avr123,avr118,wound healing accelerant,peptide nucleic acid,-,-,P0DMS8,aa3r_human,ADORA3,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
222,222,NRDD041,-,azatadine,Anti-Allergic Agents,small molecule,1977,1977,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
223,223,308,azd2066,azd2066,Analgesics; for treatment of gastroesophageal reflux disease,small molecule,-,-,P41594,grm5_human,GRM5,GPCR;Glutamate,established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
224,224,2331,azd2423,azd2423,for treatment of chronic obstructive pulmonary disorder;Analgesics; neuropathic pain,small molecule,-,-,P41597,ccr2_human,CCR2,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
225,225,MMAmay2016_0297,azd2820,azd2820,Anti-obesity agent,small molecule,-,-,P32245,mc4r_human,MC4R,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
226,226,313,azelastine,azelastine,Anti-Allergic Agents,small molecule,1996,1996,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
227,227,314,"azelastine hydrochloride nasal spray,astepro",azelastine,Anti-Allergic Agents,small molecule,1996,1996,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
228,228,456,"cdx-313, budesonide + azelastine nasal spray",azelastine,Anti-Allergic Agents,small molecule,1996,1996,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
229,229,MMAmay2016_0366,"dymista, azelastine hydrochloride + fluticasone propionate",azelastine,Anti-Allergic Agents,small molecule,1996,1996,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
230,230,679,"dymista, azelastine hydrochloride + fluticasone propionate, mp29-02",azelastine,Anti-Allergic Agents,small molecule,1996,1996,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
231,231,315,"azilsartan medoxomil, tak-491",azilsartan,Antihypertensive agent,small molecule,2011,2011,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,approved,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
232,232,MMAmay2016_0371,"edarbyclor, azilsartan medoxomil + chlorthalidone",azilsartan,Antihypertensive agent,small molecule,2011,2011,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,approved,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
233,233,MMAapril2016_0315,"azp-531, unacylated ghrelin","azp-531, unacylated ghrelin",Antidiabetic agent,peptide,-,-,Q92847,ghsr_human,GHSR,GPCR;Rhodopsin,not established,in trial,Peptide ,Ghrelin receptors,Class A (Rhodopsin)
234,234,115,alks 29,baclofen,for treatment of alcohol dependance,small molecule,1977,1977,Q9UBS5,gabr1_human,GABBR1,GPCR;Glutamate,established,approved,Amino acid ,GABAB receptors,Class C (Glutamate) 
235,235,115,alks 29,baclofen,for treatment of alcohol dependance,small molecule,1977,1977,O75899,gabr2_human,GABBR2,GPCR;Glutamate,established,approved,Amino acid ,GABAB receptors,Class C (Glutamate) 
236,236,MMAmay2016_0071,"pxt3003, baclofen + naltrexone + sorbitol",baclofen,for type 1A Charcot-Marie-Tooth disease,small molecule,1977,1977,O75899,gabr2_human,GABBR2,GPCR;Glutamate,established,approved,Amino acid ,GABAB receptors,Class C (Glutamate) 
237,237,MMAmay2016_0072,"pxt3003, baclofen + naltrexone + sorbitol",baclofen,for type 1A Charcot-Marie-Tooth disease,small molecule,1977,1977,Q9UBS5,gabr1_human,GABBR1,GPCR;Glutamate,established,approved,Amino acid ,GABAB receptors,Class C (Glutamate) 
238,238,MMAmay2016_0306,bci-838,bci-838,Anti-depressant,small molecule,-,-,Q14416,grm2_human,GRM2,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
239,239,MMAmay2016_0307,bci-838,bci-838,Anti-depressant,small molecule,-,-,Q14832,grm3_human,GRM3,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
240,240,NRDD046,-,benzphetamine,Central Nervous System Stimulants,small molecule,1960,1960,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
241,241,NRDD046,-,benzphetamine,Central Nervous System Stimulants,small molecule,1960,1960,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
242,242,NRDD047,-,benzquinamide,Antiemetics; Antipsychotic agent,small molecule,1974,1974,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
243,243,NRDD047,-,benzquinamide,Antiemetics; Antipsychotic agent,small molecule,1974,1974,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
244,244,NRDD047,-,benzquinamide,Antiemetics; Antipsychotic agent,small molecule,1974,1974,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
245,245,NRDD047,-,benzquinamide,Antiemetics; Antipsychotic agent,small molecule,1974,1974,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
246,246,NRDD047,-,benzquinamide,Antiemetics; Antipsychotic agent,small molecule,1974,1974,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
247,247,NRDD047,-,benzquinamide,Antiemetics; Antipsychotic agent,small molecule,1974,1974,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
248,248,NRDD049,-,benztropine,Antiparkinson agents,small molecule,1954,1954,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
249,249,336,"bepotastine besilate,bepreve, talion",bepotastine,Anti-Allergic Agents,small molecule,2009,2009,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
250,250,337,beraprost,beraprost,Antihypertensive agent,small molecule,-,-,P43119,pi2r_human,PTGIR,GPCR;Rhodopsin,established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
251,251,MMAmay2016_0919,betahistine,betahistine,for treatment of vertigo,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
252,252,MMAmay2016_0920,betahistine,betahistine,for treatment of vertigo,small molecule,-,-,Q9Y5N1,hrh3_human,HRH3,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
253,253,1464,"obe101,histalean,anti-obesity agent",betahistine,Anti-obesity agent,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
254,254,1464,"obe101,histalean,anti-obesity agent",betahistine,Anti-obesity agent,small molecule,-,-,Q9Y5N1,hrh3_human,HRH3,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
255,255,648,dm-71,betanechol,Antidiabetic,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
256,256,NRDD052,-,betaxolol,Antihypertensive agent,small molecule,1985,1985,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
257,257,NRDD053,-,betazole,Diagnostic Agents,small molecule,-,-,P25021,hrh2_human,HRH2,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
258,258,NRDD054,-,bethanechol,Parasympathomimetics,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
259,259,NRDD055,-,bethanidine,Antihypertensive agent,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
260,260,NRDD055,-,bethanidine,Antihypertensive agent,small molecule,-,-,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
261,261,NRDD055,-,bethanidine,Antihypertensive agent,small molecule,-,-,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
262,262,NRDD055,-,bethanidine,Antihypertensive agent,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
263,263,NRDD055,-,bethanidine,Antihypertensive agent,small molecule,-,-,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
264,264,NRDD055,-,bethanidine,Antihypertensive agent,small molecule,-,-,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
265,265,NRDD056,-,bevantolol,Antihypertensive agent,small molecule,-,-,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
266,266,343,bf-1,bf-1,Anti-migraine Agents,small molecule,-,-,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
267,267,345,bg-9928,bg-9928,for treatment of congestive heart failure,small molecule,-,-,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
268,268,347,bgc20-1531,bgc20-1531 ,Anti-migraine Agents,small molecule,-,-,P35408,pe2r4_human,PTGER4,GPCR;Rhodopsin,established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
269,269,356,"bifeprunox, du127090",bifeprunox,Antipsychotic agent; Antiparkinson agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
270,270,356,"bifeprunox, du127090",bifeprunox,Antipsychotic agent; Antiparkinson agent,small molecule,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
271,271,356,"bifeprunox, du127090",bifeprunox,Antipsychotic agent; Antiparkinson agent,small molecule,-,-,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
272,272,356,"bifeprunox, du127090",bifeprunox,Antipsychotic agent; Antiparkinson agent,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
273,273,356,"bifeprunox, du127090",bifeprunox,Antipsychotic agent; Antiparkinson agent,small molecule,-,-,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
274,274,356,"bifeprunox, du127090",bifeprunox,Antipsychotic agent; Antiparkinson agent,small molecule,-,-,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
275,275,2164,vipadenantis,biib014,Antiparkinson agent,small molecule,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
276,276,358,bim23a760,bim23a760,Antineoplastic agent; treatment for acromegaly,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
277,277,358,bim23a760,bim23a760,Antineoplastic agent; treatment for acromegaly,small molecule,-,-,P30874,ssr2_human,SSTR2,GPCR;Rhodopsin,established,in trial,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
278,278,358,bim23a760,bim23a760,Antineoplastic agent; treatment for acromegaly,small molecule,-,-,P35346,ssr5_human,SSTR5,GPCR;Rhodopsin,established,in trial,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
279,279,359,"bimatoprost,  agn 192024,lumigan",bimatoprost,Antiglaucomic Agents,small molecule,2001,2001,P34995,pe2r1_human,PTGER1,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
280,280,359,"bimatoprost,  agn 192024,lumigan",bimatoprost,Antiglaucomic Agents,small molecule,2001,2001,P43115,pe2r3_human,PTGER3,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
281,281,359,"bimatoprost,  agn 192024,lumigan",bimatoprost,Antiglaucomic Agents,small molecule,2001,2001,P43088,pf2r_human,PTGFR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
282,282,MMAmar2016_0296,"helios insert, bimatoprost ocular insert",bimatoprost,Antiglaucomic Agents,small molecule,2001,2001,P34995,pe2r1_human,PTGER1,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
283,283,MMAmar2016_0297,"helios insert, bimatoprost ocular insert",bimatoprost,Antiglaucomic Agents,small molecule,2001,2001,P43088,pf2r_human,PTGFR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
284,284,MMAmar2016_0298,"helios insert, bimatoprost ocular insert",bimatoprost,Antiglaucomic Agents,small molecule,2001,2001,P43115,pe2r3_human,PTGER3,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
285,285,363,"binodenoson, mre 0470,corvue",binodenoson,Diagnostic Agents,small molecule,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
286,286,NRDD057,-,biperiden,Antidyskinetics,small molecule,1959,1959,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
287,287,NRDD058,-,bisoprolol,Antihypertensive agent,small molecule,1992,1992,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
288,288,2424,bl-1020,bl-1020,Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
289,289,2424,bl-1020,bl-1020,Antipsychotic agent,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
290,290,2424,bl-1020,bl-1020,Antipsychotic agent,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
291,291,APR13_0001,bl-8040,bl-8040,Antineoplastic agent,peptide,-,-,P61073,cxcr4_human,CXCR4,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
292,292,369,"bms 936564, mdx-1338",bms 936564,Antineoplastic agent,antibody,-,-,P61073,cxcr4_human,CXCR4,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
293,293,2053,tracleer,bosentan,for treatment of pulmonary arterial hypertension,small molecule,2001,2001,P25101,ednra_human,EDNRA,GPCR;Rhodopsin,established,approved,Peptide ,Endothelin receptors,Class A (Rhodopsin)
294,294,2053,tracleer,bosentan,for treatment of pulmonary arterial hypertension,small molecule,2001,2001,P24530,ednrb_human,EDNRB,GPCR;Rhodopsin,established,approved,Peptide ,Endothelin receptors,Class A (Rhodopsin)
295,295,MMAjun2016_0011,"boxaban, hepatoren, vasculan, ifetroban","boxaban, hepatoren, vasculan, ifetroban",Treatment of asystemic scleroderma; hepatorenal syndrome; asthma,small molecule,-,-,P21731,ta2r_human,TBXA2R,GPCR;Rhodopsin,established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
296,296,383,bremelanotide,bremelanotide,for treatment of sexual dysfunction,peptide,-,-,Q01726,mshr_human,MC1R,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
297,297,383,bremelanotide,bremelanotide,for treatment of sexual dysfunction,peptide,-,-,P32245,mc4r_human,MC4R,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
298,298,385,"brimonidine tartrate,alphagan",brimonidine,for treatment of glaucoma,small molecule,1996,1996,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
299,299,385,"brimonidine tartrate,alphagan",brimonidine,for treatment of glaucoma,small molecule,1996,1996,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
300,300,385,"brimonidine tartrate,alphagan",brimonidine,for treatment of glaucoma,small molecule,1996,1996,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
301,301,386,"brimonidine tartrate/timolol maleate,combigan",brimonidine,for treatment of glaucoma,small molecule,1996,1996,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
302,302,386,"brimonidine tartrate/timolol maleate,combigan",brimonidine,for treatment of glaucoma,small molecule,1996,1996,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
303,303,386,"brimonidine tartrate/timolol maleate,combigan",brimonidine,for treatment of glaucoma,small molecule,1996,1996,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
304,304,2274,"cd07805/47, sansrosa, col-118",brimonidine,for treatment of erythema,small molecule,1996,1996,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
305,305,2274,"cd07805/47, sansrosa, col-118",brimonidine,for treatment of erythema,small molecule,1996,1996,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
306,306,2274,"cd07805/47, sansrosa, col-118",brimonidine,for treatment of erythema,small molecule,1996,1996,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
307,307,389,"bromocriptine mesylate,cycloset, ergoset",bromocriptine,Antidiabetic,small molecule,1978,1978,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
308,308,389,"bromocriptine mesylate,cycloset, ergoset",bromocriptine,Antidiabetic,small molecule,1978,1978,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
309,309,NRDD062,-,bromodiphenhydramine,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
310,310,NRDD063,-,brompheniramine,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
311,311,396,"bucindolol hydrochloride,gencaro",bucindolol,for treatment of heart failure,small molecule,-,-,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
312,312,396,"bucindolol hydrochloride,gencaro",bucindolol,for treatment of heart failure,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
313,313,NRDD064,-,buclizine,Antiemetics,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
314,314,NRDD064,-,buclizine,Antiemetics,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
315,315,404,"budiodarone, ati-2042",budiodarone,Anti-Arrhythmia Agents,small molecule,-,-,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
316,316,118,alks 5461,buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
317,317,118,alks 5461,buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
318,318,333,"bema buprenorphine, buccal mucosa adhesive",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
319,319,333,"bema buprenorphine, buccal mucosa adhesive",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
320,320,405,"buprenorphine + naloxone capsule,nanobup",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
321,321,405,"buprenorphine + naloxone capsule,nanobup",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
322,322,406,"buprenorphine + naloxone,suboxone",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
323,323,406,"buprenorphine + naloxone,suboxone",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
324,324,407,"buprenorphine subcutaneous implant,probuphine",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
325,325,407,"buprenorphine subcutaneous implant,probuphine",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
326,326,408,"buprenorphine sublingual tablet,subutex",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
327,327,408,"buprenorphine sublingual tablet,subutex",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
328,328,MMAmar2016_0045,"butab, rel-1028, oral, enteric-coated buprenorphine",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
329,329,MMAmar2016_0047,"butab, rel-1028, oral, enteric-coated buprenorphine",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
330,330,409,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
331,331,409,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
332,332,422,cam2038,buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
333,333,422,cam2038,buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
334,334,MMAmay2016_0514,"ox219, buprenorphine + naloxone sublingual tablet",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
335,335,MMAmay2016_0516,"ox219, buprenorphine + naloxone sublingual tablet",buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
336,336,2109,v1003,buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
337,337,2109,v1003,buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
338,338,2109,v1003,buprenorphine,Anti-depressant; Analgesics; for treatment of opioid addiction,small molecule,1981,1981,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
339,339,NRDD066,-,buspirone,Anti-anxiety Agents,small molecule,1986,1986,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
340,340,NRDD066,-,buspirone,Anti-anxiety Agents,small molecule,1986,1986,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
341,341,NRDD070,-,butorphanol,Analgesics; Opioid,small molecule,1978,1978,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
342,342,NRDD070,-,butorphanol,Analgesics; Opioid,small molecule,1978,1978,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
343,343,NRDD070,-,butorphanol,Analgesics; Opioid,small molecule,1978,1978,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
344,344,411,bvt.115959,bvt.115959,Analgesics,small molecule,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
345,345,412,bvt.28949,bvt.28949,for treatment of glaucoma,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
346,346,NRDD071,-,cabergoline,Antiparkinson agents,small molecule,1996,1996,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
347,347,NRDD072,-,caffeine,Central Nervous System Stimulants,small molecule,-,-,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
348,348,NRDD072,-,caffeine,Central Nervous System Stimulants,small molecule,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
349,349,MMAapril2016_0320,"cal-1, autologous t cell and blood stem cell therapy","cal-1, autologous t cell and blood stem cell therapy",antiviral agent; HIV,cell therapy,-,-,P51681,ccr5_human,CCR5,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
350,350,376,"bn-002,capsitonin",calcitonin,Anti-osteoporotic agent,small molecule,-,-,P30988,calcr_human,CALCR,GPCR;Secretin,established,approved,Peptide ,Calcitonin receptors,Class B1 (Secretin)
351,351,2154,viaderm-calcitonin,calcitonin,Anti-osteoporotic agent,small molecule,-,-,P30988,calcr_human,CALCR,GPCR;Secretin,established,approved,Peptide ,Calcitonin receptors,Class B1 (Secretin)
352,352,427,"candesartan cilexetil,atacand",candesartan,Antihypertensive agent,small molecule,1998,1998,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,approved,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
353,353,428,"cangrelor, ar69931",cangrelor,antithrombotic,small molecule,2015,2015,Q9H244,p2y12_human,P2RY12,GPCR;Rhodopsin,established,approved,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
354,354,MMAmar2016_0268,cannabidiol,cannabidiol,for treatment of epilepsy,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
355,355,MMAmar2016_0269,cannabidiol,cannabidiol,for treatment of epilepsy,small molecule,-,-,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
356,356,MMAmar2016_0270,"epidiolex, oral liquid cannabidiol",cannabidiol,for treatment of epilepsy,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
357,357,MMAmar2016_0271,"epidiolex, oral liquid cannabidiol",cannabidiol,for treatment of epilepsy,small molecule,-,-,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
358,358,MMAapril2016_0328,gwp42003,cannabidiol (cbd),for ulcerative colitis and schizophrenia,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
359,359,MMAapril2016_0328,gwp42003,cannabidiol (cbd),for ulcerative colitis and schizophrenia,small molecule,-,-,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
360,360,MMAmay2016_0402,gwp42006,cannabidivarin,for treatment of epilepsy,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
361,361,MMAmay2016_0403,gwp42006,cannabidivarin,for treatment of epilepsy,small molecule,-,-,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
362,362,MMAmay2016_0720,"cannabinoids,  thc + cbd","cannabinoids,  thc + cbd",Antineoplastic agent; for glioma,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
363,363,MMAmay2016_0721,"cannabinoids,  thc + cbd","cannabinoids,  thc + cbd",Antineoplastic agent; for glioma,small molecule,-,-,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
364,364,NRDD077,-,carbachol,Antiglaucomic Agents,small molecule,1972,1972,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
365,365,NRDD077,-,carbachol,Antiglaucomic Agents,small molecule,1972,1972,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
366,366,NRDD078,-,carbetocin,Labor Inducing Agents,small molecule,-,-,P30559,oxyr_human,OXTR,GPCR;Rhodopsin,established,in trial,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
367,367,NRDD080,-,carbinoxamine,Anti-Allergic Agents,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
368,368,NRDD080,-,carbinoxamine,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
369,369,NRDD081,-,carboprost tromethamine,Abortifacient Agents,small molecule,1979,1979,P34995,pe2r1_human,PTGER1,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
370,370,433,"cariprazine, rgh-188",cariprazine,Antipsychotic agent,small molecule,2015,2015,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
371,371,433,"cariprazine, rgh-188",cariprazine,Antipsychotic agent,small molecule,2015,2015,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
372,372,NRDD082,-,carphenazine,Antipsychotic agent,small molecule,-,-,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
373,373,NRDD082,-,carphenazine,Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
374,374,NRDD082,-,carphenazine,Antipsychotic agent,small molecule,-,-,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
375,375,NRDD084,-,carteolol,Antiglaucomic Agents,small molecule,1988,1988,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
376,376,434,"carvedilol, coreg",carvedilol,for treatment of congestive heart failure,small molecule,1995,1995,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
377,377,435,"carvedilol,coreg",carvedilol,cardiovascular agent,small molecule,1995,1995,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
378,378,435,"carvedilol,coreg",carvedilol,cardiovascular agent,small molecule,1995,1995,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
379,379,436,"casopitant mesilate, 679769,rezonic, zunrisa",casopitant,Antiemetics,small molecule,-,-,P25103,nk1r_human,TACR1,GPCR;Rhodopsin,established,in trial,Peptide ,Tachykinin receptors,Class A (Rhodopsin)
380,380,445,ccl2-lpm,ccl2-lpm,Anti-inflammatory agent,protein,-,-,P41597,ccr2_human,CCR2,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
381,381,446,ccx025,ccx025,Anti-inflammatory agent,small molecule,-,-,P51686,ccr9_human,CCR9,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
382,382,447,ccx140,ccx140,Anti-inflammatory agent; Antidiabetic,small molecule,-,-,P41597,ccr2_human,CCR2,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
383,383,448,ccx168,ccx168,Anti-inflammatory agent; for treatment for autoimmune disease,small molecule,-,-,P21730,c5ar_human,C5AR1,GPCR;Rhodopsin,not established,in trial,Peptide ,Complement peptide receptors,Class A (Rhodopsin)
384,384,449,"ccx282, traficet-en",ccx282,Anti-inflammatory agent; for treatment of Crohn's disease; for treatment of ulceraite colitis,small molecule,-,-,P51686,ccr9_human,CCR9,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
385,385,450,ccx354,ccx354,Anti-inflammatory agent; DMARD,small molecule,-,-,P32246,ccr1_human,CCR1,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
386,386,MMAmay2016_0216,ccx507,ccx507,for treatment of ulcerative colitis; inflammatory bowel disease,small molecule,-,-,P51686,ccr9_human,CCR9,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
387,387,451,ccx832,ccx832,Anti-inflammatory agent; for treatment for autoimmune disease,small molecule,-,-,Q99788,cml1_human,CMKLR1,GPCR;Rhodopsin,not established,in trial,Protein ,Chemerin receptor,Class A (Rhodopsin)
388,388,MMAapril2016_0147,ccx872,ccx872,Antineoplastic agent; pancreatic cancer,small molecule,-,-,P41597,ccr2_human,CCR2,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
389,389,MMA2015_0071,cer627,cer627,Dyslipidemia with low HDL,small molecule: combination,-,-,P49019,hcar3_human,HCAR3,GPCR;Rhodopsin,established,in trial,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
390,390,MMA2015_0072,cer627,cer627,Dyslipidemia with low HDL,small molecule: combination,-,-,Q8TDS4,hcar2_human,HCAR2,GPCR;Rhodopsin,established,in trial,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
391,391,MMAfeb2016_0074,"cerc-501, ly2456302","cerc-501, ly2456302",Substance use disorders,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
392,392,NRDD085,-,ceruletide,Diagnostic Agents,small molecule,-,-,P32238,cckar_human,CCKAR,GPCR;Rhodopsin,established,approved,Peptide ,Cholecystokinin receptors,Class A (Rhodopsin)
393,393,471,"cetirizine hcl,zyrtec",cetirizine,Anti-Allergic Agents,small molecule,1995,1995,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
394,394,472,"cetrorelix,cetrotide",cetrorelix,Antineoplastic agent,peptide,2000,2000,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
395,395,NRDD086,-,cevimeline,Parasympathomimetics,small molecule,2000,2000,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
396,396,NRDD086,-,cevimeline,Parasympathomimetics,small molecule,2000,2000,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
397,397,473,cf-101,cf-101,Anti-inflammatory agent; DMARD,small molecule,-,-,P0DMS8,aa3r_human,ADORA3,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
398,398,474,cf-102,cf-102,Antineoplastic agent,small molecule,-,-,P0DMS8,aa3r_human,ADORA3,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
399,399,MMAapril2016_0230,cf602,cf602,for treatment of sexual dysfunction,small molecule,-,-,P0DMS8,aa3r_human,ADORA3,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
400,400,477,cgrp,cgrp,Anti-Asthmatic Agents,peptide,-,-,Q16602,calrl_human,CALCRL,GPCR;Secretin,not established,in trial,Peptide ,Calcitonin receptors,Class B1 (Secretin)
401,401,NRDD087,-,chlophedianol,Antitussive Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
402,402,NRDD094,-,chlorpheniramine,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
403,403,NRDD096,-,chlorprothixene,Antipsychotic agent,small molecule,-,-,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
404,404,NRDD096,-,chlorprothixene,Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
405,405,NRDD096,-,chlorprothixene,Antipsychotic agent,small molecule,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
406,406,NRDD096,-,chlorprothixene,Antipsychotic agent,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
407,407,NRDD096,-,chlorprothixene,Antipsychotic agent,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
408,408,NRDD096,-,chlorprothixene,Antipsychotic agent,small molecule,-,-,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
409,409,NRDD096,-,chlorprothixene,Antipsychotic agent,small molecule,-,-,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
410,410,NRDD099,-,choriogonadotropin alfa,Fertility Agents,protein,-,2000,P23945,fshr_human,FSHR,GPCR;Rhodopsin,established,approved,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
411,411,NRDD099,-,choriogonadotropin alfa,Fertility Agents,protein,-,2000,P22888,lshr_human,LHCGR,GPCR;Rhodopsin,established,approved,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
412,412,2529,ml-04,chorionic gonadotropin (hcg),Antineoplastic agent,protein,-,-,P22888,lshr_human,LHCGR,GPCR;Rhodopsin,established,in trial,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
413,413,2271,cicletanine hydrochloride,cicletanine ,Antihypertensive agent,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
414,414,2271,cicletanine hydrochloride,cicletanine ,Antihypertensive agent,small molecule,-,-,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
415,415,2271,cicletanine hydrochloride,cicletanine ,Antihypertensive agent,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
416,416,2271,cicletanine hydrochloride,cicletanine ,Antihypertensive agent,small molecule,-,-,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
417,417,2271,cicletanine hydrochloride,cicletanine ,Antihypertensive agent,small molecule,-,-,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
418,418,2271,cicletanine hydrochloride,cicletanine ,Antihypertensive agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
419,419,NRDD104,-,cimetidine,GI Anti-Ulcer Agents; antihistamines,small molecule,1977,1977,P25021,hrh2_human,HRH2,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
420,420,MMAmay2016_0601,"tl-118, hamsa-1, cyclophosphamide + diclofenac + sulfasalazine + cimetidine",cimetidine,Antihistamines,small molecule,1977,1977,P25021,hrh2_human,HRH2,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
421,421,NRDD105,-,cinacalcet,Calcimimetics,small molecule,2004,2004,P41180,casr_human,CASR,GPCR;Glutamate,established,approved,Ion ,Calcium-sensing receptors,Class C (Glutamate) 
422,422,2327,"cinacalcet hcl, amg 073,sensipar",cinacalcet,for treatment of hyperparathyroidism,small molecule,2004,2004,P41180,casr_human,CASR,GPCR;Glutamate,established,approved,Ion ,Calcium-sensing receptors,Class C (Glutamate) 
423,423,NRDD106,-,cinalukast,Anti-Asthmatic Agents,small molecule,-,-,Q9Y271,cltr1_human,CYSLTR1,GPCR;Rhodopsin,established,in trial,Lipid ,Leukotriene receptors,Class A (Rhodopsin)
424,424,NRDD107,-,cinnarizine,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
425,425,NRDD109,-,cisapride,Parasympathomimetics,small molecule,1993,1993,Q13639,5ht4r_human,HTR4,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
426,426,MMAmay2016_0333,cis-uca eye drops,cis-uca eye drops,for ocular surface inflammation,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
427,427,2488,biocis,cis-urocanic acid,,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
428,428,495,"clazosentan, axv-343434,pivlaz",clazosentan,for treatment and prevention of vasospasm,small molecule,-,-,P25101,ednra_human,EDNRA,GPCR;Rhodopsin,established,in trial,Peptide ,Endothelin receptors,Class A (Rhodopsin)
429,429,NRDD112,-,clemastine,Anti-Allergic Agents,small molecule,1977,1977,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
430,430,NRDD113,-,clenbuterol,Bronchodilator agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
431,431,NRDD114,-,clidinium,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
432,432,220,"arc-4558, 0.1% clonidine hycrochloride gel",clonidine,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
433,433,220,"arc-4558, 0.1% clonidine hycrochloride gel",clonidine,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,small molecule,-,-,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
434,434,220,"arc-4558, 0.1% clonidine hycrochloride gel",clonidine,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,small molecule,-,-,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
435,435,501,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",clonidine,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
436,436,501,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",clonidine,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,small molecule,-,-,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
437,437,501,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",clonidine,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,small molecule,-,-,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
438,438,502,"clonidine lauriad, ba-028",clonidine,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
439,439,502,"clonidine lauriad, ba-028",clonidine,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,small molecule,-,-,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
440,440,502,"clonidine lauriad, ba-028",clonidine,for treatment of diabetic neuropathy; for treatment of ADHD; antimucositic,small molecule,-,-,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
441,441,478,cgt-2168,clopidogrel,antiplatelet agent,small molecule,1997,1997,Q9H244,p2y12_human,P2RY12,GPCR;Rhodopsin,established,approved,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
442,442,1619,plavix,clopidogrel,antithrombotic,small molecule,1997,1997,Q9H244,p2y12_human,P2RY12,GPCR;Rhodopsin,established,approved,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
443,443,NRDD120,-,clozapine,Antipsychotic agent,small molecule,1989,1989,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
444,444,NRDD120,-,clozapine,Antipsychotic agent,small molecule,1989,1989,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
445,445,NRDD120,-,clozapine,Antipsychotic agent,small molecule,1989,1989,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
446,446,NRDD120,-,clozapine,Antipsychotic agent,small molecule,1989,1989,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
447,447,NRDD120,-,clozapine,Antipsychotic agent,small molecule,1989,1989,Q9H3N8,hrh4_human,HRH4,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
448,448,NRDD120,-,clozapine,Antipsychotic agent,small molecule,1989,1989,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
449,449,NRDD120,-,clozapine,Antipsychotic agent,small molecule,1989,1989,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
450,450,NRDD120,-,clozapine,Antipsychotic agent,small molecule,1989,1989,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
451,451,NRDD123,-,cocaine,local anesthetic,small molecule,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
452,452,NRDD123,-,cocaine,local anesthetic,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
453,453,NRDD124,-,codeine,Analgesics; Opioid; Antitussive Agents,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
454,454,NRDD124,-,codeine,Analgesics; Opioid; Antitussive Agents,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
455,455,NRDD124,-,codeine,Analgesics; Opioid; Antitussive Agents,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
456,456,519,"conivaptan, ym-087,vaprisol",conivaptan,for treatment of hyponatremia,small molecule,2005,2005,P37288,v1ar_human,AVPR1A,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
457,457,519,"conivaptan, ym-087,vaprisol",conivaptan,for treatment of hyponatremia,small molecule,2005,2005,P30518,v2r_human,AVPR2,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
458,458,526,"corifollitropin alfa,elonva",corifollitropin alfa,Fertility Agents,protein,-,-,P23945,fshr_human,FSHR,GPCR;Rhodopsin,established,in trial,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
459,459,NRDD127,-,corticotropin,Diagnostic Agents,protein,1950,1950,Q01718,acthr_human,MC2R,GPCR;Rhodopsin,established,approved,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
460,460,528,"corticotropin-releasing factor,xerecept",corticotropin-releasing factor,for treatment of peritumoral brain edema,peptide,-,-,P34998,crfr1_human,CRHR1,GPCR;Secretin,not established,in trial,Peptide ,Corticotropin-releasing factor receptors,Class B1 (Secretin)
461,461,528,"corticotropin-releasing factor,xerecept",corticotropin-releasing factor,for treatment of peritumoral brain edema,peptide,-,-,Q13324,crfr2_human,CRHR2,GPCR;Secretin,not established,in trial,Peptide ,Corticotropin-releasing factor receptors,Class B1 (Secretin)
462,462,NRDD128,-,cosyntropin,Diagnostic Agents,peptide,1970,1970,Q01718,acthr_human,MC2R,GPCR;Rhodopsin,established,approved,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
463,463,MMAmar2016_0127,cpb-307,cpb-307,for treatment of autoimmune diseases,small molecule,-,-,P21453,s1pr1_human,S1PR1,GPCR;Rhodopsin,established,in trial,Lipid ,Lysophospholipid (S1P) receptors,Class A (Rhodopsin)
464,464,539,cr665,cr665,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
465,465,540,cr845,cr845,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
466,466,546,crth2 receptor antagonist,crth2 receptor antagonist,Anti-Allergic Agents,small molecule,-,-,Q9Y5Y4,gpr44_human,GPR44,GPCR;Rhodopsin,not established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
467,467,2376,ctce-9908,ctce-9908,Antineoplastic agent,protein,-,-,P61073,cxcr4_human,CXCR4,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
468,468,2268,ctp-499,ctp-499,for treatment of diabetic nephropathy,small molecule,-,-,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
469,469,2268,ctp-499,ctp-499,for treatment of diabetic nephropathy,small molecule,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
470,470,2823,cur-61414,cur-61414,Antineoplastic agent,small molecule,-,-,Q99835,smo_human,SMO,GPCR;Frizzled,established,in trial,Protein ,Frizzled,Class F (Frizzled)
471,471,568,cvt-3619,cvt-3619,Antihyperlipidemic agent,small molecule,-,-,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
472,472,569,cvt-6883,cvt-6883,Anti-Asthmatic Agents,small molecule,-,-,P29275,aa2br_human,ADORA2B,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
473,473,NRDD130,-,cyclizine,Antiemetics,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
474,474,NRDD131,-,cyclobenzaprine,Antidepressive Agents; Tricyclic,small molecule,1977,1977,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
475,475,2489,"cyclobenzaprine hydrochloride extended-release capsules,amrix",cyclobenzaprine,Muscle Relaxants,small molecule,1977,1977,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
476,476,MMAmay2016_0082,tnx-102,cyclobenzaprine,for treatment of fibromyalgia,small molecule,1977,1977,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
477,477,NRDD132,-,cyclopentolate,Mydriatics,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
478,478,NRDD134,-,cycrimine,Antiparkinson agents,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
479,479,NRDD135,-,cyproheptadine,Anti-Allergic Agents; Appetite Stimulant,small molecule,1961,1961,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
480,480,NRDD135,-,cyproheptadine,Anti-Allergic Agents; Appetite Stimulant,small molecule,1961,1961,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
481,481,590,"dac:glp-1, cjc-1131",dac:glp-1,Antidiabetic,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
482,482,591,dac:grf,dac:grf,hormone replacement,peptide,-,-,Q02643,ghrhr_human,GHRHR,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
483,483,NRDD139,-,danazol,Antiendometriosis Agent; Antineoplastic agent,small molecule,1976,1976,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
484,484,NRDD139,-,danazol,Antiendometriosis Agent; Antineoplastic agent,small molecule,1976,1976,Q96P88,gnrr2_human,GNRHR2,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
485,485,2297,optina,danazol,for treatment of diabetic macular edema,small molecule,1976,1976,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
486,486,2297,optina,danazol,for treatment of diabetic macular edema,small molecule,1976,1976,Q96P88,gnrr2_human,GNRHR2,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
487,487,NRDD141,-,dapiprazole,opthalmological agent,small molecule,1990,1990,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
488,488,NRDD141,-,dapiprazole,opthalmological agent,small molecule,1990,1990,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
489,489,NRDD141,-,dapiprazole,opthalmological agent,small molecule,1990,1990,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
490,490,598,"darifenacin,enablex, emselex",darifenacin,for treatment of overactive bladder,small molecule,2004,2004,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
491,491,599,darusentan,darusentan,Antihypertensive agent,small molecule,-,-,P25101,ednra_human,EDNRA,GPCR;Rhodopsin,established,in trial,Peptide ,Endothelin receptors,Class A (Rhodopsin)
492,492,NRDD143,-,debrisoquin,Antihypertensive agent,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
493,493,NRDD143,-,debrisoquin,Antihypertensive agent,small molecule,-,-,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
494,494,NRDD143,-,debrisoquin,Antihypertensive agent,small molecule,-,-,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
495,495,NRDD143,-,debrisoquin,Antihypertensive agent,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
496,496,NRDD143,-,debrisoquin,Antihypertensive agent,small molecule,-,-,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
497,497,NRDD143,-,debrisoquin,Antihypertensive agent,small molecule,-,-,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
498,498,610,degarelix,degarelix,Antineoplastic agent,small molecule,2008,2008,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
499,499,610,degarelix,degarelix,Antineoplastic agent,small molecule,2008,2008,Q96P88,gnrr2_human,GNRHR2,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
500,500,614,"denufosol tetrasodium, ins37217 respiratory",denufosol,for treatment of cystic fibrosis,small molecule,-,-,P41231,p2ry2_human,P2RY2,GPCR;Rhodopsin,not established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
501,501,NRDD148,-,desipramine,Antidepressive Agents; Tricyclic,small molecule,-,-,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
502,502,NRDD148,-,desipramine,Antidepressive Agents; Tricyclic,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
503,503,NRDD148,-,desipramine,Antidepressive Agents; Tricyclic,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
504,504,NRDD148,-,desipramine,Antidepressive Agents; Tricyclic,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
505,505,NRDD148,-,desipramine,Antidepressive Agents; Tricyclic,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
506,506,620,"desloratadine , clarinex",desloratadine,Anti-Allergic Agents,small molecule,2001,2001,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
507,507,1537,"ox 19, sublingual desmopressin",desmopressin,for treatment of incontinence,peptide,1978,1978,P37288,v1ar_human,AVPR1A,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
508,508,1537,"ox 19, sublingual desmopressin",desmopressin,for treatment of incontinence,peptide,1978,1978,P47901,v1br_human,AVPR1B,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
509,509,1537,"ox 19, sublingual desmopressin",desmopressin,for treatment of incontinence,peptide,1978,1978,P30518,v2r_human,AVPR2,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
510,510,MMAjun2016_0039,"nocdurna,  desmopressin",desmopressin (vasopressin),Antidiuretic Agents,peptide,-,-,P37288,v1ar_human,AVPR1A,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
511,511,MMAjun2016_0040,"nocdurna,  desmopressin",desmopressin (vasopressin),Antidiuretic Agents,peptide,-,-,P47901,v1br_human,AVPR1B,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
512,512,MMAjun2016_0041,"nocdurna,  desmopressin",desmopressin (vasopressin),Antidiuretic Agents,peptide,-,-,P30518,v2r_human,AVPR2,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
513,513,MMAmay2016_0771,jzp-386,"deuterium containing analog of sodium oxybate, gamma hydroxybutyric acid",for treatment of sleep disorders; narcolepsy,small molecule,2002,2002,O75899,gabr2_human,GABBR2,GPCR;Glutamate,established,in trial,Amino acid ,GABAB receptors,Class C (Glutamate) 
514,514,MMAmay2016_0773,jzp-386,"deuterium containing analog of sodium oxybate, gamma hydroxybutyric acid",for treatment of sleep disorders; narcolepsy,small molecule,2002,2002,Q9UBS5,gabr1_human,GABBR1,GPCR;Glutamate,established,in trial,Amino acid ,GABAB receptors,Class C (Glutamate) 
515,515,NRDD153,-,dexbrompheniramine,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
516,516,626,"dexloxiglumide, cr 2017",dexloxiglumide,motilitant,small molecule,-,-,P32238,cckar_human,CCKAR,GPCR;Rhodopsin,established,in trial,Peptide ,Cholecystokinin receptors,Class A (Rhodopsin)
517,517,MMAapril2016_0144,"dex-in, intranasal dexmedetomidin",dexmedetomidin,Analgesics,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
518,518,NRDD155,-,dexmedetomidine,Analgesics; Hypnotics and Sedatives,small molecule,-,1999,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
519,519,627,"dexpramipexole, kns-760704",dexpramipexole,for treatment of amyotrophic lateral sclerosis (ALS),small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
520,520,627,"dexpramipexole, kns-760704",dexpramipexole,for treatment of amyotrophic lateral sclerosis (ALS),small molecule,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
521,521,627,"dexpramipexole, kns-760704",dexpramipexole,for treatment of amyotrophic lateral sclerosis (ALS),small molecule,-,-,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
522,522,NRDD157,-,dezocine,Analgesics; Opioid,small molecule,-,1989,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
523,523,NRDD157,-,dezocine,Analgesics; Opioid,small molecule,-,1989,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
524,524,629,dg041,dg041,Platelet Aggregation Inhibitor,small molecule,-,-,P43115,pe2r3_human,PTGER3,GPCR;Rhodopsin,established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
525,525,632,dg3173,dg3173,hormone replacement,small molecule,-,-,P30872,ssr1_human,SSTR1,GPCR;Rhodopsin,established,in trial,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
526,526,632,dg3173,dg3173,hormone replacement,small molecule,-,-,P30874,ssr2_human,SSTR2,GPCR;Rhodopsin,established,in trial,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
527,527,632,dg3173,dg3173,hormone replacement,small molecule,-,-,P31391,ssr4_human,SSTR4,GPCR;Rhodopsin,not established,in trial,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
528,528,632,dg3173,dg3173,hormone replacement,small molecule,-,-,P35346,ssr5_human,SSTR5,GPCR;Rhodopsin,established,in trial,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
529,529,NRDD162,-,dicyclomine,Antispasmodics,small molecule,1950,1950,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
530,530,1214,"map-0004, tempo migraine,levadex",dihydroergotamine,Anti-migraine Agents,small molecule,-,-,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
531,531,1214,"map-0004, tempo migraine,levadex",dihydroergotamine,Anti-migraine Agents,small molecule,-,-,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
532,532,1356,mt 300,dihydroergotamine,Anti-migraine Agents,small molecule,-,-,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
533,533,1356,mt 300,dihydroergotamine,Anti-migraine Agents,small molecule,-,-,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
534,534,NRDD170,-,dimenhydrinate,Antiemetics,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
535,535,NRDD171,-,dinoprost tromethamine,Abortifacient Agents,small molecule,1981,1981,P43119,pi2r_human,PTGIR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
536,536,NRDD172,-,dinoprostone,Abortifacient Agents,small molecule,1977,1977,P34995,pe2r1_human,PTGER1,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
537,537,NRDD172,-,dinoprostone,Abortifacient Agents,small molecule,1977,1977,P43116,pe2r2_human,PTGER2,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
538,538,NRDD172,-,dinoprostone,Abortifacient Agents,small molecule,1977,1977,P43115,pe2r3_human,PTGER3,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
539,539,NRDD172,-,dinoprostone,Abortifacient Agents,small molecule,1977,1977,P35408,pe2r4_human,PTGER4,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
540,540,NRDD173,-,diphemanil methylsulfate,Bronchodilator agent,small molecule,1976,1976,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
541,541,NRDD174,-,diphenhydramine,Anti-Allergic Agents; Hypnotics and sedatives; Antiemetics; Antipruritics; Antitussives,small molecule,1946,1946,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
542,542,NRDD175,-,diphenidol,Antiemetics,small molecule,1967,1967,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
543,543,NRDD175,-,diphenidol,Antiemetics,small molecule,1967,1967,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
544,544,NRDD175,-,diphenidol,Antiemetics,small molecule,1967,1967,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
545,545,NRDD176,-,diphenoxylate,Antidiuretic Agents,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
546,546,NRDD177,-,diphenylpyraline,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
547,547,NRDD178,-,dipivefrin,opthalmological agent,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
548,548,644,"diquafosol tetrasodium, ins365 ophthalmic,prolacria",diquafosol,opthalmological agent,small molecule,-,-,P41231,p2ry2_human,P2RY2,GPCR;Rhodopsin,not established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
549,549,NRDD182,-,dobutamine,Cardiotonic Agents,small molecule,1978,1978,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
550,550,NRDD184,-,domperidone,Antiemetics,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
551,551,NRDD185,-,doxacurium,Muscle Relaxants,small molecule,-,1991,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
552,552,NRDD186,-,doxacurium chloride,Muscle Relaxants,small molecule,1991,1991,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
553,553,NRDD187,-,doxazosin,Anticholesteremic Agents; Antihypertensive agent; Vasodilator Agents,small molecule,1990,1990,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
554,554,NRDD187,-,doxazosin,Anticholesteremic Agents; Antihypertensive agent; Vasodilator Agents,small molecule,1990,1990,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
555,555,NRDD187,-,doxazosin,Anticholesteremic Agents; Antihypertensive agent; Vasodilator Agents,small molecule,1990,1990,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
556,556,1851,silenor (so-101),doxepin,Hypnotics and Sedatives,small molecule,1969,1969,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
557,557,1851,silenor (so-101),doxepin,Hypnotics and Sedatives,small molecule,1969,1969,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
558,558,1851,silenor (so-101),doxepin,Hypnotics and Sedatives,small molecule,1969,1969,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
559,559,1851,silenor (so-101),doxepin,Hypnotics and Sedatives,small molecule,1969,1969,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
560,560,1851,silenor (so-101),doxepin,Hypnotics and Sedatives,small molecule,1969,1969,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
561,561,1851,silenor (so-101),doxepin,Hypnotics and Sedatives,small molecule,1969,1969,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
562,562,1851,silenor (so-101),doxepin,Hypnotics and Sedatives,small molecule,1969,1969,P25021,hrh2_human,HRH2,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
563,563,1851,silenor (so-101),doxepin,Hypnotics and Sedatives,small molecule,1969,1969,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
564,564,1851,silenor (so-101),doxepin,Hypnotics and Sedatives,small molecule,1969,1969,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
565,565,1851,silenor (so-101),doxepin,Hypnotics and Sedatives,small molecule,1969,1969,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
566,566,NRDD188,-,doxylamine,Anti-Allergic Agents; Antiemetics; Antitussive Agents; Hypnotics and Sedatives,small molecule,1948,1948,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
567,567,MMAmay2016_0669,diclectin + diclegis; doxylamine succinate + pyridoxine hydrochloride dr tablets,doxylamine,Antihistamine; for nausea and vomiting of pregnancy,small molecule,1948,1948,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
568,568,MMAfeb2016_0095,"drm04, anticholinergic","drm04, anticholinergic",for treatment of hyperhidrosis,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
569,569,437,"cat-310 , relivar",dronabinol,Analgesics,small molecule,1985,1985,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,approved,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
570,570,438,"cat-310,relivar",dronabinol,Analgesics,small molecule,1985,1985,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,approved,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
571,571,667,"dronabinol ,marinol",dronabinol,Appetite stimulant,small molecule,1985,1985,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,approved,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
572,572,667,"dronabinol ,marinol",dronabinol,Appetite stimulant,small molecule,1985,1985,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,approved,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
573,573,NRDD190,-,dronedarone,Anti-Arrhythmia Agents,small molecule,2009,2009,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
574,574,NRDD190,-,dronedarone,Anti-Arrhythmia Agents,small molecule,2009,2009,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
575,575,2270,dronedarone,dronedarone,Anti-Arrhythmia Agents,small molecule,2009,2009,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
576,576,2270,dronedarone,dronedarone,Anti-Arrhythmia Agents,small molecule,2009,2009,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
577,577,NRDD191,-,droperidol,Adjuvants; Anesthesia,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
578,578,2272,droxidopa,droxidopa,for treatment of orthostatic hypotension,small molecule,2014,2014,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
579,579,2272,droxidopa,droxidopa,for treatment of orthostatic hypotension,small molecule,2014,2014,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
580,580,2272,droxidopa,droxidopa,for treatment of orthostatic hypotension,small molecule,2014,2014,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
581,581,2272,droxidopa,droxidopa,for treatment of orthostatic hypotension,small molecule,2014,2014,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
582,582,2272,droxidopa,droxidopa,for treatment of orthostatic hypotension,small molecule,2014,2014,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
583,583,2272,droxidopa,droxidopa,for treatment of orthostatic hypotension,small molecule,2014,2014,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
584,584,2272,droxidopa,droxidopa,for treatment of orthostatic hypotension,small molecule,2014,2014,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
585,585,2272,droxidopa,droxidopa,for treatment of orthostatic hypotension,small molecule,2014,2014,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
586,586,2272,droxidopa,droxidopa,for treatment of orthostatic hypotension,small molecule,2014,2014,P13945,adrb3_human,ADRB3,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
587,587,2280,dsc127,dsc127,for treatment of diabetic foot ulcers,peptide,-,-,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,in trial,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
588,588,MMAmay2016_0762,"dulaglutide, glp-1fc, trulicity, ly2189265",duglaglutide,Antidiabetic; type II diabetes,protein,-,2014,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
589,589,686,ecopipam,ecopipam,for treatment of tourettes syndrome; for treatment of pathological gambling,small molecule,-,-,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
590,590,MMAmar2016_0245,"efpeglenatide, hm11260c","efpeglenatide, hm11260c",Antidiabetic,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
591,591,1731,relpax,eletriptan,Anti-migraine Agents,small molecule,2002,2002,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
592,592,701,"elinogrel, prt060128, adp receptor antagonist",elinogrel,antiplatelet agent,small molecule,-,-,Q9H244,p2y12_human,P2RY12,GPCR;Rhodopsin,established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
593,593,2464,zp1846,elsiglutide,Antidiuretic Agents,peptide,-,-,O95838,glp2r_human,GLP2R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
594,594,MMAmar2016_0086,eltoprazine,eltoprazine,for treatment of adverse effects; dyskinesias,small molecule,-,-,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
595,595,MMAmar2016_0087,eltoprazine,eltoprazine,for treatment of adverse effects; dyskinesias,small molecule,-,-,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
596,596,MMAmay2016_0377,ema401,ema401,for treatment of peripheral neuropathic pain; post herpetic neuralgia,small molecule,-,-,P50052,agtr2_human,AGTR2,GPCR;Rhodopsin,not established,in trial,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
597,597,NRDD199,-,emedastine,Anti-Allergic Agents,small molecule,1997,1997,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
598,598,715,ep-100,ep-100,Antineoplastic agent,peptide,-,-,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,in trial,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
599,599,715,ep-100,ep-100,Antineoplastic agent,peptide,-,-,Q96P88,gnrr2_human,GNRHR2,GPCR;Rhodopsin,established,in trial,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
600,600,NRDD204,-,ephedrine,Central Nervous System Stimulants,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
601,601,719,epinastine,epinastine,Anti-Allergic Agents,small molecule,2003,2003,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
602,602,719,epinastine,epinastine,Anti-Allergic Agents,small molecule,2003,2003,P25021,hrh2_human,HRH2,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
603,603,2066,"transdermal lidocaine/epinephrine patch,lidosite",epinephrine,Anesthetics,small molecule,1976,1976,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
604,604,2066,"transdermal lidocaine/epinephrine patch,lidosite",epinephrine,Anesthetics,small molecule,1976,1976,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
605,605,2066,"transdermal lidocaine/epinephrine patch,lidosite",epinephrine,Anesthetics,small molecule,1976,1976,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
606,606,2066,"transdermal lidocaine/epinephrine patch,lidosite",epinephrine,Anesthetics,small molecule,1976,1976,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
607,607,2066,"transdermal lidocaine/epinephrine patch,lidosite",epinephrine,Anesthetics,small molecule,1976,1976,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
608,608,2066,"transdermal lidocaine/epinephrine patch,lidosite",epinephrine,Anesthetics,small molecule,1976,1976,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
609,609,2066,"transdermal lidocaine/epinephrine patch,lidosite",epinephrine,Anesthetics,small molecule,1976,1976,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
610,610,721,"eplivanserine, sr 46349,ciltyri",eplivanserine,for treatment of insomnia,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
611,611,721,"eplivanserine, sr 46349,ciltyri",eplivanserine,for treatment of insomnia,small molecule,-,-,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
612,612,NRDD206,-,epoprostenol,Antihypertensive agent; Platelet Aggregation Inhibitors,small molecule,1995,1995,P43119,pi2r_human,PTGIR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
613,613,NRDD207,-,eprosartan,Antihypertensive agent,small molecule,1997,1997,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,approved,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
614,614,NRDD209,-,ergoloid mesylate,Nootropic Agents; Vasodilator Agents,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
615,615,NRDD209,-,ergoloid mesylate,Nootropic Agents; Vasodilator Agents,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
616,616,NRDD210,-,ergotamine,Anti-migraine Agents,small molecule,-,-,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
617,617,NRDD210,-,ergotamine,Anti-migraine Agents,small molecule,-,-,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
618,618,732,"esmirtazapine, org-4420",esmirtazapine,for treatment of insomnia; for treatment of menopausal symptoms,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
619,619,732,"esmirtazapine, org-4420",esmirtazapine,for treatment of insomnia; for treatment of menopausal symptoms,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
620,620,NRDD212,-,esmolol,Anti-Arrhythmia Agents,small molecule,1986,1986,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
621,621,MMAapril2016_0047,"etelcalcetide, amg 416, velcalcetide, kai-4169, ono-5163","etelcalcetide, amg 416, velcalcetide, kai-4169, ono-5163",for treatment of parathyroid disorders,peptide,-,-,P41180,casr_human,CASR,GPCR;Glutamate,established,in trial,Ion ,Calcium-sensing receptors,Class C (Glutamate) 
622,622,NRDD217,-,ethopropazine,Antidyskinetics,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
623,623,749,"etilevodopa, tv-1203",etilevodopa,Antiparkinson agent,small molecule,-,-,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
624,624,749,"etilevodopa, tv-1203",etilevodopa,Antiparkinson agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
625,625,749,"etilevodopa, tv-1203",etilevodopa,Antiparkinson agent,small molecule,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
626,626,749,"etilevodopa, tv-1203",etilevodopa,Antiparkinson agent,small molecule,-,-,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
627,627,749,"etilevodopa, tv-1203",etilevodopa,Antiparkinson agent,small molecule,-,-,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
628,628,NRDD222,-,etomidate,Anesthetics; Intravenous,small molecule,1982,1982,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
629,629,769,exenatide,exenatide,Antidiabetic,peptide,2005,2005,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
630,630,1046,itca 650,exenatide,Antidiabetic,peptide,2005,2005,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
631,631,MMAjun2016_0019,exendin (9-39) ,exendin (9-39) ,for treatment of hypoglycemia,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
632,632,1572,pc-dac:exendin-4,exendin-4,Antidiabetic,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
633,633,929,"hzt-501,  ibuprofen + famotidine,duexa",famotidine,acid reducer,small molecule,1986,1986,P25021,hrh2_human,HRH2,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
634,634,929,"hzt-501,  ibuprofen + famotidine,duexa",famotidine,for treatment of gastric ulcer and gastroesophageal reflux,small molecule,1986,1986,P25021,hrh2_human,HRH2,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
635,635,1539,ox17,famotidine,acid reducer,small molecule,1986,1986,P25021,hrh2_human,HRH2,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
636,636,MMAmar2016_0121,nfc-1,fasoracetam monohydrate,for treatment of attention deficit hyperactivity disorder (ADHD),small molecule,-,-,Q13255,grm1_human,GRM1,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
637,637,MMAmar2016_0122,nfc-1,fasoracetam monohydrate,for treatment of attention deficit hyperactivity disorder (ADHD),small molecule,-,-,P41594,grm5_human,GRM5,GPCR;Glutamate,established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
638,638,MMAmar2016_0123,nfc-1,fasoracetam monohydrate,for treatment of attention deficit hyperactivity disorder (ADHD),small molecule,-,-,Q14832,grm3_human,GRM3,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
639,639,MMAmar2016_0124,nfc-1,fasoracetam monohydrate,for treatment of attention deficit hyperactivity disorder (ADHD),small molecule,-,-,Q14831,grm7_human,GRM7,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
640,640,MMAmar2016_0125,nfc-1,fasoracetam monohydrate,for treatment of attention deficit hyperactivity disorder (ADHD),small molecule,-,-,Q14416,grm2_human,GRM2,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
641,641,MMAmar2016_0125,nfc-1,fasoracetam monohydrate,for treatment of attention deficit hyperactivity disorder (ADHD),small molecule,-,-,Q14833,grm4_human,GRM4,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
642,642,MMAmar2016_0125,nfc-1,fasoracetam monohydrate,for treatment of attention deficit hyperactivity disorder (ADHD),small molecule,-,-,O15303,grm6_human,GRM6,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
643,643,MMAmar2016_0125,nfc-1,fasoracetam monohydrate,for treatment of attention deficit hyperactivity disorder (ADHD),small molecule,-,-,O00222,grm8_human,GRM8,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
644,644,NRDD226,-,felypressin,Hemostatic agents; Vasoconstricting Agents,peptide,-,-,P37288,v1ar_human,AVPR1A,GPCR;Rhodopsin,established,in trial,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
645,645,MMAmar2016_0273,"zx008, brabafen, low-dose fenfluramine",fenfluramine,for treatment of epilepsy; Dravet's syndrome,small molecule,-,-,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
646,646,MMAmar2016_0274,"zx008, brabafen, low-dose fenfluramine",fenfluramine,for treatment of epilepsy; Dravet's syndrome,small molecule,-,-,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
647,647,778,"fenoldopam mesylate, skf-82526,corlopam",fenoldopam,Antihypertensive agent,small molecule,1997,1997,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
648,648,778,"fenoldopam mesylate, skf-82526,corlopam",fenoldopam,Antihypertensive agent,small molecule,1997,1997,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
649,649,NRDD229,-,fenoterol,Bronchodilator agent; Tocolytic Agents,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
650,650,51,ad 923,fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
651,651,51,ad 923,fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
652,652,69,aerolef,fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
653,653,69,aerolef,fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
654,654,259,at3022,fentanyl,Analgesics; opioid,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
655,655,259,at3022,fentanyl,Analgesics; opioid,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
656,656,303,"az-003, staccato fentanyl",fentanyl,adjuvant to anesthesia,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
657,657,303,"az-003, staccato fentanyl",fentanyl,adjuvant to anesthesia,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
658,658,334,"bema fentanyl,onsolis, breakyl",fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
659,659,334,"bema fentanyl,onsolis, breakyl",fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
660,660,394,buccal fentanyl,fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
661,661,394,buccal fentanyl,fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
662,662,775,"febt,fentora, effentora",fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
663,663,775,"febt,fentora, effentora",fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
664,664,780,"fentanyl (sublingual), kw-2246,abstral, rapinyl",fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
665,665,780,"fentanyl (sublingual), kw-2246,abstral, rapinyl",fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
666,666,781,"fentanyl citrate,pecfent, nasalfent",fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
667,667,781,"fentanyl citrate,pecfent, nasalfent",fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
668,668,782,"fentanyl lauriad, ba-041",fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
669,669,782,"fentanyl lauriad, ba-041",fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
670,670,783,fentanyl mdts,fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
671,671,783,fentanyl mdts,fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
672,672,784,"fentanyl spray, intranasal,instanyl",fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
673,673,784,"fentanyl spray, intranasal,instanyl",fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
674,674,785,fentanyl sublingual spray,fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
675,675,785,fentanyl sublingual spray,fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
676,676,786,fentanyl taifun,fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
677,677,786,fentanyl taifun,fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
678,678,787,"fentanyl transdermal system,duragesic, ionsys",fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
679,679,787,"fentanyl transdermal system,duragesic, ionsys",fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
680,680,2069,"transmucosal fentanyl,actiq",fentanyl,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
681,681,2069,"transmucosal fentanyl,actiq",fentanyl,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
682,682,788,"fesoterodine fumarate, spm 907,toviaz",fesoterodine,for treatment of overactive bladder syndrome,small molecule,2008,2008,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
683,683,789,fexofenadine + ps/,fexofenadine,Anti-Allergic Agents,small molecule,1996,1996,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
684,684,794,"fingolimod, fty 720,gilenia, gilenya",fingolimod,For treatment of Multiple Sclerosis,small molecule,2010,2010,P21453,s1pr1_human,S1PR1,GPCR;Rhodopsin,established,approved,Lipid ,Lysophospholipid (S1P) receptors,Class A (Rhodopsin)
685,685,795,"fipamezole , jp-1730",fipamezole,Antiparkinson agent,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
686,686,796,"fipamezole, jp-1730",fipamezole,Antiparkinson agent,small molecule,-,-,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
687,687,796,"fipamezole, jp-1730",fipamezole,Antiparkinson agent,small molecule,-,-,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
688,688,799,fk352b,fk352b,Antihypertensive agent,small molecule,-,-,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
689,689,NRDD230,-,flavoxate,Antispasmodics,small molecule,1970,1970,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
690,690,NRDD230,-,flavoxate,Antispasmodics,small molecule,1970,1970,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
691,691,801,flibanserin,flibanserin,for treatment of female sexual dysfunction,small molecule,2015,2015,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
692,692,801,flibanserin,flibanserin,for treatment of female sexual dysfunction,small molecule,2015,2015,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
693,693,NRDD236,-,flunarizine,Anticonvulsants; Vasodilator Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
694,694,1440,"npl-2008, fluoxetine",fluoxetine,for treatment of autism,small molecule,1987,1987,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
695,695,NRDD240,-,flupenthixol,Antipsychotic agent,small molecule,-,-,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
696,696,NRDD240,-,flupenthixol,Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
697,697,NRDD241,-,fluphenazine,Antipsychotic agent,small molecule,1959,1959,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
698,698,NRDD241,-,fluphenazine,Antipsychotic agent,small molecule,1959,1959,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
699,699,NRDD244,-,fluspirilene,Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
700,700,MMAmay2016_0738,"bemfola, afolia recombinant follicle stimulating hormone",follitropin alfa,Fertility Agents,protein,-,-,P23945,fshr_human,FSHR,GPCR;Rhodopsin,established,approved,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
701,701,814,"follitropin alpha ,gonal-f",follitropin alpha,Fertility Agents,protein,-,-,P23945,fshr_human,FSHR,GPCR;Rhodopsin,established,approved,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
702,702,NRDD246,-,follitropin beta,Fertility Agents,protein,-,1997,P23945,fshr_human,FSHR,GPCR;Rhodopsin,established,approved,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
703,703,NRDD248,-,forasartan,Antihypertensive agent,small molecule,-,-,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,in trial,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
704,704,MMAmay2016_0044,aclidinium bromide + formoterol fumarate,formoterol,Anti-Asthmatic Agents; COPD,small molecule,2001,2001,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
705,705,2275,apd209,formoterol,Appetite stimulant,small molecule,2001,2001,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
706,706,397,"budesonide + formoterol,symbicort",formoterol,Bronchodilator agent,small molecule,2001,2001,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
707,707,481,"chf-1535, beclomethasone dipropionate + formoterol fumarate",formoterol,Anti-Asthmatic Agents,small molecule,2001,2001,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
708,708,815,"formoterol ,foradil",formoterol,Bronchodilator agent,small molecule,2001,2001,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
709,709,816,"formoterol fumarate,perforomist",formoterol,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,2001,2001,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
710,710,1215,map-0005,formoterol,Bronchodilator agent,small molecule,2001,2001,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
711,711,1325,"mometasone furoate + formoterol fumarate dihydrate,dulera",formoterol,Anti-Asthmatic Agents,small molecule,2001,2001,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
712,712,1681,"pt003, glycopyrrolate + formoterol inhalation aerosol",formoterol,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,2001,2001,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
713,713,1682,"pt005, formoterol fumarate hydrofluoroalkane metered dose inhaler",formoterol,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,2001,2001,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
714,714,1861,"skyepharma,flutiform",formoterol,Bronchodilator agent,small molecule,2001,2001,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
715,715,823,"frovatriptan,frovelan, frova",frovatriptan,Anti-migraine Agents,small molecule,2001,2001,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
716,716,823,"frovatriptan,frovelan, frova",frovatriptan,Anti-migraine Agents,small molecule,2001,2001,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
717,717,825,fsh-gex,fsh-gex,Fertility Agents,protein,-,-,P23945,fshr_human,FSHR,GPCR;Rhodopsin,established,in trial,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
718,718,831,fx125l,fx125l,Anti-Asthmatic Agents,small molecule,-,-,P32246,ccr1_human,CCR1,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
719,719,831,fx125l,fx125l,Anti-Asthmatic Agents,small molecule,-,-,P25024,cxcr1_human,CXCR1,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
720,720,831,fx125l,fx125l,Anti-Asthmatic Agents,small molecule,-,-,P25025,cxcr2_human,CXCR2,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
721,721,831,fx125l,fx125l,Anti-Asthmatic Agents,small molecule,-,-,P61073,cxcr4_human,CXCR4,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
722,722,1871,sodium oxybate,gamma hydroxybutyric acid,Hypnotics and Sedatives,small molecule,-,-,Q9UBS5,gabr1_human,GABBR1,GPCR;Glutamate,established,approved,Amino acid ,GABAB receptors,Class C (Glutamate) 
723,723,1871,sodium oxybate,gamma hydroxybutyric acid,Hypnotics and Sedatives,small molecule,-,-,O75899,gabr2_human,GABBR2,GPCR;Glutamate,established,approved,Amino acid ,GABAB receptors,Class C (Glutamate) 
724,724,MMAfeb2016_0055,gc021109,gc021109,for treatment of Alzheimer's disease,small molecule,-,-,Q15077,p2ry6_human,P2RY6,GPCR;Rhodopsin,not established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
725,725,848,gepirone,gepirone,Anti-depressant,small molecule,-,-,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
726,726,699,eligen pyy-3-36 + glp-1,glp,Appetite suppressant,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
727,727,2155,viaderm-glp1 agonist,glp1 agonist ,Antidiabetic,unknown,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
728,728,MMAmay2016_0156,glpg0974,glpg0974,Anti-inflammatory agent; neutrophil driven inflammation; ulcerative colitis,small molecule,-,-,O15552,ffar2_human,FFAR2,GPCR;Rhodopsin,not established,in trial,Lipid ,Free fatty acid receptors,Class A (Rhodopsin)
729,729,MMAapril2016_0323,glpg1205,glpg1205,for ulcerative colitis; IBS,small molecule,-,-,Q9NQS5,gpr84_human,GPR84,GPCR;Rhodopsin,not established,in trial,Orphan ,Class A orphans,Class A (Rhodopsin)
730,730,2458,dio-901,glucagon,for prevention of hypoglycemia,peptide,1960,1960,P47871,glr_human,GCGR,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
731,731,MMAmar2016_0239,zp-glucagon,glucagon,Antidiabetic agent,peptide,1960,1960,P47871,glr_human,GCGR,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
732,732,NRDD256,-,glucagon recombinant,Antihypoglycemic Agents,peptide,-,1960,P47871,glr_human,GCGR,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
733,733,MMAmay2016_0378,ep-101,glycopyrrolate,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,1961,1961,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
734,734,864,"glycopyrrolate, fhpc-02,cuvposa",glycopyrrolate,Antineoplastic agent,small molecule,1961,1961,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
735,735,1680,pt001,glycopyrrolate,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,1961,1961,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
736,736,1681,"pt003, glycopyrrolate + formoterol inhalation aerosol",glycopyrrolate,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,1961,1961,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
737,737,1457,"nva237, inhaled glycopyrronium bromide",glycopyrronium,for treatment of chronic obstructive pulmonary disease (COPD),small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
738,738,1702,"qva149, glycopyrronium bromide + i/",glycopyrronium bromide,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
739,739,NRDD259,-,gonadorelin,Fertility Agents,small molecule,1982,1982,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
740,740,NRDD259,-,gonadorelin,Fertility Agents,small molecule,1982,1982,Q96P88,gnrr2_human,GNRHR2,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
741,741,1904,"stem,ntx-265",gonadotropin,for treatment of stroke,protein,-,-,P22888,lshr_human,LHCGR,GPCR;Rhodopsin,established,approved,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
742,742,NRDD260,-,goserelin,Antineoplastic agents; Hormonal,peptide,1989,1989,P22888,lshr_human,LHCGR,GPCR;Rhodopsin,established,approved,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
743,743,878,gsk-1004723,gsk-1004723,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
744,744,878,gsk-1004723,gsk-1004723,Anti-Allergic Agents,small molecule,-,-,Q9Y5N1,hrh3_human,HRH3,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
745,745,881,gsk-961081,gsk-961081,Bronchodilator agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
746,746,881,gsk-961081,gsk-961081,Bronchodilator agent,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
747,747,885,gtp-010,gtp-010,for treatment of irritable bowel syndrome,protein,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
748,748,886,gtp-200,gtp-200,Appetite stimulant,peptide,-,-,Q92847,ghsr_human,GHSR,GPCR;Rhodopsin,not established,in trial,Peptide ,Ghrelin receptors,Class A (Rhodopsin)
749,749,888,gtx-758,gtx-758,Antineoplastic agent,small molecule,-,-,P22888,lshr_human,LHCGR,GPCR;Rhodopsin,established,in trial,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
750,750,NRDD261,-,guanabenz,Antihypertensive agent,small molecule,1982,1982,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
751,751,889,"guanfacine, spd 503,intuniv",guanfacine,for treatment of ADHD,small molecule,1986,1986,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
752,752,892,gw642444,gw642444,Bronchodilator agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
753,753,NRDD266,-,haloperidol,Antipsychotic agent,small molecule,1967,1967,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
754,754,463,ceplene,histamine,cytorprotective agent during cancer treatment ,small molecule,-,-,P25021,hrh2_human,HRH2,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
755,755,2177,"vp 002, histrelin implant,vantas, supprelin",histrelin,Antineoplastic agent,small molecule,1991,1991,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
756,756,2177,"vp 002, histrelin implant,vantas, supprelin",histrelin,Antineoplastic agent,small molecule,1991,1991,Q96P88,gnrr2_human,GNRHR2,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
757,757,NRDD271,-,homatropine methylbromide,GI Anti-Ulcer Agents; Antimuscarinics,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
758,758,NRDD271,-,homatropine methylbromide,GI Anti-Ulcer Agents; Antimuscarinics,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
759,759,NRDD271,-,homatropine methylbromide,GI Anti-Ulcer Agents; Antimuscarinics,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
760,760,NRDD271,-,homatropine methylbromide,GI Anti-Ulcer Agents; Antimuscarinics,small molecule,-,-,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
761,761,NRDD271,-,homatropine methylbromide,GI Anti-Ulcer Agents; Antimuscarinics,small molecule,-,-,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
762,762,1907,"substance p,homspera, radilex, viprovex",homspera,for treatment of idiopathic pulmonary fibrosis,protein,-,-,P25103,nk1r_human,TACR1,GPCR;Rhodopsin,established,in trial,Peptide ,Tachykinin receptors,Class A (Rhodopsin)
763,763,2153,viaderm hpth 1-34,h-pth 1-34,Anti-osteoporotic agent,peptide,-,-,Q03431,pth1r_human,PTH1R,GPCR;Secretin,established,approved,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
764,764,2153,viaderm hpth 1-34,h-pth 1-34,Anti-osteoporotic agent,peptide,-,-,P49190,pth2r_human,PTH2R,GPCR;Secretin,established,in trial,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
765,765,MMAmay2016_0753,hydrocodone bitartrate with acetaminophen,hydrocodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
766,766,MMAmay2016_0754,hydrocodone bitartrate with acetaminophen,hydrocodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
767,767,1686,pti-701,hydrocodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
768,768,1686,pti-701,hydrocodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
769,769,MMAmar2016_0081,"s-718632, extended release hydrocodone",hydrocodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
770,770,MMAmar2016_0082,"s-718632, extended release hydrocodone",hydrocodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
771,771,2254,"zx002, hydrocodone bitartrate",hydrocodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
772,772,2254,"zx002, hydrocodone bitartrate",hydrocodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
773,773,MMAmar2016_0009,"hysingla er, hydrocodone bitartrate extended release",hydrocodone bitartrate,Analgesics,small molecule,-,2014,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
774,774,MMAmar2016_0010,"hysingla er, hydrocodone bitartrate extended release",hydrocodone bitartrate,Analgesics,small molecule,-,2014,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
775,775,MMAapril2016_0192,hydrocodone deterx,hydrocodone deterx,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
776,776,MMAapril2016_0193,hydrocodone deterx,hydrocodone deterx,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
777,777,MMAapril2016_0260,"ltx-04,  hydromorphone hcl",hydromorphone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
778,778,MMAapril2016_0261,"ltx-04,  hydromorphone hcl",hydromorphone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
779,779,MMAapril2016_0262,"ltx-04,  hydromorphone hcl",hydromorphone,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
780,780,1422,"nmed-1077,exalgo, jurnista, dilaudid",hydromorphone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
781,781,1422,"nmed-1077,exalgo, jurnista, dilaudid",hydromorphone,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
782,782,1422,"nmed-1077,exalgo, jurnista, dilaudid",hydromorphone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
783,783,NRDD275,-,hydroxyzine,Antipruritics; Anxiolytics sedatives and hypnotics,small molecule,1956,1956,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
784,784,797,"firazyr, icatibant, je049",icatibant,for treatment of hereditary angioedema,small molecule,2011,2011,P30411,bkrb2_human,BDKRB2,GPCR;Rhodopsin,established,approved,Peptide ,Bradykinin receptors,Class A (Rhodopsin)
785,785,942,iferanserin ointment,iferanserin,Antihemorrhoidal agent,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
786,786,MMAmay2016_0414,"iferanserin ointment, ven 309",iferanserin,Antihemorrhoidal agent,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
787,787,951,"iloperidone,fanapt, fiapta, zomaril",iloperidone,Antipsychotic agent; atypical,small molecule,2009,2009,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
788,788,951,"iloperidone,fanapt, fiapta, zomaril",iloperidone,Antipsychotic agent; atypical,small molecule,2009,2009,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
789,789,951,"iloperidone,fanapt, fiapta, zomaril",iloperidone,Antipsychotic agent; atypical,small molecule,2009,2009,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
790,790,951,"iloperidone,fanapt, fiapta, zomaril",iloperidone,Antipsychotic agent; atypical,small molecule,2009,2009,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
791,791,951,"iloperidone,fanapt, fiapta, zomaril",iloperidone,Antipsychotic agent; atypical,small molecule,2009,2009,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
792,792,951,"iloperidone,fanapt, fiapta, zomaril",iloperidone,Antipsychotic agent; atypical,small molecule,2009,2009,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
793,793,951,"iloperidone,fanapt, fiapta, zomaril",iloperidone,Antipsychotic agent; atypical,small molecule,2009,2009,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
794,794,951,"iloperidone,fanapt, fiapta, zomaril",iloperidone,Antipsychotic agent; atypical,small molecule,2009,2009,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
795,795,951,"iloperidone,fanapt, fiapta, zomaril",iloperidone,Antipsychotic agent; atypical,small molecule,2009,2009,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
796,796,951,"iloperidone,fanapt, fiapta, zomaril",iloperidone,Antipsychotic agent; atypical,small molecule,2009,2009,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
797,797,952,"iloprost,ventavis",iloprost,Antihypertensive agent,small molecule,2004,2004,P34995,pe2r1_human,PTGER1,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
798,798,952,"iloprost,ventavis",iloprost,Antihypertensive agent,small molecule,2004,2004,P43119,pi2r_human,PTGIR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
799,799,966,incb3284,incb3284,Anti-inflammatory agent; DMARD,small molecule,-,-,P41597,ccr2_human,CCR2,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
800,800,969,indacaterol,indacaterol,Bronchodilator agent,small molecule,2011,2011,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
801,801,1702,"qva149, glycopyrronium bromide + indacaterol",indacaterol,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,2011,2011,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
802,802,985,ino-8875,ino-8875,for treatment of glaucoma,small molecule,-,-,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
803,803,990,ins37217,ins37217,for treatment of rhegmatogenous retinal detachment,small molecule,-,-,P41231,p2ry2_human,P2RY2,GPCR;Rhodopsin,not established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
804,804,991,ins37217 intranasal,ins37217,for treatment of cystic fibrosis; for treatment of perennial allergic rhinitis,small molecule,-,-,P41231,p2ry2_human,P2RY2,GPCR;Rhodopsin,not established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
805,805,992,ins-50589,ins-50589,antithrombotic,unknown,-,-,Q9H244,p2y12_human,P2RY12,GPCR;Rhodopsin,established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
806,806,MMAapril2016_0196,int-767,int-767,Treatment of liver fibrosis,small molecule,-,-,Q8TDU6,gpbar_human,GPBAR1,GPCR;Rhodopsin,not established,in trial,Steroid ,Bile acid receptors,Class A (Rhodopsin)
807,807,MMAmay2016_0225,"inv102, nadolol","inv102, nadolol",for inflammatory lung disease,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
808,808,2824,ipi-926,ipi-926,Antineoplastic agent,small molecule,-,-,Q99835,smo_human,SMO,GPCR;Frizzled,established,in trial,Protein ,Frizzled,Class F (Frizzled)
809,809,1021,"ipratropium bromide + albuterol sulfate,duoneb",ipratropium,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,1986,1986,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
810,810,1021,"ipratropium bromide + albuterol sulfate,duoneb",ipratropium,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,1986,1986,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
811,811,1023,"irbesartan,avapro, irbetan",irbesartan,Antihypertensive agent,small molecule,1997,1997,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,approved,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
812,812,1030,isis 325568,isis 325568,Antidiabetic,antisense oligo,-,-,P47871,glr_human,GCGR,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
813,813,NRDD290,-,isoetharine,Bronchodilator agent,small molecule,-,-,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
814,814,MMAmar2016_0022,"tnx-201, single isomer isometheptene, imh",isometheptene mucate,Anti-migraine Agents,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
815,815,NRDD293,-,isoproterenol,Bronchodilator agent; Cardiotonic Agents,small molecule,-,-,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
816,816,NRDD293,-,isoproterenol,Bronchodilator agent; Cardiotonic Agents,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
817,817,1043,"istradefylline, kw-6002",istradefylline,Antiparkinson agent,small molecule,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
818,818,1048,"iti-007, iti-722",iti-007,Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
819,819,1048,"iti-007, iti-722",iti-007,Antipsychotic agent,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
820,820,1049,"itopride,itax",itopride,motilitant,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
821,821,MMAmar2016_0140,suba-itraconazole,itraconazole,Antineoplastic agent; basal cell carcinoma,small molecule,1992,1992,Q99835,smo_human,SMO,GPCR;Frizzled,established,approved,Protein ,Frizzled,Class F (Frizzled)
822,822,1054,jnj-37822681,jnj-37822681,Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
823,823,1056,jvs-100,jvs-100,cardioprotectant,dna plasmid,-,-,P61073,cxcr4_human,CXCR4,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
824,824,2328,kai-4169,kai-4169,for treatment of hyperparathyroidism,peptide,-,-,P41180,casr_human,CASR,GPCR;Glutamate,established,in trial,Ion ,Calcium-sensing receptors,Class C (Glutamate) 
825,825,1074,"ketotifen fumarate,zaditen, zaditor",ketotifen,Anti-Allergic Agents,small molecule,1999,1999,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
826,826,1076,kn38-7271,kn38-7271,neuroprotectant,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
827,827,1076,kn38-7271,kn38-7271,neuroprotectant,small molecule,-,-,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
828,828,1078,kos-2187,kos-2187,for treatment of gastrointestinal motility disorders,small molecule,-,-,O43193,mtlr_human,MLNR,GPCR;Rhodopsin,not established,in trial,Peptide ,Motilin receptors,Class A (Rhodopsin)
829,829,1079,kp201 (prodrug of hydrocodone),kp201,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
830,830,1079,kp201 (prodrug of hydrocodone),kp201,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
831,831,1079,kp201 (prodrug of hydrocodone),kp201,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
832,832,1082,kuc-7483,kuc-7483,for treatment of overactive bladder,small molecule,-,-,P13945,adrb3_human,ADRB3,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
833,833,NRDD296,-,labetalol,Antihypertensive agent,small molecule,1984,1984,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
834,834,NRDD296,-,labetalol,Antihypertensive agent,small molecule,1984,1984,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
835,835,NRDD296,-,labetalol,Antihypertensive agent,small molecule,1984,1984,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
836,836,NRDD296,-,labetalol,Antihypertensive agent,small molecule,1984,1984,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
837,837,1088,"lanreotide ,somatuline autogel, somatuline depot",lanreotide,for treatment of acromegaly,small molecule,2007,2007,P30872,ssr1_human,SSTR1,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
838,838,1089,"lanreotide,somatuline autogel, somatuline depot",lanreotide,for treatment of acromegaly,small molecule,2007,2007,P35346,ssr5_human,SSTR5,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
839,839,1300,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",laropiprant,for counteracting niacin-induced flushing,small molecule,-,-,Q13258,pd2r_human,PTGDR,GPCR;Rhodopsin,not established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
840,840,1301,"mk-0542b, extended release niacin + laropiprant +simvastatin",laropiprant,for counteracting niacin-induced flushing,small molecule,-,-,Q13258,pd2r_human,PTGDR,GPCR;Rhodopsin,not established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
841,841,1092,las-100977,las-100977,Bronchodilator agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
842,842,1093,"lasmiditan, col-144, ly-573144",lasmiditan,Anti-migraine Agents,small molecule,-,-,P30939,5ht1f_human,HTR1F,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
843,843,MMAmay2016_0719,"eye-d, controlled-release latanoprost insert",latanoprost,for treatment of glaucoma,small molecule,1996,1996,P43088,pf2r_human,PTGFR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
844,844,1095,"latanoprost + timolol,xalcom, xalacom",latanoprost,for treatment of glaucoma,small molecule,1996,1996,P43088,pf2r_human,PTGFR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
845,845,1096,"latanoprost, (sustained release, punctal plug delivery system)",latanoprost,for treatment of glaucoma,small molecule,1996,1996,P43088,pf2r_human,PTGFR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
846,846,1097,"latanoprost,xalatan fixed flow device",latanoprost,for treatment of glaucoma,small molecule,1996,1996,P43088,pf2r_human,PTGFR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
847,847,1436,"nova21027,catioprost",latanoprost,for treatment of glaucoma,small molecule,1996,1996,P43088,pf2r_human,PTGFR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
848,848,MMAfeb2016_0059,"roclatan, rhopressa + latanoprost",latanoprost,for treatment of glaucoma,small molecule,1996,1996,P43088,pf2r_human,PTGFR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
849,849,1918,sustained release latanoprost,latanoprost,for treatment of glaucoma,small molecule,1996,1996,P43088,pf2r_human,PTGFR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
850,850,1108,"lesogaberan, azd-3355",lesogaberan,for treatment of gastrointestinal reflux disease,small molecule,-,-,Q9UBS5,gabr1_human,GABBR1,GPCR;Glutamate,established,in trial,Amino acid ,GABAB receptors,Class C (Glutamate) 
851,851,1108,"lesogaberan, azd-3355",lesogaberan,for treatment of gastrointestinal reflux disease,small molecule,-,-,O75899,gabr2_human,GABBR2,GPCR;Glutamate,established,in trial,Amino acid ,GABAB receptors,Class C (Glutamate) 
852,852,697,eligard,leuprolide,Antineoplastic agent,peptide,1985,1985,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
853,853,1113,leuprolide,leuprolide,Antineoplastic agent; for treatment of endometriosis,peptide,1985,1985,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
854,854,1114,"leuprolide acetate, tap-144 sr",leuprolide,Antineoplastic agent; for treatment of endometriosis,peptide,1985,1985,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
855,855,1115,leupromaxx,leuprolide,Antineoplastic agent; for treatment of endometriosis,peptide,1985,1985,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
856,856,1250,memryte,leuprolide,for treatment of Alzheimer's disease,peptide,1985,1985,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
857,857,NRDD298,-,levallorphan,Opiate Antagonists,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
858,858,NRDD299,-,levobunolol,Antiglaucomic Agents,small molecule,1985,1985,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
859,859,NRDD299,-,levobunolol,Antiglaucomic Agents,small molecule,1985,1985,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
860,860,NRDD301,-,levocabastine,Anti-Allergic Agents,small molecule,1993,1993,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
861,861,1118,"levocetirizine dihydrochloride,xusal, xyzal",levocetirizine,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
862,862,646,dm-1992,levodopa,Antiparkinson agent,small molecule,1970,1970,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
863,863,646,dm-1992,levodopa,Antiparkinson agent,small molecule,1970,1970,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
864,864,646,dm-1992,levodopa,Antiparkinson agent,small molecule,1970,1970,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
865,865,646,dm-1992,levodopa,Antiparkinson agent,small molecule,1970,1970,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
866,866,646,dm-1992,levodopa,Antiparkinson agent,small molecule,1970,1970,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
867,867,712,"entacapone/levodopa/carbidopa,stalevo",levodopa,Antiparkinson agent,small molecule,1970,1970,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
868,868,712,"entacapone/levodopa/carbidopa,stalevo",levodopa,Antiparkinson agent,small molecule,1970,1970,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
869,869,712,"entacapone/levodopa/carbidopa,stalevo",levodopa,Antiparkinson agent,small molecule,1970,1970,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
870,870,712,"entacapone/levodopa/carbidopa,stalevo",levodopa,Antiparkinson agent,small molecule,1970,1970,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
871,871,712,"entacapone/levodopa/carbidopa,stalevo",levodopa,Antiparkinson agent,small molecule,1970,1970,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
872,872,1119,"levodopa + carbidopa,duodopa",levodopa,Antiparkinson agent,small molecule,1970,1970,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
873,873,1119,"levodopa + carbidopa,duodopa",levodopa,Antiparkinson agent,small molecule,1970,1970,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
874,874,1119,"levodopa + carbidopa,duodopa",levodopa,Antiparkinson agent,small molecule,1970,1970,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
875,875,1119,"levodopa + carbidopa,duodopa",levodopa,Antiparkinson agent,small molecule,1970,1970,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
876,876,1119,"levodopa + carbidopa,duodopa",levodopa,Antiparkinson agent,small molecule,1970,1970,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
877,877,MMAmay2016_0101,"nd0612,  levodopa/carbidopa subcutaneous patch",levodopa,Antiparkinson agent,small molecule,1970,1970,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
878,878,MMAmay2016_0102,"nd0612,  levodopa/carbidopa subcutaneous patch",levodopa,Antiparkinson agent,small molecule,1970,1970,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
879,879,MMAmay2016_0103,"nd0612,  levodopa/carbidopa subcutaneous patch",levodopa,Antiparkinson agent,small molecule,1970,1970,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
880,880,MMAmay2016_0104,"nd0612,  levodopa/carbidopa subcutaneous patch",levodopa,Antiparkinson agent,small molecule,1970,1970,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
881,881,MMAmay2016_0105,"nd0612,  levodopa/carbidopa subcutaneous patch",levodopa,Antiparkinson agent,small molecule,1970,1970,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
882,882,NRDD302,-,levomethadyl acetate,Analgesics; Opioid,small molecule,1993,1993,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
883,883,NRDD303,-,levorphanol,Analgesics; Opioid,small molecule,-,1953,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
884,884,MMAmay2016_0453,lgd-6972,lgd-6972,Antidiabetic; type II diabetes,small molecule,-,-,P47871,glr_human,GCGR,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
885,885,MMAmay2016_0808,"ideglira,  insulin degludec + liraglutide,  nn-9068",liraglutide,Antidiabetic,protein,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
886,886,1154,liraglutide,liraglutide,Antidiabetic,protein,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
887,887,NRDD305,-,liraglutide recombinant,Antidiabetic agent,peptide,2010,2010,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
888,888,NRDD306,-,lisdexamfetamine,Central Nervous System Stimulants,small molecule,2007,2007,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
889,889,NRDD306,-,lisdexamfetamine,Central Nervous System Stimulants,small molecule,2007,2007,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
890,890,NRDD307,-,lisuride,Antiparkinson agents,small molecule,-,-,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
891,891,NRDD307,-,lisuride,Antiparkinson agents,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
892,892,NRDD307,-,lisuride,Antiparkinson agents,small molecule,-,-,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
893,893,MMAmar2016_0257,"lixilan, lantus (basal insulin) + lyxumia (lixisenatide)",lixisenatide,Antidiabetic,small molecule,2016,2016,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
894,894,1157,lixivaptan,lixivaptan,for treatment of hyponatremia,small molecule,-,-,P30518,v2r_human,AVPR2,GPCR;Rhodopsin,established,in trial,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
895,895,MMA2015_0090,athos-3,ljpc-501,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),peptide,-,-,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,in trial,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
896,896,MMA2015_0091,athos-3,ljpc-501,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),peptide,-,-,P50052,agtr2_human,AGTR2,GPCR;Rhodopsin,not established,in trial,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
897,897,1159,"lofexidine,britlofex",lofexidine,for treatment of opiate withdrawal,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
898,898,1159,"lofexidine,britlofex",lofexidine,for treatment of opiate withdrawal,small molecule,-,-,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
899,899,1159,"lofexidine,britlofex",lofexidine,for treatment of opiate withdrawal,small molecule,-,-,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
900,900,NRDD308,-,loperamide,Antidiuretic Agents,small molecule,1976,1976,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
901,901,1163,"loratadine + montelukast sodium,claritin + singulair",loratadine,Anti-Asthmatic Agents,small molecule,1993,1993,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
902,902,1164,lorcaserin,lorcaserin,Anti-obesity agent,small molecule,2012,2012,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
903,903,NRDD310,-,losartan,Antihypertensive agent,small molecule,1995,1995,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,approved,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
904,904,MMAmay2016_0431,inv-144,losartan,Antihypertensive agent; for Diabetic neuropathy,small molecule,1995,1995,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,approved,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
905,905,304,az-004,loxapine,Antipsychotic agent,small molecule,1975,1975,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
906,906,304,az-004,loxapine,Antipsychotic agent,small molecule,1975,1975,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
907,907,1170,lu 02-750,lu 02-750,Antiparkinson agent,unknown,-,-,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
908,908,1170,lu 02-750,lu 02-750,Antiparkinson agent,unknown,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
909,909,1170,lu 02-750,lu 02-750,Antiparkinson agent,unknown,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
910,910,1170,lu 02-750,lu 02-750,Antiparkinson agent,unknown,-,-,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
911,911,1170,lu 02-750,lu 02-750,Antiparkinson agent,unknown,-,-,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
912,912,1175,lu ae04621,lu ae04621,Antiparkinson agent,unknown,-,-,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
913,913,1175,lu ae04621,lu ae04621,Antiparkinson agent,unknown,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
914,914,1175,lu ae04621,lu ae04621,Antiparkinson agent,unknown,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
915,915,1175,lu ae04621,lu ae04621,Antiparkinson agent,unknown,-,-,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
916,916,1175,lu ae04621,lu ae04621,Antiparkinson agent,unknown,-,-,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
917,917,1177,"lu-ae58054 , ly-483518, sgs518",lu-ae58054,Antipsychotic agent,small molecule,-,-,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
918,918,MMAapril2016_0233,"cyclurad, d-cycloserine + lurasidone",lurasidone,Antipsychotic agent,small molecule,2010,2010,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
919,919,MMAapril2016_0234,"cyclurad, d-cycloserine + lurasidone",lurasidone,Antipsychotic agent,small molecule,2010,2010,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
920,920,MMAapril2016_0235,"cyclurad, d-cycloserine + lurasidone",lurasidone,Antipsychotic agent,small molecule,2010,2010,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
921,921,MMAapril2016_0236,"cyclurad, d-cycloserine + lurasidone",lurasidone,Antipsychotic agent,small molecule,2010,2010,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
922,922,MMAapril2016_0237,"cyclurad, d-cycloserine + lurasidone",lurasidone,Antipsychotic agent,small molecule,2010,2010,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
923,923,1184,"lurasidone, sm-13496,latuda",lurasidone,Antipsychotic agent,small molecule,2010,2010,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
924,924,1184,"lurasidone, sm-13496,latuda",lurasidone,Antipsychotic agent,small molecule,2010,2010,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
925,925,1184,"lurasidone, sm-13496,latuda",lurasidone,Antipsychotic agent,small molecule,2010,2010,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
926,926,1184,"lurasidone, sm-13496,latuda",lurasidone,Antipsychotic agent,small molecule,2010,2010,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
927,927,1184,"lurasidone, sm-13496,latuda",lurasidone,Antipsychotic agent,small molecule,2010,2010,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
928,928,2097,"tztx-001,teverelix la",luteinizing hormone-releasing hormone,Antineoplastic agent,peptide,-,-,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,in trial,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
929,929,2097,"tztx-001,teverelix la",luteinizing hormone-releasing hormone,Antineoplastic agent,peptide,-,-,Q96P88,gnrr2_human,GNRHR2,GPCR;Rhodopsin,established,in trial,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
930,930,NRDD311,-,lutropin alfa,Fertility Agents,peptide,-,2004,P22888,lshr_human,LHCGR,GPCR;Rhodopsin,established,approved,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
931,931,1190,ly2140023,ly2140023,Antipsychotic agent,small molecule,-,-,Q14416,grm2_human,GRM2,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
932,932,1190,ly2140023,ly2140023,Antipsychotic agent,small molecule,-,-,Q14832,grm3_human,GRM3,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
933,933,1192,ly-2189265,ly-2189265,Antidiabetic,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
934,934,1204,m0002,m0002,for treatemnt of ascites,small molecule,-,-,P30518,v2r_human,AVPR2,GPCR;Rhodopsin,established,in trial,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
935,935,MMAmay2016_0080,"macimorelin,  aezs-130","macimorelin,  aezs-130",for treatment of cancer cachexia,peptide,-,-,Q92847,ghsr_human,GHSR,GPCR;Rhodopsin,not established,in trial,Peptide ,Ghrelin receptors,Class A (Rhodopsin)
936,936,1209,"macitentan , act-064992",macitentan,cardiovascular agent,small molecule,2013,2013,P25101,ednra_human,EDNRA,GPCR;Rhodopsin,established,approved,Peptide ,Endothelin receptors,Class A (Rhodopsin)
937,937,1210,"macitentan, act-064992",macitentan,cardiovascular agent,small molecule,2013,2013,P24530,ednrb_human,EDNRB,GPCR;Rhodopsin,established,approved,Peptide ,Endothelin receptors,Class A (Rhodopsin)
938,938,1217,mar701,mar701,Antidiabetic,peptide,-,-,P48546,gipr_human,GIPR,GPCR;Secretin,not established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
939,939,1217,mar701,mar701,Antidiabetic,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
940,940,1834,selzentry,maraviroc,antiviral agent; HIV,small molecule,2007,2007,P51681,ccr5_human,CCR5,GPCR;Rhodopsin,established,approved,Protein ,Chemokine receptors,Class A (Rhodopsin)
941,941,NRDD314,-,marinol,Antiemetics,small molecule,-,1985,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,approved,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
942,942,1225,mbx-2982,mbx-2982,Antidiabetic,small molecule,-,-,Q8TDV5,gp119_human,GPR119,GPCR;Rhodopsin,not established,in trial,Lipid ,"GPR18, GPR55 and GPR119",Class A (Rhodopsin)
943,943,1227,mc-4232,mc-1,cardioprotectant,small molecule,-,-,Q99677,lpar4_human,LPAR4,GPCR;Rhodopsin,not established,in trial,Lipid ,Lysophospholipid (LPA) receptors,Class A (Rhodopsin)
944,944,1227,mc-4232,mc-1,cardioprotectant,small molecule,-,-,P43657,lpar6_human,LPAR6,GPCR;Rhodopsin,not established,in trial,Lipid ,Lysophospholipid (LPA) receptors,Class A (Rhodopsin)
945,945,1227,mc-4232,mc-1,cardioprotectant,small molecule,-,-,P47900,p2ry1_human,P2RY1,GPCR;Rhodopsin,not established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
946,946,1227,mc-4232,mc-1,cardioprotectant,small molecule,-,-,O00398,p2y10_human,P2RY10,GPCR;Rhodopsin,not established,in trial,Orphan ,Class A orphans,Class A (Rhodopsin)
947,947,1227,mc-4232,mc-1,cardioprotectant,small molecule,-,-,Q96G91,p2y11_human,P2RY11,GPCR;Rhodopsin,not established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
948,948,1227,mc-4232,mc-1,cardioprotectant,small molecule,-,-,Q9H244,p2y12_human,P2RY12,GPCR;Rhodopsin,established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
949,949,1227,mc-4232,mc-1,cardioprotectant,small molecule,-,-,Q9BPV8,p2y13_human,P2RY13,GPCR;Rhodopsin,not established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
950,950,1227,mc-4232,mc-1,cardioprotectant,small molecule,-,-,Q15391,p2y14_human,P2RY14,GPCR;Rhodopsin,not established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
951,951,1227,mc-4232,mc-1,cardioprotectant,small molecule,-,-,P41231,p2ry2_human,P2RY2,GPCR;Rhodopsin,not established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
952,952,1227,mc-4232,mc-1,cardioprotectant,small molecule,-,-,P51582,p2ry4_human,P2RY4,GPCR;Rhodopsin,not established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
953,953,1227,mc-4232,mc-1,cardioprotectant,small molecule,-,-,Q15077,p2ry6_human,P2RY6,GPCR;Rhodopsin,not established,in trial,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
954,954,1227,mc-4232,mc-1,cardioprotectant,small molecule,-,-,Q86VZ1,p2ry8_human,P2RY8,GPCR;Rhodopsin,not established,in trial,Orphan ,Class A orphans,Class A (Rhodopsin)
955,955,1228,mcd-386,mcd-386,for treatment of Alzheimer's disease,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
956,956,NRDD315,-,meclizine,Antiemetics,small molecule,-,1957,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
957,957,NRDD320,-,melatonin,Hypnotics and Sedatives,small molecule,-,-,P48039,mtr1a_human,MTNR1A,GPCR;Rhodopsin,established,in trial,Melatonin ,Melatonin,Class A (Rhodopsin)
958,958,NRDD320,-,melatonin,Hypnotics and Sedatives,small molecule,-,-,P49286,mtr1b_human,MTNR1B,GPCR;Rhodopsin,established,in trial,Melatonin ,Melatonin,Class A (Rhodopsin)
959,959,2110,"v-1512, chf-1512,levomet complex, sirio",melevodopa,Antiparkinson agent,small molecule,-,-,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
960,960,2110,"v-1512, chf-1512,levomet complex, sirio",melevodopa,Antiparkinson agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
961,961,2110,"v-1512, chf-1512,levomet complex, sirio",melevodopa,Antiparkinson agent,small molecule,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
962,962,2110,"v-1512, chf-1512,levomet complex, sirio",melevodopa,Antiparkinson agent,small molecule,-,-,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
963,963,2110,"v-1512, chf-1512,levomet complex, sirio",melevodopa,Antiparkinson agent,small molecule,-,-,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
964,964,NRDD322,-,menotropins,Fertility Agents,protein,-,-,P23945,fshr_human,FSHR,GPCR;Rhodopsin,established,approved,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
965,965,NRDD322,-,menotropins,Fertility Agents,protein,-,-,P22888,lshr_human,LHCGR,GPCR;Rhodopsin,established,approved,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
966,966,NRDD324,-,mepenzolate,Antispasmodics,small molecule,1956,1956,Q8TDS4,hcar2_human,HCAR2,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
967,967,NRDD324,-,mepenzolate,Antispasmodics,small molecule,1956,1956,P49019,hcar3_human,HCAR3,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
968,968,NRDD325,-,meperidine,Analgesics; Opioid,small molecule,1942,1942,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
969,969,NRDD326,-,mephentermine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
970,970,NRDD329,-,mequitazine,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
971,971,NRDD331,-,mesoridazine,Antipsychotic agent,small molecule,1970,1970,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
972,972,NRDD331,-,mesoridazine,Antipsychotic agent,small molecule,1970,1970,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
973,973,NRDD333,-,metaraminol,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
974,974,NRDD334,-,methadone,Analgesics; Opioid; Antitussive Agents,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
975,975,NRDD335,-,methadyl acetate,Analgesics; Opioid,small molecule,-,1993,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
976,976,1167,low dose intravenous methamphetamine,methamphetamine,neuroprotectant,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
977,977,1167,low dose intravenous methamphetamine,methamphetamine,neuroprotectant,small molecule,-,-,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
978,978,1167,low dose intravenous methamphetamine,methamphetamine,neuroprotectant,small molecule,-,-,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
979,979,1167,low dose intravenous methamphetamine,methamphetamine,neuroprotectant,small molecule,-,-,Q96RJ0,taar1_human,TAAR1,GPCR;Rhodopsin,established,approved,Aminergic ,Trace amine receptors,Class A (Rhodopsin)
980,980,NRDD336,-,methantheline,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,small molecule,1951,1951,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
981,981,NRDD339,-,methdilazine,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
982,982,NRDD342,-,methotrimeprazine,Antipsychotic agent,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
983,983,NRDD342,-,methotrimeprazine,Antipsychotic agent,small molecule,-,-,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
984,984,NRDD342,-,methotrimeprazine,Antipsychotic agent,small molecule,-,-,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
985,985,NRDD342,-,methotrimeprazine,Antipsychotic agent,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
986,986,NRDD342,-,methotrimeprazine,Antipsychotic agent,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
987,987,NRDD342,-,methotrimeprazine,Antipsychotic agent,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
988,988,NRDD342,-,methotrimeprazine,Antipsychotic agent,small molecule,-,-,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
989,989,NRDD342,-,methotrimeprazine,Antipsychotic agent,small molecule,-,-,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
990,990,NRDD342,-,methotrimeprazine,Antipsychotic agent,small molecule,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
991,991,NRDD342,-,methotrimeprazine,Antipsychotic agent,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
992,992,NRDD342,-,methotrimeprazine,Antipsychotic agent,small molecule,-,-,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
993,993,NRDD343,-,methoxamine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
994,994,NRDD343,-,methoxamine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,-,-,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
995,995,NRDD346,-,methyldopa,Antihypertensive agent,small molecule,1962,1962,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
996,996,NRDD347,-,methylergonovine,Abortifacient Agents,small molecule,-,1946,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
997,997,1262,methylnaltrexone,methylnaltrexone,for treatment of opioid-induced constipation,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
998,998,NRDD348,-,methylnaltrexone bromide,OIC treatment,small molecule,2008,2008,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
999,999,NRDD351,-,methylscopolamine,Antispasmodics,small molecule,-,1953,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1000,1000,NRDD353,-,methysergide,Anti-migraine agents; Vasoconstrictor Agents,small molecule,1962,1962,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1001,1001,NRDD353,-,methysergide,Anti-migraine agents; Vasoconstrictor Agents,small molecule,1962,1962,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1002,1002,NRDD353,-,methysergide,Anti-migraine agents; Vasoconstrictor Agents,small molecule,1962,1962,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1003,1003,NRDD353,-,methysergide,Anti-migraine agents; Vasoconstrictor Agents,small molecule,1962,1962,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1004,1004,NRDD354,-,metipranolol,Anti-Arrhythmia Agents; Antihypertensive agent; Anti-glaucoma agent,small molecule,1989,1989,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1005,1005,NRDD354,-,metipranolol,Anti-Arrhythmia Agents; Antihypertensive agent; Anti-glaucoma agent,small molecule,1989,1989,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1006,1006,NRDD355,-,metixene,Antiparkinson agents,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1007,1007,NRDD355,-,metixene,Antiparkinson agents,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1008,1008,NRDD355,-,metixene,Antiparkinson agents,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1009,1009,NRDD355,-,metixene,Antiparkinson agents,small molecule,-,-,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1010,1010,NRDD355,-,metixene,Antiparkinson agents,small molecule,-,-,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1011,1011,758,evk-001,metoclopramide,for treatment of diabetic gastroparesis,small molecule,1979,1979,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1012,1012,758,evk-001,metoclopramide,for treatment of diabetic gastroparesis,small molecule,1979,1979,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1013,1013,MMAmay2016_0859,"evk-001, metoclopramide nasal spray",metoclopramide,Antiemetics,small molecule,1979,1979,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1014,1014,MMAmay2016_0860,"evk-001, metoclopramide nasal spray",metoclopramide,Antiemetics,small molecule,1979,1979,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1015,1015,1268,"metoclopramide hcl,metzoliv odt",metoclopramide,motilitant; for treatment of gastroesophageal reflux disease ,small molecule,1979,1979,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1016,1016,1268,"metoclopramide hcl,metzoliv odt",metoclopramide,motilitant; for treatment of gastroesophageal reflux disease ,small molecule,1979,1979,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1017,1017,1269,"metoclopramide,emitasol, pramidin",metoclopramide,Antiemetics,small molecule,1979,1979,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1018,1018,1269,"metoclopramide,emitasol, pramidin",metoclopramide,Antiemetics,small molecule,1979,1979,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1019,1019,1355,mt 100,metoclopramide,Anti-migraine Agents,small molecule,1979,1979,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1020,1020,1355,mt 100,metoclopramide,Anti-migraine Agents,small molecule,1979,1979,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1021,1021,NRDD359,-,metoprolol,Anti-Arrhythmia Agents; Antihypertensive agent,small molecule,1978,1978,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1022,1022,1270,"metoprolol succinate,toprol-xl",metoprolol ,Antihypertensive agent,small molecule,-,-,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1023,1023,MMAmay2016_0480,"mg01ci, extended-release metadoxine,","mg01ci, extended-release metadoxine,",for treatment of neurologic disorders; ADHD,small molecule,-,-,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1024,1024,NRDD363,-,mianserin,Antidepressive Agents; Second-Generation,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1025,1025,NRDD363,-,mianserin,Antidepressive Agents; Second-Generation,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1026,1026,NRDD363,-,mianserin,Antidepressive Agents; Second-Generation,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1027,1027,NRDD363,-,mianserin,Antidepressive Agents; Second-Generation,small molecule,-,-,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1028,1028,NRDD365,-,midodrine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,1996,1996,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1029,1029,NRDD365,-,midodrine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,1996,1996,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1030,1030,1290,"milveterol. td-3327, gsk-159797",milveterol,Bronchodilator agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1031,1031,MMAapril2016_0202,"min-001,  cyr-101","min-001,  cyr-101",for treatment of schizophrenia,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1032,1032,MMAapril2016_0203,min-117,min-117,for treatment of major depressive disorder,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1033,1033,MMAapril2016_0204,min-117,min-117,for treatment of major depressive disorder,small molecule,-,-,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1034,1034,MMAapril2016_0206,min-117,min-117,for treatment of major depressive disorder,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1035,1035,MMAapril2016_0207,min-117,min-117,for treatment of major depressive disorder,small molecule,-,-,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1036,1036,MMA2016_0029,"min-202, jnj-42847922","min-202, jnj-42847922",Anti-depressant and sleep disorder therapy,small molecule,-,-,O43614,ox2r_human,HCRTR2,GPCR;Rhodopsin,established,in trial,Peptide ,Orexin receptors,Class A (Rhodopsin)
1037,1037,NRDD368,-,minaprine,Antidepressive Agents,small molecule,-,-,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1038,1038,NRDD368,-,minaprine,Antidepressive Agents,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1039,1039,NRDD368,-,minaprine,Antidepressive Agents,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1040,1040,NRDD368,-,minaprine,Antidepressive Agents,small molecule,-,-,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1041,1041,NRDD368,-,minaprine,Antidepressive Agents,small molecule,-,-,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1042,1042,1295,"mirtazapine,remeron, remeron soltab, reflex",mirtazapine,Anti-depressant,small molecule,1996,1996,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1043,1043,1295,"mirtazapine,remeron, remeron soltab, reflex",mirtazapine,Anti-depressant,small molecule,1996,1996,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1044,1044,202,"apl-202,isprelor",misoprostol,Labor Inducing Agents,small molecule,1988,1988,P43119,pi2r_human,PTGIR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
1045,1045,1296,"mitemcinal, gm-611",mitemcinal,for treatment of gastroparesis,small molecule,-,-,O43193,mtlr_human,MLNR,GPCR;Rhodopsin,not established,in trial,Peptide ,Motilin receptors,Class A (Rhodopsin)
1046,1046,NRDD370,-,mivacurium,Muscle Relaxants,small molecule,1992,1992,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1047,1047,1308,mkc-253,mkc-253,Antidiabetic,protein,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1048,1048,MMAapril2016_0263,"mle4901,  azd4901","mle4901,  azd4901",for Polycystic Ovarian Syndrome,small molecule,-,-,P29371,nk3r_human,TACR3,GPCR;Rhodopsin,not established,in trial,Peptide ,Tachykinin receptors,Class A (Rhodopsin)
1049,1049,1310,mln-1202,mln-1202,Anti-inflammatory agent; DMARD,antibody,-,-,P41597,ccr2_human,CCR2,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1050,1050,1317,mn-221,mn-221,Anti-Asthmatic Agents,unknown,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1051,1051,1318,mn-246,mn-246,for treatment of overactive bladder,small molecule,-,-,P13945,adrb3_human,ADRB3,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1052,1052,1319,mn-305,mn-305,Anti-depressant; hypnotic,small molecule,-,-,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1053,1053,MMAmay2016_0898,"mod-6031, long-acting oxyntomodulin","mod-6031, long-acting oxyntomodulin",for treatment of metabolic disorders; type II diabetes; obesity,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1054,1054,MMAmay2016_0899,"mod-6031, long-acting oxyntomodulin","mod-6031, long-acting oxyntomodulin",for treatment of metabolic disorders; type II diabetes; obesity,peptide,-,-,P47871,glr_human,GCGR,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1055,1055,MMAjun2016_0001,mogamulizumab,mogamulizumab,Antineoplastic agent,antibody,-,-,P51679,ccr4_human,CCR4,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1056,1056,NRDD372,-,molindone,Antipsychotic agent,small molecule,1974,1974,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1057,1057,2425,"spn810 ,zalvari",molindone,for treatment of ADHD,small molecule,1974,1974,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1058,1058,1163,"loratadine + montelukast sodium,claritin + singulair",montelukast,Anti-Asthmatic Agents,small molecule,1998,1998,Q9Y271,cltr1_human,CYSLTR1,GPCR;Rhodopsin,established,approved,Lipid ,Leukotriene receptors,Class A (Rhodopsin)
1059,1059,1327,"montelukast sodium,singulair",montelukast,Anti-Asthmatic Agents,small molecule,1998,1998,Q9Y271,cltr1_human,CYSLTR1,GPCR;Rhodopsin,established,approved,Lipid ,Leukotriene receptors,Class A (Rhodopsin)
1060,1060,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",morphine,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1061,1061,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",morphine,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1062,1062,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",morphine,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1063,1063,MMAmar2016_0055,"egalet-001, reformulated morphine",morphine,Analgesics; for treatment of opioid addiction,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1064,1064,MMAmar2016_0056,"egalet-001, reformulated morphine",morphine,Analgesics; for treatment of opioid addiction,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1065,1065,MMAmar2016_0057,"egalet-001, reformulated morphine",morphine,Analgesics; for treatment of opioid addiction,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1066,1066,1013,"intranasal morphine,rylomine",morphine,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1067,1067,1013,"intranasal morphine,rylomine",morphine,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1068,1068,1013,"intranasal morphine,rylomine",morphine,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1069,1069,1207,"m6g, cee 04-410",morphine,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1070,1070,1207,"m6g, cee 04-410",morphine,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1071,1071,1207,"m6g, cee 04-410",morphine,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1072,1072,1279,"mh-200, tak-453 sr, morphine hcl,anpec",morphine,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1073,1073,1279,"mh-200, tak-453 sr, morphine hcl,anpec",morphine,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1074,1074,1279,"mh-200, tak-453 sr, morphine hcl,anpec",morphine,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1075,1075,1333,"morphine sulfate,avinza",morphine,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1076,1076,1333,"morphine sulfate,avinza",morphine,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1077,1077,1333,"morphine sulfate,avinza",morphine,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1078,1078,1334,"morphine sulfate,depodur, depomorphine",morphine,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1079,1079,1334,"morphine sulfate,depodur, depomorphine",morphine,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1080,1080,1334,"morphine sulfate,depodur, depomorphine",morphine,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1081,1081,1335,"morphine/dextromethorphan,morphidex",morphine,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1082,1082,1335,"morphine/dextromethorphan,morphidex",morphine,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1083,1083,1335,"morphine/dextromethorphan,morphidex",morphine,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1084,1084,1336,morviva,morphine,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1085,1085,1336,morviva,morphine,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1086,1086,1336,morviva,morphine,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1087,1087,1341,moxduo,morphine,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1088,1088,1341,moxduo,morphine,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1089,1089,1341,moxduo,morphine,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1090,1090,1903,statex,morphine,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1091,1093,2051,tpm-1/morphine,morphine,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1092,1094,2051,tpm-1/morphine,morphine,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1093,1095,2051,tpm-1/morphine,morphine,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1094,1096,1337,"mosapride citrate, tak-370,gasmotin",mosapride,for treatment of Gastrointestinal reflux disease (GERD),small molecule,-,-,Q13639,5ht4r_human,HTR4,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1095,1097,1354,msx-122,msx-122,Antineoplastic agent,small molecule,-,-,P61073,cxcr4_human,CXCR4,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1096,1098,MMAmar2016_0211,mt-1303,mt-1303,for treatment of autoimmune diseases; Multiple Sclerosis; Crohn's disease ,small molecule,-,-,P21453,s1pr1_human,S1PR1,GPCR;Rhodopsin,established,in trial,Lipid ,Lysophospholipid (S1P) receptors,Class A (Rhodopsin)
1097,1099,1363,"mu delta, eluxadoline","mu delta, eluxadoline",for treatment of irritable bowel syndrome,small molecule,2015,2015,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1098,1100,1363,"mu delta, eluxadoline","mu delta, eluxadoline",for treatment of irritable bowel syndrome,small molecule,2015,2015,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1099,1101,1373,"nabilone,cesamet",nabilone,Antiemetics,small molecule,1985,1985,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,approved,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1100,1102,1373,"nabilone,cesamet",nabilone,Antiemetics,small molecule,1985,1985,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,approved,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1101,1103,1812,sativex,nabilone,Analgesics; neuropathic pain; for treatment of restlegs legs syndrome,small molecule,1985,1985,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,approved,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1102,1104,1812,sativex,nabilone,Analgesics; neuropathic pain; for treatment of restlegs legs syndrome,small molecule,1985,1985,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,approved,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1103,1105,NRDD376,-,nadolol,Anti-Arrhythmia Agents; Antihypertensive agent,small molecule,1979,1979,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1104,1106,NRDD376,-,nadolol,Anti-Arrhythmia Agents; Antihypertensive agent,small molecule,1979,1979,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1105,1107,NRDD377,-,nafarelin,Antiendometriosis Agent,small molecule,1990,1990,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
1106,1108,NRDD377,-,nafarelin,Antiendometriosis Agent,small molecule,1990,1990,Q96P88,gnrr2_human,GNRHR2,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
1107,1109,1374,"nalbuphine hydrochloride,  pw-4142",nalbuphine,Analgesics,small molecule,1979,1979,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1108,1110,1374,"nalbuphine hydrochloride,  pw-4142",nalbuphine,Analgesics,small molecule,1979,1979,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1109,1111,1374,"nalbuphine hydrochloride,  pw-4142",nalbuphine,Analgesics,small molecule,1979,1979,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1110,1112,1733,ren-213,nalbuphine,Analgesics,small molecule,1979,1979,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1111,1113,1733,ren-213,nalbuphine,Analgesics,small molecule,1979,1979,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1112,1114,1733,ren-213,nalbuphine,Analgesics,small molecule,1979,1979,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1113,1115,1375,"nalmefene, cph-101",nalmefene,smoking-cessation agent; for treatment of addiction,small molecule,1995,1995,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1114,1116,1375,"nalmefene, cph-101",nalmefene,smoking-cessation agent; for treatment of addiction,small molecule,1995,1995,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1115,1117,1375,"nalmefene, cph-101",nalmefene,smoking-cessation agent; for treatment of addiction,small molecule,1995,1995,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1116,1118,2766,srd174,nalmefene ,for treatment of pruritus,small molecule,-,1995,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1117,1119,2766,srd174,nalmefene ,for treatment of pruritus,small molecule,-,1995,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1118,1120,2766,srd174,nalmefene ,for treatment of pruritus,small molecule,-,1995,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1119,1121,1419,nktr-118,"naloxegol, peg-naloxol",for treatment of opioid-induced constipation,small molecule,-,2014,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1120,1122,405,"buprenorphine + naloxone capsule,nanobup",naloxone,Analgesics,small molecule,1971,1971,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1121,1123,405,"buprenorphine + naloxone capsule,nanobup",naloxone,Analgesics,small molecule,1971,1971,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1122,1124,405,"buprenorphine + naloxone capsule,nanobup",naloxone,Analgesics,small molecule,1971,1971,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1123,1125,406,"buprenorphine + naloxone,suboxone",naloxone,Analgesics; for treatment of opioid addiction,small molecule,1971,1971,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1124,1126,406,"buprenorphine + naloxone,suboxone",naloxone,Analgesics; for treatment of opioid addiction,small molecule,1971,1971,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1125,1127,406,"buprenorphine + naloxone,suboxone",naloxone,Analgesics; for treatment of opioid addiction,small molecule,1971,1971,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1126,1128,MMAmay2016_0645,"naloxone nasal spray, indivior",naloxone,Analgesics; overdose/drug toxicity,small molecule,1971,1971,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1127,1129,MMAmay2016_0646,"naloxone nasal spray, indivior",naloxone,Analgesics; overdose/drug toxicity,small molecule,1971,1971,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1128,1130,MMAmay2016_0647,"naloxone nasal spray, indivior",naloxone,Analgesics; overdose/drug toxicity,small molecule,1971,1971,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1129,1131,MMAmar2016_0088,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",naloxone,Analgesics,small molecule,1971,1971,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1130,1132,MMAmar2016_0089,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",naloxone,Analgesics,small molecule,1971,1971,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1131,1133,MMAmar2016_0090,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",naloxone,Analgesics,small molecule,1971,1971,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1132,1134,MMAmay2016_0517,"ox219, buprenorphine + naloxone sublingual tablet",naloxone,Analgesics; for treatment of opioid addiction,small molecule,1971,1971,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1133,1135,MMAmay2016_0518,"ox219, buprenorphine + naloxone sublingual tablet",naloxone,Analgesics; for treatment of opioid addiction,small molecule,1971,1971,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1134,1136,MMAmay2016_0921,"ox219, buprenorphine + naloxone sublingual tablet",naloxone,Analgesics; for treatment of opioid addiction,small molecule,1971,1971,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1135,1137,1733,ren-213,naloxone,Analgesics,small molecule,1971,1971,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1136,1138,1733,ren-213,naloxone,Analgesics,small molecule,1971,1971,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1137,1139,1733,ren-213,naloxone,Analgesics,small molecule,1971,1971,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1138,1140,MMAmay2016_0709,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",naloxone,Analgesics,small molecule,1971,1971,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1139,1141,MMAmay2016_0710,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",naloxone,Analgesics,small molecule,1971,1971,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1140,1142,MMAmay2016_0711,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",naloxone,Analgesics,small molecule,1971,1971,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1141,1143,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",naltrexone,Analgesics,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1142,1144,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",naltrexone,Analgesics,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1143,1145,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",naltrexone,Analgesics,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1144,1146,522,contrave,naltrexone,Appetite suppressant,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1145,1147,522,contrave,naltrexone,Appetite suppressant,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1146,1148,522,contrave,naltrexone,Appetite suppressant,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1147,1149,MMAfeb2016_0084,eli-200,naltrexone,Opioid antagonist - addiction therapy,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1148,1150,MMAfeb2016_0085,eli-200,naltrexone,Opioid antagonist - addiction therapy,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1149,1151,MMAfeb2016_0086,eli-200,naltrexone,Opioid antagonist - addiction therapy,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1150,1152,1336,morviva,naltrexone,Analgesics,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1151,1153,1336,morviva,naltrexone,Analgesics,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1152,1154,1336,morviva,naltrexone,Analgesics,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1153,1155,1685,pti-601,naltrexone,Analgesics,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1154,1156,1685,pti-601,naltrexone,Analgesics,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1155,1157,1685,pti-601,naltrexone,Analgesics,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1156,1158,1686,pti-701,naltrexone,Analgesics,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1157,1159,1686,pti-701,naltrexone,Analgesics,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1158,1160,1686,pti-701,naltrexone,Analgesics,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1159,1161,1687,"pti-801,oxytrex",naltrexone,Analgesics,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1160,1162,1687,"pti-801,oxytrex",naltrexone,Analgesics,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1161,1163,1687,"pti-801,oxytrex",naltrexone,Analgesics,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1162,1164,1688,pti-901,naltrexone,Analgesics,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1163,1165,1688,pti-901,naltrexone,Analgesics,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1164,1166,1688,pti-901,naltrexone,Analgesics,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1165,1167,MMAmay2016_0073,"pxt3003, baclofen + naltrexone + sorbitol",naltrexone,Analgesics; for type 1A Charcot-Marie-Tooth disease,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1166,1168,MMAmay2016_0074,"pxt3003, baclofen + naltrexone + sorbitol",naltrexone,Analgesics; for type 1A Charcot-Marie-Tooth disease,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1167,1169,MMAmay2016_0075,"pxt3003, baclofen + naltrexone + sorbitol",naltrexone,Analgesics; for type 1A Charcot-Marie-Tooth disease,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1168,1170,2168,vivitrol,naltrexone,for treatment of substance abuse,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1169,1171,2168,vivitrol,naltrexone,for treatment of substance abuse,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1170,1172,2168,vivitrol,naltrexone,for treatment of substance abuse,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1171,1173,1381,"naratriptan,naramig, amerge",naratriptan,Anti-migraine Agents,small molecule,1998,1998,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1172,1174,1381,"naratriptan,naramig, amerge",naratriptan,Anti-migraine Agents,small molecule,1998,1998,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1173,1175,1381,"naratriptan,naramig, amerge",naratriptan,Anti-migraine Agents,small molecule,1998,1998,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1174,1176,1381,"naratriptan,naramig, amerge",naratriptan,Anti-migraine Agents,small molecule,1998,1998,P30939,5ht1f_human,HTR1F,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1175,1177,869,"gnrh receptor antagonist, nbi-42902",nbi-42902,for treatment of postmenopausal symptoms; Antineoplastic agent,small molecule,-,-,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,in trial,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
1176,1178,869,"gnrh receptor antagonist, nbi-42902",nbi-42902,for treatment of postmenopausal symptoms; Antineoplastic agent,small molecule,-,-,Q96P88,gnrr2_human,GNRHR2,GPCR;Rhodopsin,established,in trial,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
1177,1179,1388,nbi-56418,nbi-56418,Antineoplastic agent,small molecule,-,-,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,in trial,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
1178,1180,1390,"ncx 1510, ox-nla",ncx 1510,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1179,1181,378,"bol-303259-x, ncx 116, pf-03187207",ncx116,for treatment of glaucoma,small molecule,-,-,P43088,pf2r_human,PTGFR,GPCR;Rhodopsin,established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
1180,1182,1394,"nebivolol ,bystolic",nebivolol,Antihypertensive agent,small molecule,2007,2007,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1181,1183,NRDD379,-,nedocromil,Anti-Allergic Agents; Anti-Asthmatic Agents,small molecule,1992,1992,Q9Y271,cltr1_human,CYSLTR1,GPCR;Rhodopsin,established,approved,Lipid ,Leukotriene receptors,Class A (Rhodopsin)
1182,1184,NRDD380,-,nefazodone,Antidepressive Agents; Second-Generation,small molecule,1994,1994,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1183,1185,NRDD380,-,nefazodone,Antidepressive Agents; Second-Generation,small molecule,1994,1994,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1184,1186,NRDD380,-,nefazodone,Antidepressive Agents; Second-Generation,small molecule,1994,1994,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1185,1187,MMAmar2016_0233,"nelotanserin, apd-125","nelotanserin, apd-125",for treatment of dementia; Parkinson's disease,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1186,1188,983,"inn-00835, nemifitide",nemifitide,Anti-depressant,peptide,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1187,1189,MMAmay2016_0499,netupitant + palonosetron,netupitant,Antiemetics; chemotherapy induced nausea and vomiting,small molecule,2014,2014,P25103,nk1r_human,TACR1,GPCR;Rhodopsin,established,approved,Peptide ,Tachykinin receptors,Class A (Rhodopsin)
1188,1190,1408,ngd-4715,ngd-4715,Appetite suppressant,small molecule,-,-,Q99705,mchr1_human,MCHR1,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanin-concentrating hormone,Class A (Rhodopsin)
1189,1191,1410,ngx267,ngx267,for treatment of dry mouth,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1190,1192,467,cer627,niacin,Antidyslipidaemic agent,small molecule,-,-,Q8TDS4,hcar2_human,HCAR2,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1191,1193,467,cer627,niacin,Antidyslipidaemic agent,small molecule,-,-,P49019,hcar3_human,HCAR3,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1192,1194,MMA2015_0071,cer627,niacin,Dyslipidemia with low HDL,small molecule: combination,-,-,P49019,hcar3_human,HCAR3,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1193,1195,MMA2015_0072,cer627,niacin,Dyslipidemia with low HDL,small molecule: combination,-,-,Q8TDS4,hcar2_human,HCAR2,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1194,1196,1300,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",niacin,Antidyslipidaemic agent,small molecule,-,-,Q8TDS4,hcar2_human,HCAR2,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1195,1197,1300,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",niacin,Antidyslipidaemic agent,small molecule,-,-,P49019,hcar3_human,HCAR3,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1196,1198,1301,"mk-0542b, extended release niacin + laropiprant +simvastatin",niacin,Antidyslipidaemic agent,small molecule,-,-,Q8TDS4,hcar2_human,HCAR2,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1197,1199,1301,"mk-0542b, extended release niacin + laropiprant +simvastatin",niacin,Antidyslipidaemic agent,small molecule,-,-,P49019,hcar3_human,HCAR3,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1198,1200,2468,"niacin extended-release tablets,niaspan",niacin,Antihyperlipidemic agent,small molecule,-,-,Q8TDS4,hcar2_human,HCAR2,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1199,1201,2468,"niacin extended-release tablets,niaspan",niacin,Antihyperlipidemic agent,small molecule,-,-,P49019,hcar3_human,HCAR3,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1200,1202,1546,"oxycodone hcl + niacin,acurox, oxyadf",niacin,substance abuse deterrant,small molecule,-,-,Q8TDS4,hcar2_human,HCAR2,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1201,1203,1546,"oxycodone hcl + niacin,acurox, oxyadf",niacin,substance abuse deterrant,small molecule,-,-,P49019,hcar3_human,HCAR3,GPCR;Rhodopsin,established,approved,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1202,1204,1412,niacin receptor agonist,niacin receptor agonist,Anti-atherosclerotic agent,small molecule,-,-,Q8TDS4,hcar2_human,HCAR2,GPCR;Rhodopsin,established,in trial,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1203,1205,1412,niacin receptor agonist,niacin receptor agonist,Anti-atherosclerotic agent,small molecule,-,-,P49019,hcar3_human,HCAR3,GPCR;Rhodopsin,established,in trial,Alicarboxylic acid ,Hydroxycarboxylic acid receptors,Class A (Rhodopsin)
1204,1206,NRDD384,-,nicergoline,Nootropic Agents; Vasodilator Agents,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1205,1207,NRDD394,-,nizatidine,GI Anti-Ulcer Agents; antihistamines,small molecule,1988,1988,P25021,hrh2_human,HRH2,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1206,1208,1420,nktr-181,nktr-181,Analgesics,small molecule polymer conjugate,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
1207,1209,1429,nn9924,nn9924,Antidiabetic,protein,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1208,1210,NRDD395,-,norepinephrine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,-,1950,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1209,1211,NRDD395,-,norepinephrine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,-,1950,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1210,1212,NRDD395,-,norepinephrine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,-,1950,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1211,1213,NRDD395,-,norepinephrine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,-,1950,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1212,1214,NRDD395,-,norepinephrine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,-,1950,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1213,1215,NRDD395,-,norepinephrine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,-,1950,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1214,1216,NRDD395,-,norepinephrine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,-,1950,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1215,1217,NRDD395,-,norepinephrine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,-,1950,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1216,1218,NRDD395,-,norepinephrine,Antihypotensive Agents; Vasoconstrictor Agents,small molecule,-,1950,P13945,adrb3_human,ADRB3,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1217,1219,2273,dermx,norepinephrine,for prevention of dermatitis during radiotherapy,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1218,1220,2273,dermx,norepinephrine,for prevention of dermatitis during radiotherapy,small molecule,-,-,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1219,1221,2273,dermx,norepinephrine,for prevention of dermatitis during radiotherapy,small molecule,-,-,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1220,1222,2273,dermx,norepinephrine,for prevention of dermatitis during radiotherapy,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1221,1223,2273,dermx,norepinephrine,for prevention of dermatitis during radiotherapy,small molecule,-,-,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1222,1224,2273,dermx,norepinephrine,for prevention of dermatitis during radiotherapy,small molecule,-,-,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1223,1225,2273,dermx,norepinephrine,for prevention of dermatitis during radiotherapy,small molecule,-,-,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1224,1226,2273,dermx,norepinephrine,for prevention of dermatitis during radiotherapy,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1225,1227,2273,dermx,norepinephrine,for prevention of dermatitis during radiotherapy,small molecule,-,-,P13945,adrb3_human,ADRB3,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1226,1228,1684,pti-202,not disclosed,Analgesics,unknown,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1227,1229,1684,pti-202,not disclosed,Analgesics,unknown,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1228,1230,1684,pti-202,not disclosed,Analgesics,unknown,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1229,1231,2421,np2 enkephalin,np2 enkephalin,Analgesics,viral gene delivery,-,-,P41143,oprd_human,DOR,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
1230,1232,1441,nps-2143,nps-2143,Anti-osteoporotic agent,small molecule,-,-,P41180,casr_human,CASR,GPCR;Glutamate,established,in trial,Ion ,Calcium-sensing receptors,Class C (Glutamate) 
1231,1233,MMAmar2016_0202,npsp795,npsp795,for treatment of hypocalcaemia,small molecule,-,-,P41180,casr_human,CASR,GPCR;Glutamate,established,in trial,Ion ,Calcium-sensing receptors,Class C (Glutamate) 
1232,1234,2199,vyvanse,nrp104,for treatment of ADHD,small molecule,-,-,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1233,1235,1444,nrp290,nrp290,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
1234,1236,1444,nrp290,nrp290,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
1235,1237,1444,nrp290,nrp290,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
1236,1238,1448,ns-304,ns-304,Antihypertensive agent,small molecule,-,-,P43119,pi2r_human,PTGIR,GPCR;Rhodopsin,established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
1237,1239,2528,"nu206, r-spondin1",nu206,for treatment of gastrointestinal disease,protein,-,-,Q9BXB1,lgr4_human,LGR4,GPCR;Rhodopsin,not established,in trial,Orphan ,Class A orphans,Class A (Rhodopsin)
1238,1240,2528,"nu206, r-spondin1",nu206,for treatment of gastrointestinal disease,protein,-,-,O75473,lgr5_human,LGR5,GPCR;Rhodopsin,not established,in trial,Orphan ,Class A orphans,Class A (Rhodopsin)
1239,1241,1460,nxn-188,nxn-188,Anti-migraine Agents,small molecule,-,-,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1240,1242,1460,nxn-188,nxn-188,Anti-migraine Agents,small molecule,-,-,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1241,1243,MMAapril2016_0035,obe001,obe001,for treatment of labor and delivery,small molecule,-,-,P30559,oxyr_human,OXTR,GPCR;Rhodopsin,established,in trial,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1242,1244,2027,"tm30338,obinepitide",obinepitide,Anti-obesity agent,small molecule,-,-,P49146,npy2r_human,NPY2R,GPCR;Rhodopsin,not established,in trial,Peptide ,Neuropeptide Y receptors,Class A (Rhodopsin)
1243,1245,2027,"tm30338,obinepitide",obinepitide,Anti-obesity agent,small molecule,-,-,P50391,npy4r_human,PPYR1,GPCR;Rhodopsin,not established,in trial,Peptide ,Neuropeptide Y receptors,Class A (Rhodopsin)
1244,1246,1466,oc000459,oc000459 ,Anti-Allergic Agents,small molecule,-,-,Q9Y5Y4,gpr44_human,PD2R2,GPCR;Rhodopsin,not established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
1245,1247,MMAmay2016_0684,oc459,oc459,for allergic rhinitis,small molecule,-,-,Q9Y5Y4,gpr44_human,GPR44,GPCR;Rhodopsin,not established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
1246,1248,421,cam-2029,octreotide,Antineoplastic agent,peptide,1988,1988,P30872,ssr1_human,SSTR1,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1247,1249,421,cam-2029,octreotide,Antineoplastic agent,peptide,1988,1988,P30874,ssr2_human,SSTR2,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1248,1250,421,cam-2029,octreotide,Antineoplastic agent,peptide,1988,1988,P35346,ssr5_human,SSTR5,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1249,1251,981,"injectable octreotide acetate,sandostatin lar",octreotide,Antineoplastic agent,peptide,1988,1988,P30872,ssr1_human,SSTR1,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1250,1252,981,"injectable octreotide acetate,sandostatin lar",octreotide,Antineoplastic agent,peptide,1988,1988,P30874,ssr2_human,SSTR2,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1251,1253,981,"injectable octreotide acetate,sandostatin lar",octreotide,Antineoplastic agent,peptide,1988,1988,P35346,ssr5_human,SSTR5,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1252,1254,1470,"octrotide,atrigel",octreotide,Antineoplastic agent,peptide,1988,1988,P30872,ssr1_human,SSTR1,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1253,1255,1470,"octrotide,atrigel",octreotide,Antineoplastic agent,peptide,1988,1988,P30874,ssr2_human,SSTR2,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1254,1256,1470,"octrotide,atrigel",octreotide,Antineoplastic agent,peptide,1988,1988,P35346,ssr5_human,SSTR5,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1255,1257,1508,"oral octreotide actetate ,octreolin",octreotide,Antihypertensive agent,peptide,1988,1988,P30872,ssr1_human,SSTR1,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1256,1258,1509,"oral octreotide actetate,octreolin",octreotide,Antihypertensive agent,peptide,1988,1988,P30874,ssr2_human,SSTR2,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1257,1259,1509,"oral octreotide actetate,octreolin",octreotide,Antihypertensive agent,peptide,1988,1988,P35346,ssr5_human,SSTR5,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1258,1260,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1259,1261,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1260,1262,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1261,1263,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1262,1264,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1263,1265,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1264,1266,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1265,1267,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1266,1268,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1267,1269,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1268,1270,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1269,1271,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1270,1272,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1271,1273,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1272,1274,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1273,1275,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1274,1276,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1275,1277,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1276,1278,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1277,1279,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P28566,5ht1e_human,HTR1E,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1278,1280,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1279,1281,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1280,1282,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1281,1283,APR13_0013,alks 3831,olanzapine,Antipsychotic agent,small molecule,1996,1996,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1282,1284,MMAmay2016_0185,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent; antipsychotic-related metabolic weight gain,small molecule,1996,1996,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1283,1285,MMAmay2016_0186,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1284,1286,MMAmay2016_0187,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1285,1287,MMAmay2016_0188,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1286,1288,MMAmay2016_0189,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1287,1289,MMAmay2016_0190,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1288,1290,MMAmay2016_0191,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1289,1291,MMAmay2016_0192,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1290,1292,MMAmay2016_0193,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1291,1293,MMAmay2016_0194,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1292,1294,MMAmay2016_0195,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1293,1295,MMAmay2016_0196,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1294,1296,MMAmay2016_0197,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1295,1297,MMAmay2016_0198,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1296,1298,MMAmay2016_0199,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1297,1299,MMAmay2016_0200,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1298,1300,MMAmay2016_0201,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1299,1301,MMAmay2016_0202,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28566,5ht1e_human,HTR1E,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1300,1302,MMAmay2016_0203,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1301,1303,MMAmay2016_0204,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1302,1304,MMAmay2016_0205,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1303,1305,MMAmay2016_0206,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1304,1306,MMAmay2016_0207,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1305,1307,MMAmay2016_0209,"alks 3831,  olanzapine + alks 33,samidorphan",olanzapine,Antipsychotic agent,small molecule,1996,1996,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1306,1308,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1307,1309,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1308,1310,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1309,1311,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1310,1312,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1311,1313,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1312,1314,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1313,1315,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1314,1316,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1315,1317,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1316,1318,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1317,1319,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1318,1320,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1319,1321,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1320,1322,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1321,1323,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1322,1324,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1323,1325,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1324,1326,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1325,1327,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28566,5ht1e_human,HTR1E,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1326,1328,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1327,1329,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1328,1330,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1329,1331,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",olanzapine,Antipsychotic agent,small molecule,1996,1996,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1330,1332,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1331,1333,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1332,1334,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1333,1335,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1334,1336,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1335,1337,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1336,1338,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1337,1339,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1338,1340,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1339,1341,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1340,1342,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1341,1343,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1342,1344,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1343,1345,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1344,1346,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1345,1347,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1346,1348,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1347,1349,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1348,1350,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1349,1351,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P28566,5ht1e_human,HTR1E,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1350,1352,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1351,1353,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1352,1354,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1353,1355,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",olanzapine,Anti-depressant; for treatment of bipolar disorder,small molecule,1996,1996,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1354,1356,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1355,1357,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1356,1358,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1357,1359,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1358,1360,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1359,1361,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1360,1362,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1361,1363,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1362,1364,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1363,1365,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1364,1366,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1365,1367,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1366,1368,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1367,1369,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1368,1370,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1369,1371,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1370,1372,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1371,1373,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1372,1374,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1373,1375,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28566,5ht1e_human,HTR1E,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1374,1376,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1375,1377,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1376,1378,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1377,1379,1515,"orex-003, olanzapine plus zonisamide sr",olanzapine,Antipsychotic agent,small molecule,1996,1996,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1378,1380,557,"cs-8663, amlodipine + olmesartan,azor, sevikar",olmesartan,Antihypertensive agent,small molecule,2002,2002,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,approved,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
1379,1381,1478,"olmesartan medoxomil (cs-866),benicar",olmesartan,Antihypertensive agent,small molecule,2002,2002,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,approved,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
1380,1382,1479,"olmesartan, de-092",olmesartan,for treatment of glaucoma,small molecule,2002,2002,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,approved,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
1381,1383,2080,tribenzor,olmesartan,Antihypertensive agent,small molecule,2002,2002,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,approved,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
1382,1384,351,bi-1744-cl,olodaterol,Bronchodilator agent,small molecule,2014,2014,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1383,1385,MMAmay2016_0592,tiotropium + olodaterol,olodaterol,Bronchodilator agent; COPD,small molecule,2014,2014,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1384,1386,1480,"olopatadine hydrochloride,patanase",olopatadine,Anti-Allergic Agents,small molecule,1996,1996,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1385,1387,2457,omp-18r5,omp-18r5,Antineoplastic agent,antibody,-,-,O75084,fzd7_human,FZD7,GPCR;Frizzled,not established,in trial,Protein ,Frizzled,Class F (Frizzled)
1386,1388,MMAmay2016_0512,opa-6566,opa-6566,for treatment of glaucoma,small molecule,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1387,1389,1662,"prs-013, opc-14523",opc-14523,Anti-depressant,small molecule,-,-,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1388,1390,1662,"prs-013, opc-14523",opc-14523,Anti-depressant,small molecule,-,-,O00264,pgrc1_human,PGRMC1,GPCR;Rhodopsin,not established,in trial,,,
1389,1391,1501,opc-28326,opc-28326,vasodilator,small molecule,-,-,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1390,1392,1501,opc-28326,opc-28326,vasodilator,small molecule,-,-,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1391,1393,1502,"opc-34712, brexpiprazole","opc-34712, brexpiprazole",Anti-depressant,small molecule,2015,2015,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1392,1394,1502,"opc-34712, brexpiprazole","opc-34712, brexpiprazole",Anti-depressant,small molecule,2015,2015,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1393,1395,1502,"opc-34712, brexpiprazole","opc-34712, brexpiprazole",Anti-depressant,small molecule,2015,2015,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1394,1396,1502,"opc-34712, brexpiprazole","opc-34712, brexpiprazole",Anti-depressant,small molecule,2015,2015,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1395,1397,1503,opc-51803,opc-51803,for treatment of incontinence,small molecule,-,-,P30518,v2r_human,AVPR2,GPCR;Rhodopsin,established,in trial,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1396,1398,NRDD399,-,orciprenaline,Bronchodilator agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1397,1399,2422,acr325,ordopidine,Antiparkinson agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1398,1400,1519,"ormd-0901, oral glp-1 analog",ormd-0901,Antidiabetic,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1399,1401,NRDD400,-,orphenadrine,Antiparkinson agents; Muscle Relaxants; Central,small molecule,1957,1957,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1400,1402,1530,"ostabolin-c,  zt-031",ostabolin-c,Anti-osteoporotic agent,peptide,-,-,Q03431,pth1r_human,PTH1R,GPCR;Secretin,established,in trial,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
1401,1403,1530,"ostabolin-c,  zt-031",ostabolin-c,Anti-osteoporotic agent,peptide,-,-,P49190,pth2r_human,PTH2R,GPCR;Secretin,established,in trial,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
1402,1404,1533,ot-730,ot-730,for treatment of glaucoma,small molecule,-,-,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1403,1405,1533,ot-730,ot-730,for treatment of glaucoma,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1404,1406,NRDD405,-,oxprenolol,Antihypertensive agent; Anti-Arrhythmia Agents,small molecule,-,1983,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1405,1407,NRDD405,-,oxprenolol,Antihypertensive agent; Anti-Arrhythmia Agents,small molecule,-,1983,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1406,1408,14,aa-2010,oxybutynin,for treatment of incontinence,small molecule,1975,1975,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1407,1409,14,aa-2010,oxybutynin,for treatment of incontinence,small molecule,1975,1975,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1408,1410,14,aa-2010,oxybutynin,for treatment of incontinence,small molecule,1975,1975,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1409,1411,190,"ap-1034,anturol",oxybutynin,for treatment of overactive bladder,small molecule,1975,1975,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1410,1412,190,"ap-1034,anturol",oxybutynin,for treatment of overactive bladder,small molecule,1975,1975,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1411,1413,190,"ap-1034,anturol",oxybutynin,for treatment of overactive bladder,small molecule,1975,1975,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1412,1414,2351,dr-3001,oxybutynin,Anti-incontinence agent,small molecule,1975,1975,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1413,1415,2351,dr-3001,oxybutynin,Anti-incontinence agent,small molecule,1975,1975,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1414,1416,2351,dr-3001,oxybutynin,Anti-incontinence agent,small molecule,1975,1975,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1415,1417,MMAapril2016_0197,jnp-010,oxybutynin,for treatment of overactive bladder,small molecule,1975,1975,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1416,1418,MMAapril2016_0198,jnp-010,oxybutynin,for treatment of overactive bladder,small molecule,1975,1975,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1417,1419,MMAapril2016_0199,jnp-010,oxybutynin,for treatment of overactive bladder,small molecule,1975,1975,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1418,1420,2067,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",oxybutynin,for treatment of incontinence,small molecule,1975,1975,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1419,1421,2067,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",oxybutynin,for treatment of incontinence,small molecule,1975,1975,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1420,1422,2067,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",oxybutynin,for treatment of incontinence,small molecule,1975,1975,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1421,1423,514,"col-003, sustained release oxycodone",oxycodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1422,1424,514,"col-003, sustained release oxycodone",oxycodone,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1423,1425,514,"col-003, sustained release oxycodone",oxycodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1424,1426,515,"col-172, extended-release oxycodone",oxycodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1425,1427,515,"col-172, extended-release oxycodone",oxycodone,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1426,1428,515,"col-172, extended-release oxycodone",oxycodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1427,1429,696,"eli-154, oxycodone (once daily)",oxycodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1428,1430,696,"eli-154, oxycodone (once daily)",oxycodone,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1429,1431,696,"eli-154, oxycodone (once daily)",oxycodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1430,1432,MMAfeb2016_0087,eli-200,oxycodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1431,1433,MMAfeb2016_0088,eli-200,oxycodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1432,1434,MMAfeb2016_0089,eli-200,oxycodone,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1433,1435,1341,moxduo,oxycodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1434,1436,1341,moxduo,oxycodone,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1435,1437,1341,moxduo,oxycodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1436,1438,1545,"oxycodone art, eli216,oxynal",oxycodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1437,1439,1545,"oxycodone art, eli216,oxynal",oxycodone,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1438,1440,1545,"oxycodone art, eli216,oxynal",oxycodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1439,1441,1546,"oxycodone hcl + niacin,acurox, oxyadf",oxycodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1440,1442,1546,"oxycodone hcl + niacin,acurox, oxyadf",oxycodone,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1441,1443,1546,"oxycodone hcl + niacin,acurox, oxyadf",oxycodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1442,1444,1547,"oxycodone, pti-821,remoxy",oxycodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1443,1445,1547,"oxycodone, pti-821,remoxy",oxycodone,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1444,1446,1547,"oxycodone, pti-821,remoxy",oxycodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1445,1447,1687,"pti-801,oxytrex",oxycodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1446,1448,1687,"pti-801,oxytrex",oxycodone,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1447,1449,1687,"pti-801,oxytrex",oxycodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1448,1450,MMAmay2016_0706,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",oxycodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1449,1451,MMAmay2016_0707,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",oxycodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1450,1452,MMAmay2016_0708,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",oxycodone,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1451,1453,2068,transdermal oxycodone,oxycodone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1452,1454,2068,transdermal oxycodone,oxycodone,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1453,1455,2068,transdermal oxycodone,oxycodone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1454,1456,MMAmar2016_0078,"rexista, oxycodone xr",oxycodone xr,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1455,1457,MMAmar2016_0079,"rexista, oxycodone xr",oxycodone xr,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1456,1458,MMAmar2016_0080,"rexista, oxycodone xr",oxycodone xr,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1457,1459,1491,oms-103hp,oxymetazoline,Analgesics,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1458,1460,1491,oms-103hp,oxymetazoline,Analgesics,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1459,1461,1548,"oxymorphone hydrochloride, en3202,opana, opana er",oxymorphone,Analgesics,small molecule,-,-,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1460,1462,1548,"oxymorphone hydrochloride, en3202,opana, opana er",oxymorphone,Analgesics,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1461,1463,NRDD407,-,oxyphencyclimine,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1462,1464,NRDD407,-,oxyphencyclimine,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1463,1465,NRDD407,-,oxyphencyclimine,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1464,1466,NRDD408,-,oxyphenonium,Mydriatics,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1465,1467,MMA2016_0022,"opn-300, intranasal oxytocin",oxytocin,for treatment of autism,peptide,-,-,P30559,oxyr_human,OXTR,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1466,1468,2014,"ti-001, intranasal oxytocin",oxytocin,Analgesics,peptide,-,-,P30559,oxyr_human,OXTR,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1467,1469,1891,"spi-153, d-63153,ozarelix",ozarelix,Antineoplastic agent,peptide,-,-,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,in trial,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
1468,1470,1891,"spi-153, d-63153,ozarelix",ozarelix,Antineoplastic agent,peptide,-,-,Q96P88,gnrr2_human,GNRHR2,GPCR;Rhodopsin,established,in trial,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
1469,1471,MMAmay2016_0746,"p2045, 188re-p2045","p2045, 188re-p2045",Antineoplastic agent; lung cancer,peptide,-,-,P30874,ssr2_human,SSTR2,GPCR;Rhodopsin,established,in trial,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1470,1472,MMAmar2016_0133,pa101b,pa101b,for treatment of autoimmune diseases,small molecule,-,-,Q9HC97,gpr35_human,GPR35,GPCR;Rhodopsin,not established,in trial,Orphan ,Class A orphans,Class A (Rhodopsin)
1471,1473,1553,"pa-401, pa04-001",pa-401,Anti-inflammatory agent; immunosuppressant,protein,-,-,P25024,cxcr1_human,CXCR1,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1472,1474,1553,"pa-401, pa04-001",pa-401,Anti-inflammatory agent; immunosuppressant,protein,-,-,P25025,cxcr2_human,CXCR2,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1473,1475,1558,"paliperidone er, paliperidone palmitate",paliperidone,Antipsychotic agent,small molecule,2006,2006,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1474,1476,1558,"paliperidone er, paliperidone palmitate",paliperidone,Antipsychotic agent,small molecule,2006,2006,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1475,1477,377,"bn-003,capthymone",parathyroid hormone,Anti-osteoporotic agent,protein,-,-,Q03431,pth1r_human,PTH1R,GPCR;Secretin,established,in trial,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
1476,1478,2012,thpth,parathyroid hormone,Anti-osteoporotic agent,protein,-,-,Q03431,pth1r_human,PTH1R,GPCR;Secretin,established,approved,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
1477,1479,2012,thpth,parathyroid hormone,Anti-osteoporotic agent,protein,-,-,P49190,pth2r_human,PTH2R,GPCR;Secretin,established,approved,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
1478,1480,MMAmay2016_0745,"natpara, npsp558, parathyroid horomone",parathyroid horomone,Control hypocalcemia,protein,-,2015,Q03431,pth1r_human,PTHR1,GPCR;Secretin,established,approved,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
1479,1481,1563,"pardoprunox, slv 308",pardoprunox,Antiparkinson agent,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1480,1482,1563,"pardoprunox, slv 308",pardoprunox,Antiparkinson agent,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1481,1483,1563,"pardoprunox, slv 308",pardoprunox,Antiparkinson agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1482,1484,1563,"pardoprunox, slv 308",pardoprunox,Antiparkinson agent,small molecule,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1483,1485,1563,"pardoprunox, slv 308",pardoprunox,Antiparkinson agent,small molecule,-,-,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1484,1486,1563,"pardoprunox, slv 308",pardoprunox,Antiparkinson agent,small molecule,-,-,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1485,1487,1563,"pardoprunox, slv 308",pardoprunox,Antiparkinson agent,small molecule,-,-,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1486,1488,1567,"pasireotide, som230",pasireotide,Antineoplastic agent; for treatment of acromegaly,peptide,2012,2012,P30872,ssr1_human,SSTR1,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1487,1489,1567,"pasireotide, som230",pasireotide,Antineoplastic agent; for treatment of acromegaly,peptide,2012,2012,P30874,ssr2_human,SSTR2,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1488,1490,1567,"pasireotide, som230",pasireotide,Antineoplastic agent; for treatment of acromegaly,peptide,2012,2012,P32745,ssr3_human,SSTR3,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1489,1491,1567,"pasireotide, som230",pasireotide,Antineoplastic agent; for treatment of acromegaly,peptide,2012,2012,P35346,ssr5_human,SSTR5,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1490,1492,1569,"pb1023, glp-1-elp-120,glymera",pb1023,Antidiabetic,protein,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1491,1493,MMAapril2016_0077,pbf-509,pbf-509,Antineoplastic agent; lung cancer,small molecule,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1492,1494,MMAmar2016_0115,pbf-680,pbf-680,antiasthmatic,small molecule,-,-,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1493,1495,MMAapril2016_0022,pbf-999,pbf-999,for treatment of Huntington's disease,small molecule,-,-,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1494,1496,1575,"pd-6735, ly-156735",pd-6735,Hypnotics and Sedatives,small molecule,-,-,P48039,mtr1a_human,MTNR1A,GPCR;Rhodopsin,established,in trial,Melatonin ,Melatonin,Class A (Rhodopsin)
1495,1497,1575,"pd-6735, ly-156735",pd-6735,Hypnotics and Sedatives,small molecule,-,-,P49286,mtr1b_human,MTNR1B,GPCR;Rhodopsin,established,in trial,Melatonin ,Melatonin,Class A (Rhodopsin)
1496,1498,MMAmay2016_0526,pdc31,pdc31,for treatment of pre-term labor; dysmenorrhea ,peptide,-,-,P43088,pf2r_human,PTGFR,GPCR;Rhodopsin,established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
1497,1499,NRDD416,-,pemirolast,Anti-Allergic Agents,small molecule,1999,1999,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1498,1500,NRDD417,-,penbutolol,Antihypertensive agent,small molecule,1987,1987,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1499,1501,NRDD417,-,penbutolol,Antihypertensive agent,small molecule,1987,1987,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1500,1502,NRDD418,-,pentagastrin,Diagnostic Agents,small molecule,1974,1974,P32239,gasr_human,CCKBR,GPCR;Rhodopsin,established,approved,Peptide ,Cholecystokinin receptors,Class A (Rhodopsin)
1501,1503,NRDD419,-,pentazocine,Analgesics; Opioid,small molecule,1967,1967,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1502,1504,NRDD419,-,pentazocine,Analgesics; Opioid,small molecule,1967,1967,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1503,1505,1586,"pentoxifylline, eht0201",pentoxifylline,for treatment of amyotrophic lateral sclerosis (ALS),small molecule,1984,1984,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,approved,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1504,1506,1586,"pentoxifylline, eht0201",pentoxifylline,for treatment of amyotrophic lateral sclerosis (ALS),small molecule,1984,1984,P29274,aa2ar_human,ADORA2B,GPCR;Rhodopsin,established,approved,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1505,1507,699,eligen pyy-3-36 + glp-1,peptide yy,Appetite suppressant,peptide,-,-,P49146,npy2r_human,NPY2R,GPCR;Rhodopsin,not established,in trial,Peptide ,Neuropeptide Y receptors,Class A (Rhodopsin)
1506,1508,NRDD422,-,pergolide,Antiparkinson agents,small molecule,-,1988,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1507,1509,NRDD422,-,pergolide,Antiparkinson agents,small molecule,-,1988,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1508,1510,NRDD425,-,perphenazine,Antipsychotic agent,small molecule,1957,1957,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1509,1511,NRDD425,-,perphenazine,Antipsychotic agent,small molecule,1957,1957,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1510,1512,1591,pf-00610355,pf-00610355,Bronchodilator agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1511,1513,NRDD427,-,phendimetrazine,Appetite Depressants,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1512,1514,NRDD427,-,phendimetrazine,Appetite Depressants,small molecule,-,-,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1513,1515,NRDD431,-,pheniramine,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1514,1516,NRDD434,-,phenoxybenzamine,Anticonvulsants; Hypnotics and Sedatives,small molecule,1953,1953,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1515,1517,NRDD437,-,phentolamine,Antihypertensive agent,small molecule,1952,1952,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1516,1518,288,"aviptadil,invicorp",phentolamine ,for treatment of erectile dysfunction,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1517,1519,288,"aviptadil,invicorp",phentolamine ,for treatment of erectile dysfunction,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1518,1520,1675,"psd-503, phenylephrine",phenylephrine,for treatment of incontinence,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1519,1521,1675,"psd-503, phenylephrine",phenylephrine,for treatment of incontinence,small molecule,-,-,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1520,1522,1675,"psd-503, phenylephrine",phenylephrine,for treatment of incontinence,small molecule,-,-,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1521,1523,NRDD439,-,phenylpropanolamine,Appetite Depressants; Nasal Decongestants,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1522,1524,NRDD439,-,phenylpropanolamine,Appetite Depressants; Nasal Decongestants,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1523,1525,2013,thvd-201,pilocarpine,for treatment of incontinence,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1524,1526,2013,thvd-201,pilocarpine,for treatment of incontinence,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1525,1527,2013,thvd-201,pilocarpine,for treatment of incontinence,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1526,1528,1610,pimavanserin,pimavanserin,Antiparkinson agent,small molecule,2016,2016,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1527,1529,NRDD443,-,pimozide,Antidyskinetics; Antipsychotic agent,small molecule,1984,1984,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1528,1530,NRDD444,-,pindolol,Antihypertensive agent,small molecule,1982,1982,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1529,1531,NRDD444,-,pindolol,Antihypertensive agent,small molecule,1982,1982,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1530,1532,NRDD446,-,pirenzepine,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1531,1533,1342,mozobil,plerixafor,Antineoplastic agent,small molecule,2008,2008,P61073,cxcr4_human,CXCR4,GPCR;Rhodopsin,established,approved,Protein ,Chemokine receptors,Class A (Rhodopsin)
1532,1534,1630,ponesimod,ponesimod,Anti-inflammatory agent; for treatment of multiple sclerosis,small molecule,-,-,P21453,s1pr1_human,S1PR1,GPCR;Rhodopsin,established,in trial,Lipid ,Lysophospholipid (S1P) receptors,Class A (Rhodopsin)
1533,1535,NRDD449,-,practolol,Anti-Arrhythmia Agents,small molecule,-,-,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1534,1536,1293,mirapex,pramipexole,Antiparkinson agent,small molecule,1997,1997,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1535,1537,1293,mirapex,pramipexole,Antiparkinson agent,small molecule,1997,1997,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1536,1538,1293,mirapex,pramipexole,Antiparkinson agent,small molecule,1997,1997,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1537,1539,MMAmar2016_0004,p2b001,pramipexole,Antiparkinson agent,small molecule,1997,1997,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1538,1540,MMAmar2016_0005,p2b001,pramipexole,Antiparkinson agent,small molecule,1997,1997,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1539,1541,MMAmar2016_0006,p2b001,pramipexole,Antiparkinson agent,small molecule,1997,1997,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1540,1542,1924,symlin,pramlintide,Antidiabetic; Anti-obesity agent,peptide,2005,2005,P30988,calcr_human,CALCR,GPCR;Secretin,established,approved,Peptide ,Calcitonin receptors,Class B1 (Secretin)
1541,1543,NRDD451,-,pranlukast,Anti-Asthmatic Agents,small molecule,-,-,Q9Y271,cltr1_human,CYSLTR1,GPCR;Rhodopsin,established,in trial,Lipid ,Leukotriene receptors,Class A (Rhodopsin)
1542,1544,1640,"prasugrel, cs-747,efient",prasugrel,antithrombotic,small molecule,2009,2009,Q9H244,p2y12_human,P2RY12,GPCR;Rhodopsin,established,approved,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
1543,1545,NRDD453,-,prazosin,Antihypertensive agent; antispasmodics,small molecule,1976,1976,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1544,1546,NRDD453,-,prazosin,Antihypertensive agent; antispasmodics,small molecule,1976,1976,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1545,1547,NRDD453,-,prazosin,Antihypertensive agent; antispasmodics,small molecule,1976,1976,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1546,1548,1645,"preladenant, sch-420814",preladenant,Antiparkinson agent,small molecule,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1547,1549,1647,"pridopidine, acr-16,huntexil",pridopidine,for treatment of Huntington's disease,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1548,1550,1649,pro 140,pro 140,antiviral agent; HIV,antibody,-,-,P51681,ccr5_human,CCR5,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1549,1551,NRDD459,-,procaterol,Bronchodilator agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1550,1552,301,"az-001, staccato prochlorperazine",prochlorperazine,Anti-migraine Agents,small molecule,1956,1956,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1551,1553,395,"buccal prochlorperazine maleate,emezine",prochlorperazine ,Antiemetics,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1552,1554,NRDD460,-,procyclidine,Antidyskinetics; Antiparkinson agents,small molecule,1955,1955,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1553,1555,NRDD460,-,procyclidine,Antidyskinetics; Antiparkinson agents,small molecule,1955,1955,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1554,1556,NRDD460,-,procyclidine,Antidyskinetics; Antiparkinson agents,small molecule,1955,1955,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1555,1557,NRDD461,-,progabide,Anticonvulsants,small molecule,-,-,Q9UBS5,gabr1_human,GABBR1,GPCR;Glutamate,established,in trial,Amino acid ,GABAB receptors,Class C (Glutamate) 
1556,1558,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1557,1559,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1558,1560,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1559,1561,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1560,1562,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1561,1563,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1562,1564,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1563,1565,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1564,1566,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1565,1567,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1566,1568,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1567,1569,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1568,1570,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1569,1571,NRDD462,-,promazine,Antiemetics; Antipsychotic agent,small molecule,1956,1956,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1570,1572,NRDD463,-,promethazine,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1571,1573,NRDD463,-,promethazine,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1572,1574,NRDD463,-,promethazine,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1573,1575,NRDD463,-,promethazine,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents,small molecule,-,-,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1574,1576,NRDD463,-,promethazine,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents,small molecule,-,-,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1575,1577,NRDD463,-,promethazine,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1576,1578,MMAapril2016_0100,"cl-h1t, promethazine + sumatriptan",promethazine,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents; Treat migraines and cluster headaches,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1577,1579,MMAapril2016_0101,"cl-h1t, promethazine + sumatriptan",promethazine,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents; Treat migraines and cluster headaches,small molecule,-,-,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1578,1580,MMAapril2016_0102,"cl-h1t, promethazine + sumatriptan",promethazine,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents; Treat migraines and cluster headaches,small molecule,-,-,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1579,1581,MMAapril2016_0103,"cl-h1t, promethazine + sumatriptan",promethazine,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents; Treat migraines and cluster headaches,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1580,1582,MMAapril2016_0104,"cl-h1t, promethazine + sumatriptan",promethazine,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents; Treat migraines and cluster headaches,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1581,1583,MMAapril2016_0105,"cl-h1t, promethazine + sumatriptan",promethazine,Hypnotics and Sedatives; Anti-anxiety agents; Anti-allergic Agents; Treat migraines and cluster headaches,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1582,1584,NRDD464,-,propantheline,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,small molecule,1953,1953,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1583,1585,NRDD466,-,propericiazine,Antipsychotic agent,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1584,1586,NRDD466,-,propericiazine,Antipsychotic agent,small molecule,-,-,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1585,1587,NRDD466,-,propericiazine,Antipsychotic agent,small molecule,-,-,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1586,1588,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1587,1589,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1588,1590,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1589,1591,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1590,1592,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1591,1593,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1592,1594,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1593,1595,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1594,1596,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1595,1597,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1596,1598,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1597,1599,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1598,1600,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1599,1601,NRDD467,-,propiomazine,Hypnotics and Sedatives,small molecule,1960,1960,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1600,1602,NRDD468,-,propoxyphene,Analgesics; Opioid; Antitussive Agents,small molecule,1957,1957,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1601,1603,NRDD468,-,propoxyphene,Analgesics; Opioid; Antitussive Agents,small molecule,1957,1957,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1602,1604,NRDD468,-,propoxyphene,Analgesics; Opioid; Antitussive Agents,small molecule,1957,1957,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1603,1605,2183,vt-122,propranolol,for treatment of cancer cachexia,small molecule,1967,1967,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1604,1606,429,cannabinor,prs-211375,Analgesics,small molecule,-,-,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1605,1607,1665,"prucalopride ,resolor",prucalopride,motilitant,small molecule,-,-,Q13639,5ht4r_human,HTR4,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1606,1608,1666,prx-00023,prx-00023,Anti-depressant; anxiolytic,small molecule,-,-,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1607,1609,1667,prx-07034,prx-07034,Anti-obesity agent; nootropic,small molecule,-,-,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1608,1610,1668,prx-08066,prx-08066,Antihypertensive agent,small molecule,-,-,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1609,1611,1671,prx-3140,prx-3140,for treatment of Alzheimer's disease,small molecule,-,-,Q13639,5ht4r_human,HTR4,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1610,1612,1673,ps433540,ps433540,Antihypertensive agent,small molecule,-,-,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,in trial,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
1611,1613,1673,ps433540,ps433540,Antihypertensive agent,small molecule,-,-,P50052,agtr2_human,AGTR2,GPCR;Rhodopsin,not established,in trial,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
1612,1614,1673,ps433540,ps433540,Antihypertensive agent,small molecule,-,-,P25101,ednra_human,EDNRA,GPCR;Rhodopsin,established,in trial,Peptide ,Endothelin receptors,Class A (Rhodopsin)
1613,1615,1676,psd-506,psd-506,for treatment of overactive bladder,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1614,1616,1676,psd-506,psd-506,for treatment of overactive bladder,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1615,1617,789,fexofenadine + ps/,pseudoephedrine,Anti-Allergic Agents,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1616,1618,789,fexofenadine + ps/,pseudoephedrine,Anti-Allergic Agents,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1617,1619,1678,psn602,psn602,Anti-obesity agent,small molecule,-,-,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1618,1620,1679,psn821,psn821,Antidiabetic,small molecule,-,-,Q8TDV5,gp119_human,GPR119,GPCR;Rhodopsin,not established,in trial,Lipid ,"GPR18, GPR55 and GPR119",Class A (Rhodopsin)
1619,1621,1690,pw2101,pw2101,Antihypertensive agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1620,1622,MMAmay2016_0906,pxt002331,pxt002331,Antiparkinson agents,small molecule,-,-,Q14833,grm4_human,GRM4,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
1621,1623,1698,pyy3-36,pyy3-36,Anti-obesity agent,peptide,-,-,P49146,npy2r_human,NPY2R,GPCR;Rhodopsin,not established,in trial,Peptide ,Neuropeptide Y receptors,Class A (Rhodopsin)
1622,1624,MMAmar2016_0157,q-122,q-122,Anti-inflammatory agent; hot flashes,small molecule,-,-,P61073,cxcr4_human,CXCR4,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1623,1625,1840,seroquel,quetiapine,Antipsychotic agent; Anti-depressant,small molecule,1997,1997,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1624,1626,1840,seroquel,quetiapine,Antipsychotic agent; Anti-depressant,small molecule,1997,1997,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1625,1627,1840,seroquel,quetiapine,Antipsychotic agent; Anti-depressant,small molecule,1997,1997,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1626,1628,1840,seroquel,quetiapine,Antipsychotic agent; Anti-depressant,small molecule,1997,1997,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1627,1630,1713,"ramelteon, tak-375,rozerem",ramelteon,for treatment of insomnia,small molecule,2005,2005,P48039,mtr1a_human,MTNR1A,GPCR;Rhodopsin,established,approved,Melatonin ,Melatonin,Class A (Rhodopsin)
1628,1631,1713,"ramelteon, tak-375,rozerem",ramelteon,for treatment of insomnia,small molecule,2005,2005,P49286,mtr1b_human,MTNR1B,GPCR;Rhodopsin,established,approved,Melatonin ,Melatonin,Class A (Rhodopsin)
1629,1632,1716,"ranitidine bismuth citrate,tritec",ranitidine,antiulcer agent,small molecule,1983,1983,P25021,hrh2_human,HRH2,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1630,1633,2238,"zantac,ranitidine hydrochloride",ranitidine,antiulcer agent,small molecule,1983,1983,P25021,hrh2_human,HRH2,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1631,1634,2222,xp19986,r-baclofen,for treatment of gastrointestinal reflux disease,small molecule,-,-,Q9UBS5,gabr1_human,GABBR1,GPCR;Glutamate,established,approved,Amino acid ,GABAB receptors,Class C (Glutamate) 
1632,1635,2222,xp19986,r-baclofen,for treatment of gastrointestinal reflux disease,small molecule,-,-,O75899,gabr2_human,GABBR2,GPCR;Glutamate,established,approved,Amino acid ,GABAB receptors,Class C (Glutamate) 
1633,1636,MMAapril2016_0044,"re-021, sparsentan","re-021, sparsentan",for treatment of kidney disease; nephropathy,small molecule,-,-,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,in trial,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
1634,1637,MMAapril2016_0045,"re-021, sparsentan","re-021, sparsentan",for treatment of kidney disease; nephropathy,small molecule,-,-,P25101,ednra_human,EDNRA,GPCR;Rhodopsin,established,in trial,Peptide ,Endothelin receptors,Class A (Rhodopsin)
1635,1638,MMAmar2016_0275,"re-034, cosyntropin, tetracosactid","re-034, cosyntropin, tetracosactid",for treatment of epilepsy,small molecule,-,-,Q01718,acthr_human,MC2R,GPCR;Rhodopsin,established,approved,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
1636,1639,1756,"r-hcg,ovidrel",recombinant human chorionic gonadotropin,Antineoplastic agent,protein,-,-,P22888,lshr_human,LHCGR,GPCR;Rhodopsin,established,approved,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
1637,1640,2799,"air parathyroid hormone, air pth",recombinant parathyroid hormone,,protein,-,-,Q03431,pth1r_human,PTH1R,GPCR;Secretin,established,approved,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
1638,1641,1726,"regadenoson,lexiscan",regadenoson,Diagnostic Agents,small molecule,2008,2008,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,approved,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1639,1642,MMAapril2016_0214,remd-477,remd-477,Antidiabetic agent,antibody,-,-,P47871,glr_human,GCGR,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1640,1643,1732,"remifentanil,ultiva",remifentanil,Analgesics,small molecule,1996,1996,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1641,1644,NRDD479,-,remoxipride,Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1642,1645,1734,renzapride,renzapride,for treatment of irritable bowel syndrome,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1643,1646,1734,renzapride,renzapride,for treatment of irritable bowel syndrome,small molecule,-,-,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1644,1647,1734,renzapride,renzapride,for treatment of irritable bowel syndrome,small molecule,-,-,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1645,1648,1734,renzapride,renzapride,for treatment of irritable bowel syndrome,small molecule,-,-,Q13639,5ht4r_human,HTR4,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1646,1649,MMAmay2016_0551,reparixin,reparixin,Antidiabetic; type I diabetes,small molecule,-,-,P25024,cxcr1_human,CXCR1,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1647,1650,MMAmay2016_0552,reparixin,reparixin,Antidiabetic; type I diabetes,small molecule,-,-,P25025,cxcr2_human,CXCR2,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1648,1651,1745,rev131,rev131,Anti-Allergic Agents,small molecule,-,-,Q9H3N8,hrh4_human,HRH4,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1649,1652,1749,"rg1068, synthetic secretin,secreflo",rg1068,for treatment of autism,peptide,-,-,P47872,sctr_human,SCTR,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1650,1653,MMAjun2016_0002,ridogrel,ridogrelum,for the prevention of systemic thrombo-embolism; adjunctive agent to thrombolytic therapy,small molecule,-,-,P21731,ta2r_human,TBXA2R,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
1651,1654,1766,rimonabant,rimonabant,Anti-obesity agent,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1652,1655,1770,risperdal,risperdal,Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1653,1656,1770,risperdal,risperdal,Antipsychotic agent,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1654,1657,NRDD484,-,risperidone,Antipsychotic agent,small molecule,1993,1993,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1655,1658,NRDD484,-,risperidone,Antipsychotic agent,small molecule,1993,1993,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1656,1659,NRDD485,-,ritodrine,Tocolytic Agents,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1657,1660,NRDD486,-,rizatriptan,Anti-migraine Agents,small molecule,1998,1998,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1658,1661,NRDD486,-,rizatriptan,Anti-migraine Agents,small molecule,1998,1998,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1659,1662,MMAmay2016_0229,"rm-493, setmelanotide","rm-493, setmelanotide",Anti-obesity agent,peptide,-,-,P32245,mc4r_human,MC4R,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
1660,1663,MMAmay2016_0177,ro4917523,ro4917523,for Fragile X syndrome and Major Depressive Disorder,small molecule,-,-,P41594,grm5_human,GRM5,GPCR;Glutamate,established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
1661,1664,1776,"rocuronium bromide,esmeron, zemuron, eslax",rocuronium,Muscle Relaxants,small molecule,1994,1994,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1662,1665,MMAmay2016_0753,"sch 619734, rolapitant",rolapitant,Anti-emetic,small molecule,2015,2015,P25103,nk1r_human,TACR1,GPCR;Rhodopsin,established,approved,Peptide ,Tachykinin receptors,Class A (Rhodopsin)
1663,1666,1780,"rolofylline, mk-7418, kw-3902",rolofylline,for treatment of congestive heart failure,small molecule,-,-,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1664,1667,1782,"ronacaleret, 751689",ronacaleret,Anti-osteoporotic agent,small molecule,-,-,P41180,casr_human,CASR,GPCR;Glutamate,established,in trial,Ion ,Calcium-sensing receptors,Class C (Glutamate) 
1665,1668,1057,jzp-7,ropinirole,for treatment of restlegs legs syndrome,small molecule,1997,1997,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1666,1669,1057,jzp-7,ropinirole,for treatment of restlegs legs syndrome,small molecule,1997,1997,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1667,1670,1737,requip,ropinirole,Antiparkinson agent,small molecule,1997,1997,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1668,1671,1737,requip,ropinirole,Antiparkinson agent,small molecule,1997,1997,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1669,1672,1404,neupro,rotigotine,Antiparkinson agent ,small molecule,2007,2007,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1670,1673,1404,neupro,rotigotine,Antiparkinson agent ,small molecule,2007,2007,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1671,1674,1404,neupro,rotigotine,Antiparkinson agent ,small molecule,2007,2007,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1672,1675,1790,rpc1063,rpc1063,For treatment of Multiple Sclerosis,small molecule,-,-,P21453,s1pr1_human,S1PR1,GPCR;Rhodopsin,established,in trial,Lipid ,Lysophospholipid (S1P) receptors,Class A (Rhodopsin)
1673,1676,2048,"tp-508,chrysalin",rusalatide,for treatment of diabetic foot ulcers,peptide,-,-,P25116,par1_human,F2R,GPCR;Rhodopsin,established,in trial,Peptide ,Proteinase-activated receptors,Class A (Rhodopsin)
1674,1677,2048,"tp-508,chrysalin",rusalatide,for treatment of diabetic foot ulcers,peptide,-,-,O00254,par3_human,F2RL2,GPCR;Rhodopsin,established,in trial,Peptide ,Proteinase-activated receptors,Class A (Rhodopsin)
1675,1678,2048,"tp-508,chrysalin",rusalatide,for treatment of diabetic foot ulcers,peptide,-,-,Q96RI0,par4_human,F2RL3,GPCR;Rhodopsin,established,in trial,Peptide ,Proteinase-activated receptors,Class A (Rhodopsin)
1676,1679,MMAmar2016_0106,"rvt-101, sb-742457, gsk 742457","rvt-101, sb-742457, gsk 742457",for treatment of Alzheimer's disease,small molecule,-,-,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1677,1680,2317,rx-10045,rx-10045,for treatment of dry eye,small molecule,-,-,Q15722,lt4r1_human,BLT1,GPCR;Rhodopsin,not established,in trial,Lipid ,Leukotriene receptors,Class A (Rhodopsin)
1678,1681,2317,rx-10045,rx-10045,for treatment of dry eye,small molecule,-,-,Q99788,cml1_human,CMKLR1,GPCR;Rhodopsin,not established,in trial,Protein ,Chemerin receptor,Class A (Rhodopsin)
1679,1682,MMAapril2016_0280,ryi-018,ryi-018,for treatment of liver disease; nonalcoholic steatohepatitis,antibody,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1680,1683,102,"albuterol,ventolin",salbutamol,Bronchodilator agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1681,1684,1021,"ipratropium bromide + albuterol sulfate,duoneb",salbutamol,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1682,1685,1116,levalbuterol,salbutamol,Bronchodilator agent,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1683,1686,1146,"lipo-102, salmeterol xinafoate + fluticasone propionate",salbutamol,for treatment of symptomatic exophthalmos associated with thyroid-related eye disease,small molecule,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1684,1687,61,advair/seretide/adoair,salmeterol,Bronchodilator agent,small molecule,1994,1994,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1685,1688,1839,serevent,salmeterol,Bronchodilator agent,small molecule,1994,1994,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1686,1689,817,fortical,salmon calcitonin,Anti-osteoporotic agent,peptide,-,-,P30988,calcr_human,CALCR,GPCR;Secretin,established,approved,Peptide ,Calcitonin receptors,Class B1 (Secretin)
1687,1690,APR13_0013,alks 3831,samidoprhan,for treatment of addiction,small molecule,-,-,P35372,oprm_human,MOR,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
1688,1691,NRDD489,-,saprisartan,Antihypertensive agent,small molecule,-,-,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,in trial,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
1689,1692,1810,"saredutant, sr 48968",saredutant,Anti-depressant; anxiolytic,small molecule,-,-,P21452,nk2r_human,TACR2,GPCR;Rhodopsin,not established,in trial,Peptide ,Tachykinin receptors,Class A (Rhodopsin)
1690,1693,1822,"sch-527123, ps-291822, ps-938285",sch-527123,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,-,-,P25024,cxcr1_human,CXCR1,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1691,1694,1822,"sch-527123, ps-291822, ps-938285",sch-527123,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,-,-,P25025,cxcr2_human,CXCR2,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1692,1695,NRDD491,-,scopolamine,Adjuvants; Anesthesia; Antispasmodics; Mydriatics,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1693,1696,NRDD493,-,secretin,Diagnostic Agents,peptide,2004,2004,P47872,sctr_human,SCTR,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1694,1697,1831,"selexipag, act-293987",selexipag,Antihypertensive agent,small molecule,2015,2015,P43119,pi2r_human,PTGIR,GPCR;Rhodopsin,established,in trial,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
1695,1698,MMAmay2016_0563,"semaglutide, nn9535 ","semaglutide, nn9535 ",Antidiabetic; type II diabetes,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1696,1699,MMAapril2016_0282,sens-111,sens-111,for vertigo and tinnitus,small molecule,-,-,Q9H3N8,hrh4_human,HRH4,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1697,1700,MMAmay2016_0735,ser100,ser100, for hypertension,small molecule,-,-,P41146,oprx_human,OPRL1,GPCR;Rhodopsin,not established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
1698,1701,NRDD494,-,sermorelin,Hormone Replacement Agents,peptide,1990,1990,Q02643,ghrhr_human,GHRHR,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1699,1702,1838,serdolect,sertindole,Antipsychotic agent,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1700,1703,1838,serdolect,sertindole,Antipsychotic agent,small molecule,-,-,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1701,1704,1838,serdolect,sertindole,Antipsychotic agent,small molecule,-,-,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1702,1705,1838,serdolect,sertindole,Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1703,1706,1838,serdolect,sertindole,Antipsychotic agent,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1704,1707,1838,serdolect,sertindole,Antipsychotic agent,small molecule,-,-,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1705,1708,1838,serdolect,sertindole,Antipsychotic agent,small molecule,-,-,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1706,1709,1852,silodosin,silodosin,for treatment of BPH-related urinary symptoms,small molecule,2008,2008,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1707,1710,2010,thelin,sitaxsentan,for treatment of pulmonary arterial hypertension,small molecule,-,-,P25101,ednra_human,EDNRA,GPCR;Rhodopsin,established,approved,Peptide ,Endothelin receptors,Class A (Rhodopsin)
1708,1711,MMAmay2016_0805,bbi-4000,sofpironium bromide,Anticholinergics; for the topical treatment of primary axillary hyperhidrosis,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1709,1712,1874,"solabegron, gw 427353",solabegron,Antidiabetic; for treatment of irritable bowel syndrome; antiincontinence agent,small molecule,-,-,P13945,adrb3_human,ADRB3,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1710,1713,1876,"solifenacin succinate, ym-905,vesicare",solifenacin,for treatment of incontinence,small molecule,2004,2004,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1711,1714,1876,"solifenacin succinate, ym-905,vesicare",solifenacin,for treatment of incontinence,small molecule,2004,2004,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1712,1715,1876,"solifenacin succinate, ym-905,vesicare",solifenacin,for treatment of incontinence,small molecule,2004,2004,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1713,1716,1876,"solifenacin succinate, ym-905,vesicare",solifenacin,for treatment of incontinence,small molecule,2004,2004,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1714,1717,1876,"solifenacin succinate, ym-905,vesicare",solifenacin,for treatment of incontinence,small molecule,2004,2004,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1715,1718,1101,lde225,sonidegib,Antineoplastic agent,small molecule,2015,2015,Q99835,smo_human,SMO,GPCR;Frizzled,established,approved,Protein ,Frizzled,Class F (Frizzled)
1716,1719,1881,"sou-001, drp-001",sou-001,for treatment of incontinence,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1717,1720,1881,"sou-001, drp-001",sou-001,for treatment of incontinence,small molecule,-,-,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1718,1721,1881,"sou-001, drp-001",sou-001,for treatment of incontinence,small molecule,-,-,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1719,1722,1882,"sou-003, opc-51803",sou-003,for treatment of incontinence,small molecule,-,-,P30518,v2r_human,AVPR2,GPCR;Rhodopsin,established,in trial,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1720,1723,1892,spi-1620,spi-1620,adjuvant to chemotherapy,peptide,-,-,P25101,ednra_human,EDNRA,GPCR;Rhodopsin,established,in trial,Peptide ,Endothelin receptors,Class A (Rhodopsin)
1721,1724,1892,spi-1620,spi-1620,adjuvant to chemotherapy,peptide,-,-,P24530,ednrb_human,EDNRB,GPCR;Rhodopsin,established,in trial,Peptide ,Endothelin receptors,Class A (Rhodopsin)
1722,1725,MMAapril2016_0099,srx-1177,srx-1177,Antineoplastic agent; melanoma,peptide,-,-,Q01726,mshr_human,MC1R,GPCR;Rhodopsin,not established,in trial,Peptide ,Melanocortin receptors,Class A (Rhodopsin)
1723,1726,1905,"strontium ranelate, s12911",strontium ranelate,Anti-osteoporotic agent,small molecule,-,-,P41180,casr_human,CASR,GPCR;Glutamate,established,in trial,Ion ,Calcium-sensing receptors,Class C (Glutamate) 
1724,1727,1906,stx107,stx107,for treatment of Fragile X symptoms,small molecule,-,-,P41594,grm5_human,GRM5,GPCR;Glutamate,established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
1725,1728,NRDD501,-,succinylcholine,Muscle Relaxants; Skeletal,small molecule,1952,1952,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1726,1729,242,"arx-01, sufentanil nanotab",sufentanil,Analgesics; adjuvant to anesthesia,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1727,1730,242,"arx-01, sufentanil nanotab",sufentanil,Analgesics; adjuvant to anesthesia,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1728,1731,242,"arx-01, sufentanil nanotab",sufentanil,Analgesics; adjuvant to anesthesia,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1729,1732,243,"arx-03, sufentanil + triazolam nanotab",sufentanil,Analgesics; adjuvant to anesthesia,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1730,1733,243,"arx-03, sufentanil + triazolam nanotab",sufentanil,Analgesics; adjuvant to anesthesia,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1731,1734,243,"arx-03, sufentanil + triazolam nanotab",sufentanil,Analgesics; adjuvant to anesthesia,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1732,1735,1909,"sufentanil transdermal patch,transdur-sufentanil",sufentanil,Analgesics,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1733,1736,1909,"sufentanil transdermal patch,transdur-sufentanil",sufentanil,Analgesics,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1734,1737,1909,"sufentanil transdermal patch,transdur-sufentanil",sufentanil,Analgesics,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1735,1738,1910,"sufentanil,chronogesic",sufentanil,Analgesics,small molecule,1984,1984,P41143,oprd_human,OPRD1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1736,1739,1910,"sufentanil,chronogesic",sufentanil,Analgesics,small molecule,1984,1984,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1737,1740,1910,"sufentanil,chronogesic",sufentanil,Analgesics,small molecule,1984,1984,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1738,1741,NRDD504,-,sulpiride,Antidepressive Agents; Second-Generation; Antipsychotic agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1739,1742,MMAapril2016_0106,"cl-h1t, promethazine + sumatriptan",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1740,1743,MMAapril2016_0107,"cl-h1t, promethazine + sumatriptan",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1741,1744,MMAapril2016_0108,"cl-h1t, promethazine + sumatriptan",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1742,1745,MMAapril2016_0109,"cl-h1t, promethazine + sumatriptan",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P30939,5ht1f_human,HTR1F,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1743,1746,1357,"mt 400,treximet",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1744,1747,1357,"mt 400,treximet",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1745,1748,1357,"mt 400,treximet",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1746,1749,1357,"mt 400,treximet",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P30939,5ht1f_human,HTR1F,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1747,1750,1438,"np101,zelrix",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1748,1751,1438,"np101,zelrix",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1749,1752,1438,"np101,zelrix",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1750,1753,1438,"np101,zelrix",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P30939,5ht1f_human,HTR1F,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1751,1754,1914,sumatriptan,sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1752,1755,1914,sumatriptan,sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1753,1756,1914,sumatriptan,sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1754,1757,1914,sumatriptan,sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P30939,5ht1f_human,HTR1F,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1755,1758,1915,"sumatriptan, triptan",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1756,1759,1915,"sumatriptan, triptan",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1757,1760,1915,"sumatriptan, triptan",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1758,1761,1915,"sumatriptan, triptan",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P30939,5ht1f_human,HTR1F,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1759,1762,1916,"sumatriptan,imitrex",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1760,1763,1916,"sumatriptan,imitrex",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1761,1764,1916,"sumatriptan,imitrex",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1762,1765,1916,"sumatriptan,imitrex",sumatriptan,Anti-migraine Agents,small molecule,1992,1992,P30939,5ht1f_human,HTR1F,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1763,1766,1917,"surinabant, sr 147778",surinabant,smoking-cessation agent,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1764,1767,1920,suvn-502,suvn-502,for treatment of Alzheimer's disease,small molecule,-,-,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1765,1768,MMAmar2016_0094,suvn-d4010,suvn-d4010,for treatment of Alzheimer's disease,small molecule,-,-,Q13639,5ht4r_human,HTR4,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1766,1769,MMAmar2016_0093,suvn-g3031,suvn-g3031,for treatment of Alzheimer's disease,small molecule,-,-,Q9Y5N1,hrh3_human,HRH3,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1767,1770,1304,mk-4305,suvorexant,Hypnotics and Sedatives,small molecule,2014,2014,O43613,ox1r_human,HCRTR1,GPCR;Rhodopsin,established,approved,Peptide ,Orexin receptors,Class A (Rhodopsin)
1768,1771,1304,mk-4305,suvorexant,Hypnotics and Sedatives,small molecule,2014,2014,O43614,ox2r_human,HCRTR2,GPCR;Rhodopsin,established,approved,Peptide ,Orexin receptors,Class A (Rhodopsin)
1769,1772,1921,svt-40776,svt-40776,for treatment of incontinence,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1770,1773,1922,syl040012,syl040012,for treatment of glaucoma,sirna,-,-,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1771,1774,MMAapril2016_0309,syn120,syn120,for treatment of cognitive disorders,small molecule,-,-,P50406,5ht6r_human,HTR6,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1772,1775,MMAapril2016_0310,syn120,syn120,for treatment of cognitive disorders,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1773,1776,MMAmay2016_0579,t111,t111,for treatment of pruritus,small molecule,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1774,1777,1930,t-62,t-62,Analgesics,small molecule,-,-,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1775,1778,MMAmay2016_0794,"taflotan, tapros, zioptan, tafluprost, saflutan, de-085, mk-2452",tafluprost,Reduce intraocular pressure,small molecule,2012,2012,P43088,pf2r_human,PTGFR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
1776,1779,MMAmay2016_0580,"tak-875, fasiglifam","tak-875, fasiglifam",Antidiabetic; type II diabetes,small molecule,-,-,O14842,ffar1_human,FFAR1,GPCR;Rhodopsin,not established,in trial,Lipid ,Free fatty acid receptors,Class A (Rhodopsin)
1777,1780,MMAmar2016_0177,"taladegib, ly2940680","taladegib, ly2940680",Antineoplastic agent,small molecule,-,-,Q99835,smo_human,SMO,GPCR;Frizzled,established,in trial,Protein ,Frizzled,Class F (Frizzled)
1778,1781,1943,"talnetant, sb 223412",talnetant,Antipsychotic agent,small molecule,-,-,P29371,nk3r_human,TACR3,GPCR;Rhodopsin,not established,in trial,Peptide ,Tachykinin receptors,Class A (Rhodopsin)
1779,1782,675,"dutasteride + tamsulosin,jalyn",tamsulosin,for treatment of benign prostatic hyperplasia,small molecule,1997,1997,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1780,1783,1946,"tamsulosin, ym-617,harnal, flomax",tamsulosin,for treatment of urinary symptoms associated with BPH,small molecule,1997,1997,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1781,1784,1946,"tamsulosin, ym-617,harnal, flomax",tamsulosin,for treatment of urinary symptoms associated with BPH,small molecule,1997,1997,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1782,1785,1946,"tamsulosin, ym-617,harnal, flomax",tamsulosin,for treatment of urinary symptoms associated with BPH,small molecule,1997,1997,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1783,1786,1950,tapentadol,tapentadol,Analgesics,small molecule,2008,2008,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1784,1787,1951,"tapentadol hydrochloride, cg-5503, r331333",tapentadol,Analgesics; opioid,small molecule,2008,2008,P35372,oprm_human,MOR,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
1785,1788,1952,"taranabant, mk-0364",taranabant,Anti-obesity agent; smoking-cessation agent,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1786,1789,1956,"tasimelteon, vec-162",tasimelteon,Hypnotics and Sedatives,small molecule,2014,2014,P48039,mtr1a_human,MTNR1A,GPCR;Rhodopsin,established,approved,Melatonin ,Melatonin,Class A (Rhodopsin)
1787,1790,1956,"tasimelteon, vec-162",tasimelteon,Hypnotics and Sedatives,small molecule,2014,2014,P49286,mtr1b_human,MTNR1B,GPCR;Rhodopsin,established,approved,Melatonin ,Melatonin,Class A (Rhodopsin)
1788,1791,NRDD509,-,tasosartan,Antihypertensive agent,small molecule,-,-,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,in trial,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
1789,1792,1958,"taspoglutide, itm-077, r1583, bim-51077",taspoglutide,Antidiabetic,protein,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1790,1793,1962,"tbr-652, tak-652",tbr-652,antiviral agent; HIV,small molecule,-,-,P51681,ccr5_human,CCR5,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1791,1794,1971,td-1211,td-1211,for treatment of opioid-induced gastrointestinal side-effects,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
1792,1795,1972,td-2749,td-2749,motilitant,unknown,-,-,Q13639,5ht4r_human,HTR4,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1793,1796,MMAmay2016_0081,td-4208,td-4208,for treatment of chronic obstructive pulmonary disease (COPD),small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,in trial,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1794,1797,1973,tecadenoson,tecadenoson,Anti-Arrhythmia Agents,small molecule,-,-,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1795,1798,1173,lu aa24530,tedatioxetine,Anti-depressant,small molecule,-,-,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1796,1799,1173,lu aa24530,tedatioxetine,Anti-depressant,small molecule,-,-,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1797,1800,2463,teduglutide,teduglutide,for treatment of short bowel syndrome,peptide,2012,2012,O95838,glp2r_human,GLP2R,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1798,1801,1975,"tegaserod,zelnorm, zelmac",tegaserod,motilitant,small molecule,2002,2002,Q13639,5ht4r_human,HTR4,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1799,1802,1977,"telmisartan,micardis, micardis hct",telmisartan,Antihypertensive agent,small molecule,1998,1998,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,in trial,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
1800,1803,NRDD514,-,terazosin,Antineoplastic agents; Antihypertensive agent,small molecule,1987,1987,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1801,1804,NRDD514,-,terazosin,Antineoplastic agents; Antihypertensive agent,small molecule,1987,1987,P35368,ada1b_human,ADRA1B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1802,1805,NRDD514,-,terazosin,Antineoplastic agents; Antihypertensive agent,small molecule,1987,1987,P25100,ada1d_human,ADRA1D,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1803,1806,NRDD515,-,terbutaline,Bronchodilator agent; Tocolytic Agents,small molecule,1974,1974,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1804,1807,NRDD516,-,terfenadine,Anti-Allergic Agents,small molecule,-,1985,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1805,1808,1981,terguride,terguride,for treatment of pulmonary arterial hypertension,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1806,1809,1981,terguride,terguride,for treatment of pulmonary arterial hypertension,small molecule,-,-,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1807,1810,MMAmay2016_0763,"cp046, intranasal teriparatide",teriparatide,Anti-osteoporotic agent,peptide,-,-,Q03431,pth1r_human,PTHR1,GPCR;Secretin,established,approved,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
1808,1811,1983,"teriparatide, inhaled air",teriparatide,Anti-osteoporotic agent,peptide,-,-,Q03431,pth1r_human,PTHR1,GPCR;Secretin,established,approved,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
1809,1812,1984,"teriparatide, pth1-34 nasal spray",teriparatide,Anti-osteoporotic agent,peptide,-,-,Q03431,pth1r_human,PTHR1,GPCR;Secretin,established,approved,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
1810,1813,1985,"teriparatide,forteo, forsteo",teriparatide,Anti-osteoporotic agent,peptide,-,-,Q03431,pth1r_human,PTHR1,GPCR;Secretin,established,approved,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
1811,1814,2252,"zt-034, teriparatide nasal spray",teriparatide,Anti-osteoporotic agent,peptide,-,-,Q03431,pth1r_human,PTH1R,GPCR;Secretin,established,approved,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
1812,1815,2252,"zt-034, teriparatide nasal spray",teriparatide,Anti-osteoporotic agent,peptide,-,-,Q03431,pth1r_human,PTHR1,GPCR;Secretin,established,approved,Peptide ,Parathyroid hormone receptors,Class B1 (Secretin)
1813,1816,1986,"terlipressin,lucassin",terlipressin,for treatment of hepatorenal syndrome,small molecule,-,-,P37288,v1ar_human,AVPR1A,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1814,1817,1986,"terlipressin,lucassin",terlipressin,for treatment of hepatorenal syndrome,small molecule,-,-,P47901,v1br_human,AVPR1B,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1815,1818,1986,"terlipressin,lucassin",terlipressin,for treatment of hepatorenal syndrome,small molecule,-,-,P30518,v2r_human,AVPR2,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1816,1819,1987,tesamorelin,tesamorelin,for treatment of HIV-associated lipodystrophy,peptide,2010,2010,Q02643,ghrhr_human,GHRHR,GPCR;Secretin,established,approved,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1817,1820,1812,sativex,tetrahydrocannabinol,Analgesics; neuropathic pain; for treatment of restlegs legs syndrome,plant extract,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,approved,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1818,1821,1812,sativex,tetrahydrocannabinol,Analgesics; neuropathic pain; for treatment of restlegs legs syndrome,plant extract,-,-,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,approved,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1819,1822,MMAapril2016_0329,gwp42004,tetrahydrocannabivarin (thcv),Antidiabetic agent; Type 2,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1820,1823,2002,tg-0054,tg-0054,adjuvant to stem cell transplantation,small molecule,-,-,P61073,cxcr4_human,CXCR4,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1821,1824,2008,th0318,th0318,Antidiabetic,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1822,1825,MMAapril2016_0119,thc:cbd oral formulation,thc:cbd oral formulation,For treatment of Multiple Sclerosis,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1823,1826,MMAapril2016_0120,thc:cbd oral formulation,thc:cbd oral formulation,For treatment of Multiple Sclerosis,small molecule,-,-,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1824,1827,53,"adc4022, low-dose inhaled theophylline",theophylline,Bronchodilator agent,small molecule,-,-,P30542,aa1r_human,ADORA1,GPCR;Rhodopsin,established,approved,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1825,1828,53,"adc4022, low-dose inhaled theophylline",theophylline,Bronchodilator agent,small molecule,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,approved,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1826,1829,53,"adc4022, low-dose inhaled theophylline",theophylline,Bronchodilator agent,small molecule,-,-,P29275,aa2br_human,ADORA2B,GPCR;Rhodopsin,established,approved,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1827,1830,NRDD519,-,thiethylperazine,Antiemetics,small molecule,1961,1961,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1828,1831,NRDD519,-,thiethylperazine,Antiemetics,small molecule,1961,1961,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1829,1832,NRDD519,-,thiethylperazine,Antiemetics,small molecule,1961,1961,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1830,1833,NRDD519,-,thiethylperazine,Antiemetics,small molecule,1961,1961,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1831,1834,NRDD519,-,thiethylperazine,Antiemetics,small molecule,1961,1961,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1832,1835,NRDD519,-,thiethylperazine,Antiemetics,small molecule,1961,1961,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1833,1836,NRDD519,-,thiethylperazine,Antiemetics,small molecule,1961,1961,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1834,1837,NRDD519,-,thiethylperazine,Antiemetics,small molecule,1961,1961,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1835,1838,NRDD519,-,thiethylperazine,Antiemetics,small molecule,1961,1961,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1836,1839,NRDD519,-,thiethylperazine,Antiemetics,small molecule,1961,1961,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1837,1840,NRDD519,-,thiethylperazine,Antiemetics,small molecule,1961,1961,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1838,1841,NRDD521,-,thioridazine,Antipsychotic agent,small molecule,1962,1962,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1839,1842,NRDD521,-,thioridazine,Antipsychotic agent,small molecule,1962,1962,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1840,1843,NRDD521,-,thioridazine,Antipsychotic agent,small molecule,1962,1962,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1841,1844,NRDD521,-,thioridazine,Antipsychotic agent,small molecule,1962,1962,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1842,1845,NRDD522,-,thyrotropin alfa,Diagnostic Agents,protein,1998,1998,P16473,tshr_human,TSHR,GPCR;Rhodopsin,established,approved,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
1843,1846,2015,ticagrelor,ticagrelor,antithrombotic,small molecule,2011,2011,Q9H244,p2y12_human,P2RY12,GPCR;Rhodopsin,established,approved,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
1844,1847,NRDD525,-,ticlopidine,Platelet Aggregation Inhibitors,small molecule,1991,1991,Q9H244,p2y12_human,P2RY12,GPCR;Rhodopsin,established,approved,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
1845,1848,386,"brimonidine tartrate/timolol maleate,combigan",timolol,for treatment of glaucoma,small molecule,1978,1978,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1846,1849,386,"brimonidine tartrate/timolol maleate,combigan",timolol,for treatment of glaucoma,small molecule,1978,1978,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1847,1850,1095,"latanoprost + timolol,xalcom, xalacom",timolol,for treatment of glaucoma,small molecule,1978,1978,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1848,1851,1095,"latanoprost + timolol,xalcom, xalacom",timolol,for treatment of glaucoma,small molecule,1978,1978,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1849,1852,2071,"travoprost + timolol,extravan, duotrav",timolol,for treatment of glaucoma,small molecule,1978,1978,P08588,adrb1_human,ADRB1,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1850,1853,2071,"travoprost + timolol,extravan, duotrav",timolol,for treatment of glaucoma,small molecule,1978,1978,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1851,1854,MMAmay2016_0589,tiotropium + olodaterol,tiotropium,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,2004,2004,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1852,1855,MMAmay2016_0590,tiotropium + olodaterol,tiotropium,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,2004,2004,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1853,1856,MMAmay2016_0591,tiotropium + olodaterol,tiotropium,for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,2004,2004,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1854,1857,2019,"tiotropium bromide,spiriva",tiotropium,for treatment of cystic fibrosis; for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,2004,2004,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1855,1858,2019,"tiotropium bromide,spiriva",tiotropium,for treatment of cystic fibrosis; for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,2004,2004,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1856,1859,2019,"tiotropium bromide,spiriva",tiotropium,for treatment of cystic fibrosis; for treatment of chronic obstructive pulmonary disorder (COPD),small molecule,2004,2004,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1857,1860,1458,"nvd-422, tizanidine oral spray",tizanidine,for treatment of skeletal muscular spasticity,small molecule,1996,1996,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1858,1861,1458,"nvd-422, tizanidine oral spray",tizanidine,for treatment of skeletal muscular spasticity,small molecule,1996,1996,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1859,1862,1458,"nvd-422, tizanidine oral spray",tizanidine,for treatment of skeletal muscular spasticity,small molecule,1996,1996,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1860,1863,2021,"tizanidine hydrochloride,zanaflex",tizanidine,Muscle Relaxants,small molecule,1996,1996,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1861,1864,2021,"tizanidine hydrochloride,zanaflex",tizanidine,Muscle Relaxants,small molecule,1996,1996,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1862,1865,2021,"tizanidine hydrochloride,zanaflex",tizanidine,Muscle Relaxants,small molecule,1996,1996,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1863,1866,2028,tm30339,tm30339,Anti-obesity agent,small molecule,-,-,P50391,npy4r_human,PPYR1,GPCR;Rhodopsin,not established,in trial,Peptide ,Neuropeptide Y receptors,Class A (Rhodopsin)
1864,1867,2029,tm38837,tm38837,Anti-obesity agent,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1865,1868,NRDD530,-,tolazoline,Antihypertensive agent,small molecule,-,1948,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1866,1869,2013,thvd-201,tolterodine,for treatment of incontinence,small molecule,1998,1998,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1867,1870,2013,thvd-201,tolterodine,for treatment of incontinence,small molecule,1998,1998,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1868,1871,2013,thvd-201,tolterodine,for treatment of incontinence,small molecule,1998,1998,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1869,1872,2013,thvd-201,tolterodine,for treatment of incontinence,small molecule,1998,1998,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1870,1873,2013,thvd-201,tolterodine,for treatment of incontinence,small molecule,1998,1998,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1871,1874,2036,"tolterodine extended release capsules,detrol la",tolterodine ,for treatment of incontinence,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1872,1875,2036,"tolterodine extended release capsules,detrol la",tolterodine ,for treatment of incontinence,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1873,1876,2036,"tolterodine extended release capsules,detrol la",tolterodine ,for treatment of incontinence,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1874,1877,2036,"tolterodine extended release capsules,detrol la",tolterodine ,for treatment of incontinence,small molecule,-,-,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1875,1878,2036,"tolterodine extended release capsules,detrol la",tolterodine ,for treatment of incontinence,small molecule,-,-,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1876,1879,2037,"tolvaptan, opc-41061,samsca",tolvaptan,Antihypertensive agent,small molecule,2009,2009,P30518,v2r_human,AVPR2,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1877,1880,2038,tonabersat,tonabersat,Anti-migraine Agents,small molecule,-,-,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1878,1881,1926,syn-115,tozadenant,Antiparkinson agent,small molecule,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1879,1882,2049,tpi-asm8,tpi-asm8,Anti-Asthmatic Agents,antisense oligo,-,-,P51677,ccr3_human,CCR3,GPCR;Rhodopsin,not established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1880,1883,MMAmay2016_0676,e-58425,tramadol,Analgesics,small molecule,1995,1995,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1881,1884,MMAmay2016_0678,e-58425,tramadol,Analgesics,small molecule,1995,1995,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1882,1885,MMAmay2016_0679,e-58425,tramadol,Analgesics,small molecule,1995,1995,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1883,1886,1685,pti-601,tramadol,Analgesics,small molecule,1995,1995,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1884,1887,1685,pti-601,tramadol,Analgesics,small molecule,1995,1995,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1885,1888,1685,pti-601,tramadol,Analgesics,small molecule,1995,1995,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1886,1889,2055,"tramadol extended-release,raliva er",tramadol,Analgesics,small molecule,1995,1995,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1887,1890,2055,"tramadol extended-release,raliva er",tramadol,Analgesics,small molecule,1995,1995,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1888,1891,2055,"tramadol extended-release,raliva er",tramadol,Analgesics,small molecule,1995,1995,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1889,1892,2056,"tramadol hydrochloride,ultram",tramadol,Analgesics,small molecule,1995,1995,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1890,1893,2056,"tramadol hydrochloride,ultram",tramadol,Analgesics,small molecule,1995,1995,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1891,1894,2056,"tramadol hydrochloride,ultram",tramadol,Analgesics,small molecule,1995,1995,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1892,1895,2057,"tramadol,tridural, ryzolt",tramadol,Analgesics,small molecule,1995,1995,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1893,1896,2057,"tramadol,tridural, ryzolt",tramadol,Analgesics,small molecule,1995,1995,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1894,1897,2057,"tramadol,tridural, ryzolt",tramadol,Analgesics,small molecule,1995,1995,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,approved,Peptide ,Opioid receptors,Class A (Rhodopsin)
1895,1898,2071,"travoprost + timolol,extravan, duotrav",travoprost,for treatment of glaucoma,small molecule,2001,2001,P43088,pf2r_human,PTGFR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
1896,1899,MMAmay2016_0460,"lorexys, sip-104, bupropion/trazodone",trazodone,Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,small molecule,1981,1981,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1897,1900,MMAmay2016_0461,"lorexys, sip-104, bupropion/trazodone",trazodone,Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,small molecule,1981,1981,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1898,1901,MMAmay2016_0462,"lorexys, sip-104, bupropion/trazodone",trazodone,Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,small molecule,1981,1981,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1899,1902,2072,"trazodone extended release, dds-04a,oleptro",trazodone,Anti-depressant,small molecule,1981,1981,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1900,1903,2072,"trazodone extended release, dds-04a,oleptro",trazodone,Anti-depressant,small molecule,1981,1981,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1901,1904,2072,"trazodone extended release, dds-04a,oleptro",trazodone,Anti-depressant,small molecule,1981,1981,P28335,5ht2c_human,HTR2C,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1902,1905,2074,"trelanserin, sl 65.0472",trelanserin,for treatment of intermittent claudication,small molecule,-,-,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1903,1906,2074,"trelanserin, sl 65.0472",trelanserin,for treatment of intermittent claudication,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1904,1907,NRDD537,-,treprostinil,Antihypertensive agent; Antithrombotic Agents,small molecule,2002,2002,Q9H244,p2y12_human,P2RY12,GPCR;Rhodopsin,established,approved,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
1905,1908,MMA2016_0038,"transcon treprostinil, subcutaneous injection",treprostinil,for treatment of pulmonary arterial hypertension,small molecule,2002,2002,P43119,pi2r_human,PTGIR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
1906,1909,MMA2016_0040,"transcon treprostinil, subcutaneous injection",treprostinil,for treatment of pulmonary arterial hypertension,small molecule,2002,2002,Q9H244,p2y12_human,P2RY12,GPCR;Rhodopsin,established,approved,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
1907,1910,2767,"treprostinil inhaled/oral,tyvaso, viveta",treprostinil,for treatment of pulmonary arterial hypertension,small molecule,2002,2002,Q9H244,p2y12_human,P2RY12,GPCR;Rhodopsin,established,approved,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
1908,1911,2767,"treprostinil inhaled/oral,tyvaso, viveta",treprostinil,for treatment of pulmonary arterial hypertension,small molecule,2002,2002,P43119,pi2r_human,PTGIR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
1909,1912,2768,"treprostinil subcutaneous/intravenous,remodulin",treprostinil,for treatment of pulmonary arterial hypertension,small molecule,2002,2002,Q9H244,p2y12_human,P2RY12,GPCR;Rhodopsin,established,approved,Nucleotide ,P2Y receptors,Class A (Rhodopsin)
1910,1913,2768,"treprostinil subcutaneous/intravenous,remodulin",treprostinil,for treatment of pulmonary arterial hypertension,small molecule,2002,2002,P43119,pi2r_human,PTGIR,GPCR;Rhodopsin,established,approved,Lipid ,Prostanoid receptors,Class A (Rhodopsin)
1911,1914,NRDD540,-,tridihexethyl,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,small molecule,1954,1954,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1912,1915,NRDD540,-,tridihexethyl,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,small molecule,1954,1954,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1913,1916,NRDD540,-,tridihexethyl,GI Anti-Ulcer Agents; anticholinergic; Antispasmodics,small molecule,1954,1954,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1914,1917,NRDD541,-,trifluoperazine,Antiemetics; Antipsychotic agent,small molecule,1959,1959,P35348,ada1a_human,ADRA1A,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1915,1918,NRDD541,-,trifluoperazine,Antiemetics; Antipsychotic agent,small molecule,1959,1959,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1916,1919,NRDD542,-,triflupromazine,Antiemetics; Antipsychotic agent,small molecule,-,1957,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1917,1920,NRDD542,-,triflupromazine,Antiemetics; Antipsychotic agent,small molecule,-,1957,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1918,1921,NRDD542,-,triflupromazine,Antiemetics; Antipsychotic agent,small molecule,-,1957,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1919,1922,NRDD542,-,triflupromazine,Antiemetics; Antipsychotic agent,small molecule,-,1957,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
1920,1923,NRDD542,-,triflupromazine,Antiemetics; Antipsychotic agent,small molecule,-,1957,P41595,5ht2b_human,HTR2B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1921,1924,NRDD543,-,trihexyphenidyl,Antiparkinson agents,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1922,1925,NRDD545,-,trimeprazine,Antipruritics,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1923,1926,NRDD550,-,tripelennamine,Anti-Allergic Agents,small molecule,1948,1948,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1924,1927,NRDD551,-,triprolidine,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,approved,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1925,1928,2084,"triptorelin pamoate,trelstar, decapeptyl, salvacyl, moapar, pamorelin",triptorelin pamoate,Antineoplastic agent; chemical castration agent,peptide,2000,2000,P30968,gnrhr_human,GNRHR,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
1926,1929,2084,"triptorelin pamoate,trelstar, decapeptyl, salvacyl, moapar, pamorelin",triptorelin pamoate,Antineoplastic agent; chemical castration agent,peptide,2000,2000,Q96P88,gnrr2_human,GNRHR2,GPCR;Rhodopsin,established,approved,Peptide ,Gonadotrophin-releasing hormone receptors,Class A (Rhodopsin)
1927,1930,NRDD552,-,tropicamide,Diagnostic Agents; Mydriatics,small molecule,1960,1960,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1928,1931,2086,"trospium chloride,sanctura",trospium,for treatment of incontinence,small molecule,-,-,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1929,1932,2086,"trospium chloride,sanctura",trospium,for treatment of incontinence,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1930,1933,2086,"trospium chloride,sanctura",trospium,for treatment of incontinence,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1931,1934,2086,"trospium chloride,sanctura",trospium,for treatment of incontinence,small molecule,-,-,P08173,acm4_human,CHRM4,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1932,1935,2086,"trospium chloride,sanctura",trospium,for treatment of incontinence,small molecule,-,-,P08912,acm5_human,CHRM5,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1933,1936,2350,alks,trospium chloride,for treatment of chronic pulmonary obstructive disorder,small molecule,2004,2004,P11229,acm1_human,CHRM1,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1934,1937,2279,trv120027,trv120027,Antihypertensive agent,protein,-,-,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,in trial,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
1935,1938,MMAmay2016_0607,trv130,trv130,Analgesics; post-operative pain,small molecule,-,-,P35372,oprm_human,OPRM1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
1936,1939,MMAapril2016_0140,trv734,trv734,Analgesics,small molecule,-,-,P41145,oprk_human,OPRK1,GPCR;Rhodopsin,established,in trial,Peptide ,Opioid receptors,Class A (Rhodopsin)
1937,1940,2090,"ts-032, pf-4802540","ts-032, pf-4802540",Antipsychotic agent,unknown,-,-,Q14416,grm2_human,GRM2,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
1938,1941,2090,"ts-032, pf-4802540","ts-032, pf-4802540",Antipsychotic agent,unknown,-,-,Q14832,grm3_human,GRM3,GPCR;Glutamate,not established,in trial,Amino acid ,Metabotropic glutamate receptors,Class C (Glutamate) 
1939,1942,2092,tt-223,tt-223,Antidiabetic; injectable islet neogenesis therapy for diabetes,injectible islet neogenesis therapy,-,-,P32239,gasr_human,CCKBR,GPCR;Rhodopsin,established,in trial,Peptide ,Cholecystokinin receptors,Class A (Rhodopsin)
1940,1943,2092,tt-223,tt-223,Antidiabetic; injectable islet neogenesis therapy for diabetes,injectible islet neogenesis therapy,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1941,1944,MMAmay2016_0612,tt-401,tt-401,Antidiabetic; anti-obesity,peptide,-,-,P47871,glr_human,GCGR,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1942,1945,MMAmay2016_0613,tt-401,tt-401,Antidiabetic; anti-obesity,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1943,1946,MMAmay2016_0113,ttp054,ttp054,Antidiabetic agent; Type 2,small molecule,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1944,1947,MMAmar2016_0255,ttp273,ttp273,Antidiabetic,small molecule,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1945,1948,MMAmay2016_0617,"txa127, angiotensin (1-7)","txa127, angiotensin (1-7)",for stem cell engraftment and thrombocytopenia,peptide,-,-,P04201,mas_human,MAS1,GPCR;Rhodopsin,not established,in trial,Orphan ,Class A orphans,Class A (Rhodopsin)
1946,1949,2095,tzp-101,tzp-101,for treatment of gastroparesis,small molecule,-,-,Q92847,ghsr_human,GHSR,GPCR;Rhodopsin,not established,in trial,Peptide ,Ghrelin receptors,Class A (Rhodopsin)
1947,1950,2096,tzp-102,tzp-102,for treatment of gastroparesis,small molecule,-,-,Q92847,ghsr_human,GHSR,GPCR;Rhodopsin,not established,in trial,Peptide ,Ghrelin receptors,Class A (Rhodopsin)
1948,1951,MMAmar2016_0193,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",umeclidinium,Anticholinergic; treatment of COPD,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1949,1952,MMAmar2016_0194,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",umeclidinium,Anticholinergic; treatment of COPD,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1950,1953,MMAmay2016_0713,"incruse ellipta,  umeclidinium bromide",umeclidinium,Anticholinergic; treatment of COPD,small molecule,-,-,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1951,1954,MMAmay2016_0714,"incruse ellipta,  umeclidinium bromide",umeclidinium,Anticholinergic; treatment of COPD,small molecule,-,-,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1952,1955,MMAmay2016_0618,umeclidinium bromide (gsk573719) + vilanterol (gw642444),umeclidinium bromide (gsk573719),Bronchodilator agent; COPD,small molecule,-,2013,P08172,acm2_human,CHRM2,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1953,1956,MMAmay2016_0618,umeclidinium bromide (gsk573719) + vilanterol (gw642444),umeclidinium bromide (gsk573719),Bronchodilator agent; COPD,small molecule,-,2013,P20309,acm3_human,CHRM3,GPCR;Rhodopsin,established,approved,Aminergic ,Acetylcholine receptors (muscarinic),Class A (Rhodopsin)
1954,1957,2105,"urocortin 2, 358-086-15",urocortin 2,for treatment of congestive heart failure,peptide,-,-,Q13324,crfr2_human,CRHR2,GPCR;Secretin,not established,in trial,Peptide ,Corticotropin-releasing factor receptors,Class B1 (Secretin)
1955,1958,NRDD554,-,urofollitropin,Fertility Agents,protein,-,1986,P23945,fshr_human,FSHR,GPCR;Rhodopsin,established,approved,Protein ,Glycoprotein hormone receptors,Class A (Rhodopsin)
1956,1959,2112,v24343,v24343,Anti-obesity agent,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
1957,1960,MMAmay2016_0766,v81444,v81444,Antiparkinson agent,small molecule,-,-,P29274,aa2ar_human,ADORA2A,GPCR;Rhodopsin,established,in trial,Nucleotide ,Adenosine receptors,Class A (Rhodopsin)
1958,1961,2115,va106483,va106483,for treatment of BPH-related urinary symptoms,small molecule,-,-,P30518,v2r_human,AVPR2,GPCR;Rhodopsin,established,in trial,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1959,1962,2116,va111913,va111913,for treatment of dysmenorrhea,small molecule,-,-,P37288,v1ar_human,AVPR1A,GPCR;Rhodopsin,established,in trial,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1960,1963,2116,va111913,va111913,for treatment of dysmenorrhea,small molecule,-,-,P47901,v1br_human,AVPR1B,GPCR;Rhodopsin,established,in trial,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1961,1964,2116,va111913,va111913,for treatment of dysmenorrhea,small molecule,-,-,P30518,v2r_human,AVPR2,GPCR;Rhodopsin,established,in trial,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1962,1965,MMAmay2016_0742,sacubitril + valsartan,valsartan,Antihypertensive agent,small molecule,2015,2015,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,approved,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
1963,1966,2122,"valsartan,diovan",valsartan,Antihypertensive agent,small molecule,2015,2015,P30556,agtr1_human,AGTR1,GPCR;Rhodopsin,established,approved,Peptide ,Angiotensin receptors,Class A (Rhodopsin)
1964,1967,2123,"vapitadine dihydrochloride,hivenyl",vapitadine,Anti-Allergic Agents,small molecule,-,-,P35367,hrh1_human,HRH1,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
1965,1968,2124,"vapreotide, debio 8609,sanvar, docrised",vapreotide,for treatment of liver cirrhosis-related variceal bleeding,small molecule,-,-,P30874,ssr2_human,SSTR2,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1966,1969,2124,"vapreotide, debio 8609,sanvar, docrised",vapreotide,for treatment of liver cirrhosis-related variceal bleeding,small molecule,-,-,P35346,ssr5_human,SSTR5,GPCR;Rhodopsin,established,approved,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
1967,1970,288,"aviptadil,invicorp",vasoactive intestinal peptide,for treatment of erectile dysfunction,peptide,-,-,P32241,vipr1_human,VIPR1,GPCR;Secretin,not established,in trial,Peptide ,VIP and PACAP receptors,Class B1 (Secretin)
1968,1971,288,"aviptadil,invicorp",vasoactive intestinal peptide,for treatment of erectile dysfunction,peptide,-,-,P41587,vipr2_human,VIPR2,GPCR;Rhodopsin,not established,in trial,Peptide ,VIP and PACAP receptors,Class B1 (Secretin)
1969,1972,MMAmay2016_0630,"vasomera, pb1046","vasomera, pb1046",Antihypertensive agent,peptide,-,-,P41587,vipr2_human,VIPR2,GPCR;Rhodopsin,not established,in trial,Peptide ,VIP and PACAP receptors,Class B1 (Secretin)
1970,1973,NRDD560,-,vasopressin,Antidiuretic Agents,peptide,-,-,P37288,v1ar_human,AVPR1A,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1971,1974,NRDD560,-,vasopressin,Antidiuretic Agents,peptide,-,-,P47901,v1br_human,AVPR1B,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1972,1975,NRDD560,-,vasopressin,Antidiuretic Agents,peptide,-,-,P30518,v2r_human,AVPR2,GPCR;Rhodopsin,established,approved,Peptide ,Vasopressin and oxytocin receptors,Class A (Rhodopsin)
1973,1976,2144,"velneperit, s-2367",velneperit,Anti-obesity agent,small molecule,-,-,Q15761,npy5r_human,NPY5R,GPCR;Rhodopsin,not established,in trial,Peptide ,Neuropeptide Y receptors,Class A (Rhodopsin)
1974,1977,2145,"velusetrag, td-5108",velusetrag,motilitant,small molecule,-,-,Q13639,5ht4r_human,HTR4,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1975,1978,MMA2016_0047,"verucerfont, nbi-77860","verucerfont, nbi-77860",For treatment of Congenital Adrenal Hyperplasia,small molecule,-,-,P34998,crfr1_human,CRHR1,GPCR;Secretin,not established,in trial,Peptide ,Corticotropin-releasing factor receptors,Class B1 (Secretin)
1976,1979,2148,"vestipitant, gw 597599",vestipitant,for treatment of tinnitus; hypnotic,small molecule,-,-,P25103,nk1r_human,TACR1,GPCR;Rhodopsin,established,in trial,Peptide ,Tachykinin receptors,Class A (Rhodopsin)
1977,1980,MMAmay2016_0133,viaderm-glp1 agonist,viaderm-glp1 agonist,Antidiabetic agent; Type 2,small molecule,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1978,1981,2157,vicriviroc,vicriviroc,antiviral agent; HIV,small molecule,-,-,P51681,ccr5_human,CCR5,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1979,1982,2159,"vigabatrin is a selective, irreversible enzyme-activated gaba transaminase inhibitor. gaba (gamma-aminobutyric acid) is a n/",vigabatrin,for treatment of addiction,small molecule,2009,2009,Q9UBS5,gabr1_human,GABBR1,GPCR;Glutamate,established,approved,Amino acid ,GABAB receptors,Class C (Glutamate) 
1980,1983,MMAmar2016_0195,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",vilanterol,for treatment of chronic obstructive pulmonary disease (COPD),small molecule,2013,2013,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1981,1984,MMAmay2016_0779,fluticasone furoate and vilanterol inhalation powder,vilanterol,for treatment of chronic obstructive pulmonary disease (COPD),small molecule,2013,2013,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1982,1985,MMAmay2016_0619,umeclidinium bromide (gsk573719) + vilanterol (gw642444),vilanterol (gw642444),for treatment of chronic obstructive pulmonary disease (COPD),small molecule,-,2013,P07550,adrb2_human,ADRB2,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
1983,1986,2160,"vilazodone hydrochloride, sb 659746a",vilazodone ,Anti-depressant,small molecule,2011,2011,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1984,1987,2822,"gdc-0449, hedgehog pathway inhibitor",vismodegib,Antineoplastic agent,small molecule,2012,2012,Q99835,smo_human,SMO,GPCR;Frizzled,established,approved,Protein ,Frizzled,Class F (Frizzled)
1985,1988,2170,"vofopitant, gr-205171",vofopitant,for treatment of post-traumatic stress disorder; hypnotic,small molecule,-,-,P25103,nk1r_human,TACR1,GPCR;Rhodopsin,established,in trial,Peptide ,Tachykinin receptors,Class A (Rhodopsin)
1986,1989,2172,volinanserin,volinanserin,Hypnotics and Sedatives,small molecule,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1987,1990,2175,"vorapaxar , sch-530348",vorapaxar,cardiovascular agent,small molecule,2014,2014,P25116,par1_human,F2R,GPCR;Rhodopsin,established,approved,Peptide ,Proteinase-activated receptors,Class A (Rhodopsin)
1988,1991,2175,"vorapaxar , sch-530348",vorapaxar,cardiovascular agent,small molecule,2014,2014,O00254,par3_human,F2RL2,GPCR;Rhodopsin,established,approved,Peptide ,Proteinase-activated receptors,Class A (Rhodopsin)
1989,1992,2175,"vorapaxar , sch-530348",vorapaxar,cardiovascular agent,small molecule,2014,2014,Q96RI0,par4_human,F2RL3,GPCR;Rhodopsin,established,approved,Peptide ,Proteinase-activated receptors,Class A (Rhodopsin)
1990,1993,1171,lu aa21004,vortioxetine,Anti-depressant,small molecule,2013,2013,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1991,1994,1171,lu aa21004,vortioxetine,Anti-depressant,small molecule,2013,2013,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1992,1995,1171,lu aa21004,vortioxetine,Anti-depressant,small molecule,2013,2013,P34969,5ht7r_human,HTR7,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1993,1996,MMAmay2016_0635,"vpd-737, serlopitant","vpd-737, serlopitant",for treatment of pruritus,small molecule,-,-,P25103,nk1r_human,TACR1,GPCR;Rhodopsin,established,in trial,Peptide ,Tachykinin receptors,Class A (Rhodopsin)
1994,1997,2179,vr-147,vr-147,Anti-migraine Agents,small molecule,-,-,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1995,1998,2179,vr-147,vr-147,Anti-migraine Agents,small molecule,-,-,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
1996,1999,2182,vrs-859,vrs-859,Antidiabetic,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
1997,2000,MMAmay2016_0803,vsn16r,vsn16r,Antispasmodics;  for spatisity related to multiple sclerosis,small molecule,-,-,Q9Y2T6,gpr55_human,GPR55,GPCR;Rhodopsin,not established,in trial,Lipid ,"GPR18, GPR55 and GPR119",Class A (Rhodopsin)
1998,2001,MMAapril2016_0220,x4p-001,x4p-001,Antineoplastic agent; renal cell carcinoma,small molecule,-,-,P61073,cxcr4_human,CXCR4,GPCR;Rhodopsin,established,in trial,Protein ,Chemokine receptors,Class A (Rhodopsin)
1999,2002,2200,"xaliproden, sr 57746a",xaliproden,neuroprotectant,small molecule,-,-,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
2000,2003,2223,xp21279,xp21279,Antiparkinson agent,small molecule,-,-,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
2001,2004,2223,xp21279,xp21279,Antiparkinson agent,small molecule,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
2002,2005,2223,xp21279,xp21279,Antiparkinson agent,small molecule,-,-,P35462,drd3_human,DRD3,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
2003,2006,2223,xp21279,xp21279,Antiparkinson agent,small molecule,-,-,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
2004,2007,2223,xp21279,xp21279,Antiparkinson agent,small molecule,-,-,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
2005,2008,MMAmay2016_0641,ykp10811,ykp10811,for chronic or functional constipation,small molecule,-,-,Q13639,5ht4r_human,HTR4,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
2006,2009,2226,ykp-1358,ykp-1358,Antipsychotic agent,unknown,-,-,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
2007,2010,2226,ykp-1358,ykp-1358,Antipsychotic agent,unknown,-,-,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,in trial,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
2008,2011,2229,ym-178,ym-178,for treatment of overactive bladder,small molecule,-,-,P13945,adrb3_human,ADRB3,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
2009,2012,MMAmay2016_0790,"ym178, mirabegron","ym178, mirabegron",for treatment of incontinence,small molecule,2012,2012,P13945,adrb3_human,ADRB3,GPCR;Rhodopsin,established,approved,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
2010,2013,2230,ym-598,ym-598,Antineoplastic agent,small molecule,-,-,P25101,ednra_human,EDNRA,GPCR;Rhodopsin,established,in trial,Peptide ,Endothelin receptors,Class A (Rhodopsin)
2011,2014,NRDD564,-,yohimbine,Mydriatics; Anti-impotence Agents,small molecule,-,-,P08913,ada2a_human,ADRA2A,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
2012,2015,NRDD564,-,yohimbine,Mydriatics; Anti-impotence Agents,small molecule,-,-,P18089,ada2b_human,ADRA2B,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
2013,2016,NRDD564,-,yohimbine,Mydriatics; Anti-impotence Agents,small molecule,-,-,P18825,ada2c_human,ADRA2C,GPCR;Rhodopsin,established,in trial,Aminergic ,Adrenoceptors,Class A (Rhodopsin)
2014,2017,2232,"yttrium-90 edotreotide,onalta",yttrium-90 edotreotide,Antineoplastic agent,peptide,-,-,P30872,ssr1_human,SSTR1,GPCR;Rhodopsin,established,in trial,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
2015,2018,2232,"yttrium-90 edotreotide,onalta",yttrium-90 edotreotide,Antineoplastic agent,peptide,-,-,P30874,ssr2_human,SSTR2,GPCR;Rhodopsin,established,in trial,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
2016,2019,2232,"yttrium-90 edotreotide,onalta",yttrium-90 edotreotide,Antineoplastic agent,peptide,-,-,P35346,ssr5_human,SSTR5,GPCR;Rhodopsin,established,in trial,Peptide ,Somatostatin receptors,Class A (Rhodopsin)
2017,2020,2235,"zafirlukast,accolate",zafirlukast,Anti-Asthmatic Agents,small molecule,1996,1996,Q9Y271,cltr1_human,CYSLTR1,GPCR;Rhodopsin,established,approved,Lipid ,Leukotriene receptors,Class A (Rhodopsin)
2018,2021,2241,"zibotentan, zd-4054, azd-4054",zibotentan,Antineoplastic agent,small molecule,-,-,P25101,ednra_human,EDNRA,GPCR;Rhodopsin,established,in trial,Peptide ,Endothelin receptors,Class A (Rhodopsin)
2019,2022,1176,lu-31130,zicronapine,Antipsychotic agent,small molecule,-,-,P21917,drd4_human,DRD4,GPCR;Rhodopsin,established,in trial,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
2020,2023,2243,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",ziprasidone ,Antipsychotic agent,small molecule,2001,2001,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
2021,2024,2243,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",ziprasidone ,Antipsychotic agent,small molecule,2001,2001,P28223,5ht2a_human,HTR2A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
2022,2025,2246,"zolmitriptan,zomig",zolmitriptan,Anti-migraine Agents,small molecule,1997,1997,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
2023,2026,2246,"zolmitriptan,zomig",zolmitriptan,Anti-migraine Agents,small molecule,1997,1997,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
2024,2027,2246,"zolmitriptan,zomig",zolmitriptan,Anti-migraine Agents,small molecule,1997,1997,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
2025,2028,2246,"zolmitriptan,zomig",zolmitriptan,Anti-migraine Agents,small molecule,1997,1997,P30939,5ht1f_human,HTR1F,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
2026,2029,MMAapril2016_0110,zp-triptan,zolmitriptan,Anti-migraine Agents,small molecule,1997,1997,P08908,5ht1a_human,HTR1A,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
2027,2030,MMAapril2016_0111,zp-triptan,zolmitriptan,Anti-migraine Agents,small molecule,1997,1997,P28221,5ht1d_human,HTR1D,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
2028,2031,MMAapril2016_0112,zp-triptan,zolmitriptan,Anti-migraine Agents,small molecule,1997,1997,P28222,5ht1b_human,HTR1B,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
2029,2032,MMAapril2016_0113,zp-triptan,zolmitriptan,Anti-migraine Agents,small molecule,1997,1997,P30939,5ht1f_human,HTR1F,GPCR;Rhodopsin,established,approved,Aminergic ,5-Hydroxytryptamine receptors,Class A (Rhodopsin)
2030,2033,2251,zp1848,zp1848,for treatment of Crohn's disease,peptide,-,-,O95838,glp2r_human,GLP2R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
2031,2034,MMAmar2016_0120,"zpl-389, zpl-3893787","zpl-389, zpl-3893787",Anti-inflammatory agent; atopic dermatitis,small molecule,-,-,Q9H3N8,hrh4_human,HRH4,GPCR;Rhodopsin,established,in trial,Aminergic ,Histamine receptors,Class A (Rhodopsin)
2032,2035,NRDD567,-,zuclopenthixol,Antipsychotic agent,small molecule,-,1962,P21728,drd1_human,DRD1,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
2033,2036,NRDD567,-,zuclopenthixol,Antipsychotic agent,small molecule,-,1962,P14416,drd2_human,DRD2,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
2034,2037,NRDD567,-,zuclopenthixol,Antipsychotic agent,small molecule,-,1962,P21918,drd5_human,DRD5,GPCR;Rhodopsin,established,approved,Aminergic ,Dopamine receptors,Class A (Rhodopsin)
2035,2038,2256,zyd1,zyd1,Antidiabetic,peptide,-,-,P43220,glp1r_human,GLP1R,GPCR;Secretin,established,in trial,Peptide ,Glucagon receptor family,Class B1 (Secretin)
2036,2039,MMAapril2016_0296,zyn002,zyn002,Anticonvulsants; Antiepileptics,small molecule,-,-,P21554,cnr1_human,CNR1,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
2037,2040,MMAapril2016_0297,zyn002,zyn002,Anticonvulsants; Antiepileptics,small molecule,-,-,P34972,cnr2_human,CNR2,GPCR;Rhodopsin,established,in trial,Lipid ,Cannabinoid receptors,Class A (Rhodopsin)
